data_2ki0_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ki0 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.4 t . . . . . 0 C--O 1.235 0.301 0 CA-C-O 121.746 0.784 . . . . 0.0 109.371 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -159.63 176.67 11.74 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 127.46 2.304 . . . . 0.0 106.826 -173.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.4 m -139.91 155.63 47.08 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 -176.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.447 HG12 ' H ' ' A' ' 32' ' ' THR . 2.9 pt -121.02 167.37 14.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 125.022 1.329 . . . . 0.0 108.792 -172.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.26 43.37 1.12 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.71 0.804 . . . . 0.0 109.35 173.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.2 m -75.27 150.39 6.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 O-C-N 121.189 -0.945 . . . . 0.0 110.319 -177.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -88.07 33.69 3.97 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 124.867 1.222 . . . . 0.0 112.271 178.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 61.37 38.52 95.86 Favored Glycine 0 CA--C 1.531 1.037 0 CA-C-N 117.576 0.688 . . . . 0.0 112.976 174.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.3 m -62.79 136.12 96.21 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 172.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -51.32 -32.88 43.44 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 122.766 2.311 . . . . 0.0 113.801 177.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -73.51 -39.19 65.0 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.702 0.401 . . . . 0.0 110.14 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -77.07 -36.15 56.1 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -177.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 34.2 mt -59.41 -26.61 65.3 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.419 1.088 . . . . 0.0 111.451 169.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -83.81 -63.94 1.26 Allowed 'General case' 0 C--N 1.339 0.147 0 CA-C-N 119.237 0.926 . . . . 0.0 109.046 174.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -61.81 -49.21 77.22 Favored 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 122.75 0.42 . . . . 0.0 111.466 -169.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 52.4 mt -75.8 -30.29 59.0 Favored 'General case' 0 C--O 1.226 -0.134 0 CA-C-O 119.124 -0.465 . . . . 0.0 110.255 -171.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -62.95 -38.76 92.36 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.225 0.921 . . . . 0.0 110.059 169.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -61.88 -42.87 99.58 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 118.762 0.71 . . . . 0.0 109.938 174.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -62.35 -39.31 92.72 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.361 0.982 . . . . 0.0 111.23 175.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.34 -46.34 90.27 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 118.771 0.714 . . . . 0.0 110.319 175.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 43.1 mtpt -66.75 -37.24 84.23 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 122.982 0.513 . . . . 0.0 110.904 177.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -83.7 -33.12 25.22 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 118.755 -0.641 . . . . 0.0 112.035 -170.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -128.52 5.65 5.66 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.858 0.863 . . . . 0.0 113.081 -169.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 64.84 3.64 2.12 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.555 1.942 . . . . 0.0 114.309 178.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.0 pp -65.11 156.4 5.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 123.777 0.831 . . . . 0.0 111.577 -173.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 51.5 mtt85 -71.1 143.59 50.58 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -176.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.9 m -141.13 141.76 30.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 169.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.447 ' H ' HG12 ' A' ' 8' ' ' ILE . 19.7 m -145.06 130.16 18.46 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 175.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -120.93 110.99 16.95 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 -169.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 11.9 m-90 -86.75 148.2 25.52 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -85.81 44.68 3.38 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 169.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.6 t70 . . . . . 0 C--O 1.25 1.086 0 C-N-CA 125.022 1.329 . . . . 0.0 111.397 -173.397 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.7 t . . . . . 0 C--O 1.235 0.31 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -149.13 178.84 8.37 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 124.443 1.097 . . . . 0.0 110.089 -174.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 38.3 m -132.28 153.4 50.71 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 169.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.406 HG12 ' H ' ' A' ' 32' ' ' THR . 5.3 pt -126.2 170.34 16.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 125.443 1.497 . . . . 0.0 108.109 -174.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.3 34.9 0.88 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.302 0.572 . . . . 0.0 111.092 174.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.3 m -74.33 158.37 5.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 O-C-N 121.205 -0.935 . . . . 0.0 109.769 176.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -169.72 154.97 24.55 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 108.521 -1.832 . . . . 0.0 108.521 169.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 51.54 28.76 22.52 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 124.385 0.993 . . . . 0.0 114.29 178.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 26.4 m -138.63 74.91 38.63 Favored Pre-proline 0 CA--C 1.537 0.446 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 -170.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -59.55 -27.51 85.15 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.327 2.018 . . . . 0.0 111.778 -177.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -63.6 -17.32 62.75 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.392 1.077 . . . . 0.0 112.168 -178.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -126.92 -34.56 2.35 Favored 'General case' 0 C--N 1.34 0.172 0 C-N-CA 123.453 0.701 . . . . 0.0 111.262 -177.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.16 -25.43 68.34 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 119.47 1.032 . . . . 0.0 110.155 173.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -68.47 -42.88 78.09 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.803 1.183 . . . . 0.0 110.79 173.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -75.29 -29.69 60.17 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.325 0.966 . . . . 0.0 111.536 178.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.0 mt -72.71 -34.87 67.41 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.445 1.021 . . . . 0.0 109.916 172.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.7 mmtt -60.02 -45.41 92.87 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 119.51 1.05 . . . . 0.0 109.829 169.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -57.82 -46.04 85.29 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.575 0.75 . . . . 0.0 109.717 177.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -60.73 -41.64 95.72 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.227 0.921 . . . . 0.0 110.704 176.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.95 -2.96 11.07 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 177.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -117.19 -26.12 6.88 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.978 1.311 . . . . 0.0 109.806 175.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.0 tttm -72.43 -39.95 67.46 Favored 'General case' 0 C--O 1.23 0.073 0 C-N-CA 124.844 1.258 . . . . 0.0 109.521 173.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -133.64 167.88 19.7 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.873 1.669 . . . . 0.0 108.954 178.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -78.82 4.04 15.08 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.722 1.209 . . . . 0.0 113.114 -174.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.1 pp -59.75 151.58 5.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 121.997 0.904 . . . . 0.0 112.978 -169.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.13 144.38 42.86 Favored 'General case' 0 C--O 1.23 0.076 0 C-N-CA 124.003 0.921 . . . . 0.0 109.05 178.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.1 m -143.46 153.76 16.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 125.79 1.636 . . . . 0.0 107.156 169.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.406 ' H ' HG12 ' A' ' 8' ' ' ILE . 25.6 m -146.75 141.65 26.95 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 173.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -128.39 111.83 13.75 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -169.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 18.6 m-90 -86.67 156.11 20.12 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 122.838 0.455 . . . . 0.0 110.679 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -83.46 48.49 4.05 Favored Glycine 0 CA--C 1.529 0.969 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 170.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.7 t70 . . . . . 0 C--O 1.247 0.942 0 C-N-CA 124.918 1.287 . . . . 0.0 111.513 -173.869 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.7 t . . . . . 0 CA--C 1.538 0.519 0 CA-C-O 121.574 0.702 . . . . 0.0 109.818 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.32 179.43 6.4 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.408 1.883 . . . . 0.0 106.945 170.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.8 m -140.05 152.27 46.07 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 126.456 1.902 . . . . 0.0 106.426 178.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.433 HG12 ' H ' ' A' ' 32' ' ' THR . 13.6 pt -128.33 170.82 17.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 125.052 1.341 . . . . 0.0 108.6 -170.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -150.89 37.88 0.65 Allowed 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 121.727 0.775 . . . . 0.0 110.335 176.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 27.2 m -68.75 152.36 9.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 O-C-N 121.325 -0.86 . . . . 0.0 111.42 -177.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -158.28 41.14 0.51 Allowed Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.071 1.32 . . . . 0.0 110.719 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 162.1 -170.49 37.77 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 108.979 -1.649 . . . . 0.0 108.979 -175.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.5 m 58.38 73.83 0.68 Allowed Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 124.954 1.301 . . . . 0.0 110.061 176.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -58.64 -23.37 65.23 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.396 2.064 . . . . 0.0 112.924 -177.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -62.7 -43.39 98.92 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.346 0.521 . . . . 0.0 110.191 172.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -74.92 -32.11 61.71 Favored 'General case' 0 N--CA 1.438 -1.069 0 C-N-CA 124.085 0.954 . . . . 0.0 109.721 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 78.3 mt -60.36 -43.67 96.32 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-N 120.086 1.312 . . . . 0.0 108.718 172.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -64.42 -47.23 79.92 Favored 'General case' 0 C--N 1.339 0.114 0 CA-C-O 119.212 -0.423 . . . . 0.0 110.323 176.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -63.18 -45.7 90.58 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.995 0.816 . . . . 0.0 111.091 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 73.2 mt -66.69 -37.23 84.31 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 118.815 0.734 . . . . 0.0 110.108 178.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -60.52 -41.06 93.64 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 119.194 0.906 . . . . 0.0 110.606 171.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -63.06 -40.89 99.02 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 118.707 0.685 . . . . 0.0 110.444 177.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -62.29 -41.57 98.61 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 119.472 1.033 . . . . 0.0 110.809 174.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.02 -45.34 95.18 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-N 118.623 0.647 . . . . 0.0 110.545 176.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -66.23 -35.55 80.71 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 119.072 -0.49 . . . . 0.0 111.044 177.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -81.64 -39.53 24.27 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.812 0.733 . . . . 0.0 111.748 -172.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -117.3 4.96 12.58 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.582 0.753 . . . . 0.0 112.855 -170.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 55.4 t30 65.54 1.32 1.66 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 127.141 2.177 . . . . 0.0 114.186 -178.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.7 pp -63.3 147.1 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 124.095 0.958 . . . . 0.0 111.079 -174.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -78.64 133.93 37.21 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.5 m -120.15 155.51 23.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 125.064 1.346 . . . . 0.0 108.396 173.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.433 ' H ' HG12 ' A' ' 8' ' ' ILE . 0.8 OUTLIER -137.94 92.57 2.68 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -169.728 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -92.43 93.98 8.87 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -175.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 5.9 m-90 -66.33 -46.31 77.29 Favored 'General case' 0 C--O 1.232 0.153 0 O-C-N 122.341 -0.224 . . . . 0.0 110.724 173.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.49 -50.14 3.14 Favored Glycine 0 CA--C 1.531 1.084 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -169.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.0 t70 . . . . . 0 C--O 1.249 1.037 0 C-N-CA 126.818 2.047 . . . . 0.0 108.259 169.52 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.9 t . . . . . 0 C--O 1.235 0.307 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 30.7 ptt-85 -160.58 -178.14 6.68 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.896 1.278 . . . . 0.0 108.704 -176.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.8 m -116.15 154.71 29.53 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 171.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 11.0 pt -120.99 174.98 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.985 1.314 . . . . 0.0 109.038 -171.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.9 68.31 0.88 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 175.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.8 m -122.33 166.04 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 177.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -169.25 -26.24 0.02 OUTLIER Glycine 0 CA--C 1.527 0.839 0 CA-C-N 115.623 -0.717 . . . . 0.0 113.879 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -157.95 38.61 0.53 Allowed Glycine 0 CA--C 1.527 0.798 0 C-N-CA 124.022 0.82 . . . . 0.0 111.274 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.5 p -68.33 159.72 79.31 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 123.806 0.842 . . . . 0.0 109.967 177.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -54.08 -41.73 73.05 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.783 2.322 . . . . 0.0 112.719 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -161.11 2.91 0.06 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.248 1.019 . . . . 0.0 112.692 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -68.95 -28.09 66.32 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 120.2 1.364 . . . . 0.0 110.501 -175.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.3 mt -51.18 -39.62 56.83 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 125.168 1.387 . . . . 0.0 109.755 169.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -71.43 -45.35 62.9 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-N 118.655 0.661 . . . . 0.0 109.46 -177.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.0 mmtt -64.0 -46.22 85.53 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -177.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 92.6 mt -73.08 -38.28 66.47 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 118.795 -0.621 . . . . 0.0 110.112 -176.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.9 tptt -59.84 -40.15 87.56 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.402 1.001 . . . . 0.0 110.848 170.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -63.7 -43.58 96.2 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 119.084 0.856 . . . . 0.0 110.077 176.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -60.7 -35.09 75.42 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 120.143 1.338 . . . . 0.0 111.686 177.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.78 -23.78 65.28 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.04 0.836 . . . . 0.0 112.099 173.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -104.84 -20.72 13.5 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.068 1.347 . . . . 0.0 111.776 -177.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -110.69 -20.34 12.55 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 119.324 0.965 . . . . 0.0 112.358 -173.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -129.97 0.06 4.75 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.231 1.412 . . . . 0.0 111.539 178.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 63.77 6.94 2.92 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 127.05 2.14 . . . . 0.0 114.316 177.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.3 pp -65.03 157.0 5.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 O-C-N 121.63 -0.668 . . . . 0.0 111.878 -171.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 96.9 mtt-85 -67.35 142.11 56.89 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 22.6 m -137.61 151.96 26.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 173.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.8 m -146.18 130.91 17.97 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -125.16 112.48 16.5 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -169.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 8.2 m-90 -78.29 158.31 28.93 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.889 0.876 . . . . 0.0 110.533 178.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -82.53 48.06 3.89 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 109.866 -1.293 . . . . 0.0 109.866 169.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.2 t70 . . . . . 0 C--O 1.247 0.935 0 C-N-CA 124.914 1.286 . . . . 0.0 111.363 -174.228 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.1 t . . . . . 0 C--O 1.235 0.299 0 CA-C-O 121.782 0.801 . . . . 0.0 110.111 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -151.41 174.94 12.76 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 126.196 1.798 . . . . 0.0 108.69 -174.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.8 m -136.69 147.74 46.96 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 169.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.7 pt -126.68 163.5 28.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 123.638 0.775 . . . . 0.0 108.936 -169.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.28 40.77 0.87 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.669 0.788 . . . . 0.0 109.254 176.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 27.5 m -67.07 133.18 31.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 O-C-N 121.243 -0.91 . . . . 0.0 108.584 177.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.46 -52.58 42.13 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 171.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 160.12 41.91 0.02 OUTLIER Glycine 0 CA--C 1.526 0.763 0 CA-C-O 119.086 -0.841 . . . . 0.0 112.923 176.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.7 m -67.05 123.17 85.58 Favored Pre-proline 0 N--CA 1.454 -0.227 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 176.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -50.91 -34.77 47.0 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.274 1.983 . . . . 0.0 113.218 -178.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -74.48 -36.29 63.28 Favored 'General case' 0 N--CA 1.456 -0.148 0 O-C-N 122.121 -0.362 . . . . 0.0 110.161 -175.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -80.6 -35.88 33.52 Favored 'General case' 0 CA--C 1.521 -0.142 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -177.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 88.0 mt -56.62 -41.87 77.84 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 169.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -66.77 -56.45 10.44 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 118.544 0.611 . . . . 0.0 109.907 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -61.94 -45.35 94.05 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 118.495 0.589 . . . . 0.0 111.083 -175.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.4 mt -74.62 -35.08 62.92 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 118.517 -0.754 . . . . 0.0 110.382 -174.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.4 tptt -61.76 -39.87 93.16 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 119.935 1.243 . . . . 0.0 110.092 169.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -63.06 -39.14 93.84 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.95 0.795 . . . . 0.0 110.407 178.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -63.9 -40.43 96.49 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 119.866 1.212 . . . . 0.0 111.336 172.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.7 -23.99 66.89 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.048 0.84 . . . . 0.0 112.343 177.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 41.4 mtpt -84.35 -38.09 20.77 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.643 0.777 . . . . 0.0 110.11 172.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -70.47 -42.21 71.74 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.883 0.873 . . . . 0.0 110.426 -174.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -135.84 165.71 25.0 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.064 1.346 . . . . 0.0 109.738 -173.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -71.03 7.04 1.31 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.064 1.346 . . . . 0.0 113.535 -175.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.0 pp -64.42 154.66 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 124.294 1.038 . . . . 0.0 111.347 -171.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -89.95 152.15 21.35 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.014 0.435 . . . . 0.0 110.307 178.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.0 m -142.89 157.07 17.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 125.9 1.68 . . . . 0.0 107.568 174.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 32.2 m -149.41 133.53 17.23 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 173.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -121.76 110.45 15.94 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 -169.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -70.68 -32.7 70.05 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -170.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 64.49 39.9 97.23 Favored Glycine 0 CA--C 1.532 1.113 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -172.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.5 t70 . . . . . 0 C--O 1.248 0.989 0 C-N-CA 125.037 1.335 . . . . 0.0 111.298 -176.682 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.2 t . . . . . 0 C--O 1.236 0.353 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 33.0 ptt85 -144.28 167.36 22.63 Favored 'General case' 0 C--O 1.231 0.1 0 C-N-CA 125.495 1.518 . . . . 0.0 107.691 175.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.3 m -126.99 153.57 45.73 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.428 HG12 ' H ' ' A' ' 32' ' ' THR . 10.5 pt -126.78 170.56 16.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 124.658 1.183 . . . . 0.0 108.163 -173.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.13 75.68 1.45 Allowed 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 -178.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.7 m -125.08 153.53 32.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 C-N-CA 123.434 0.694 . . . . 0.0 109.713 -173.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -81.68 33.34 2.58 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 124.477 1.037 . . . . 0.0 112.574 -177.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 54.81 39.01 66.04 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-N 118.084 0.942 . . . . 0.0 111.428 -172.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -60.59 126.69 85.51 Favored Pre-proline 0 N--CA 1.451 -0.414 0 C-N-CA 125.038 1.335 . . . . 0.0 109.459 -169.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -53.59 -23.24 24.84 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.187 2.591 . . . . 0.0 113.91 173.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -92.37 -4.18 54.22 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.246 1.018 . . . . 0.0 111.878 -177.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -117.45 -36.69 3.66 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 123.763 0.825 . . . . 0.0 109.424 -178.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 28.4 mt -47.05 -34.65 6.01 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.523 1.129 . . . . 0.0 111.481 169.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.4 mttp -56.62 -25.66 53.76 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -118.53 -38.56 3.12 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 118.97 0.804 . . . . 0.0 110.303 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -68.39 -41.07 81.04 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-N 118.468 0.576 . . . . 0.0 111.277 -175.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 48.9 tptt -68.92 -34.74 75.88 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 118.499 0.591 . . . . 0.0 110.092 176.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -63.62 -45.39 90.52 Favored 'General case' 0 C--O 1.222 -0.367 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 175.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -60.1 -41.6 92.86 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 119.287 0.949 . . . . 0.0 110.516 178.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.13 -2.59 4.34 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.485 1.114 . . . . 0.0 113.829 176.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -121.72 -27.4 4.7 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.226 1.41 . . . . 0.0 110.308 175.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -70.41 -39.94 74.14 Favored 'General case' 0 C--N 1.338 0.107 0 C-N-CA 124.109 0.963 . . . . 0.0 109.343 175.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -122.84 166.58 14.76 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.729 1.211 . . . . 0.0 109.195 178.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -73.23 -1.31 17.25 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.632 1.173 . . . . 0.0 113.014 -178.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.2 pp -61.39 162.61 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 124.669 1.188 . . . . 0.0 110.83 -178.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.48 147.66 52.57 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.0 m -127.07 167.54 21.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 124.853 1.261 . . . . 0.0 110.173 -169.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.428 ' H ' HG12 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -129.69 125.19 35.4 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.277 1.431 . . . . 0.0 108.657 -169.727 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -128.56 94.83 3.97 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 -175.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -71.75 -24.7 61.82 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -171.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.16 25.75 68.54 Favored Glycine 0 CA--C 1.537 1.465 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 -169.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.5 t70 . . . . . 0 C--O 1.249 1.038 0 C-N-CA 125.394 1.478 . . . . 0.0 111.48 -177.439 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.9 t . . . . . 0 CA--C 1.532 0.259 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 36.9 mtp180 -144.64 160.6 40.92 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 129.171 2.989 . . . . 0.0 104.146 170.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.5 m -139.84 151.84 46.01 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 169.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.479 HG12 ' H ' ' A' ' 32' ' ' THR . 2.5 pt -127.2 165.89 25.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.216 1.006 . . . . 0.0 109.007 -169.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -142.91 40.85 1.53 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.804 0.842 . . . . 0.0 109.593 -178.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 34.6 m -69.25 144.1 14.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 O-C-N 121.425 -0.797 . . . . 0.0 109.365 178.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -166.48 30.93 0.2 Allowed Glycine 0 CA--C 1.528 0.878 0 C-N-CA 123.573 0.606 . . . . 0.0 112.591 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -176.32 27.02 0.07 OUTLIER Glycine 0 CA--C 1.529 0.911 0 CA-C-N 117.705 0.753 . . . . 0.0 112.644 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.0 p -143.83 59.68 7.45 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 125.304 1.442 . . . . 0.0 108.226 -169.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -62.42 -26.05 76.44 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.6 2.2 . . . . 0.0 113.11 -169.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -71.27 -30.82 66.75 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.454 0.57 . . . . 0.0 110.96 177.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -75.64 -19.4 59.22 Favored 'General case' 0 N--CA 1.462 0.144 0 O-C-N 121.262 -0.899 . . . . 0.0 111.358 -176.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.0 mt -52.54 -31.21 34.55 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.116 0.966 . . . . 0.0 110.613 169.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 42.0 mtmt -62.66 -32.23 73.26 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 118.837 0.744 . . . . 0.0 111.444 177.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -85.39 -48.89 8.58 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 177.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -64.66 -40.84 96.13 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.309 0.644 . . . . 0.0 111.478 -170.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -64.7 -31.46 72.69 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 119.012 -0.518 . . . . 0.0 111.14 175.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -68.82 -46.58 68.21 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 118.921 0.782 . . . . 0.0 109.1 174.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -59.07 -37.75 77.82 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 119.451 1.023 . . . . 0.0 111.062 177.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.25 -13.89 21.96 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.253 1.021 . . . . 0.0 113.572 176.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -117.38 -30.49 5.55 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 125.052 1.341 . . . . 0.0 110.291 -179.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -77.66 -24.32 49.44 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 123.967 0.907 . . . . 0.0 111.109 177.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -138.83 168.72 19.19 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.69 1.196 . . . . 0.0 110.303 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -71.78 -10.35 59.64 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.423 1.489 . . . . 0.0 113.359 -177.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.8 pp -58.15 151.32 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 124.458 1.103 . . . . 0.0 113.547 -169.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 43.7 ttm105 -83.67 150.16 26.04 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 174.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.6 m -135.85 149.06 27.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 107.273 -1.381 . . . . 0.0 107.273 169.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.479 ' H ' HG12 ' A' ' 8' ' ' ILE . 2.6 m -144.66 139.75 28.2 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 178.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -131.12 118.26 20.26 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 -169.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 12.9 m-90 -95.82 151.24 19.57 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 122.907 0.483 . . . . 0.0 109.955 173.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -72.96 -41.77 47.34 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 108.928 -1.669 . . . . 0.0 108.928 169.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.3 t70 . . . . . 0 C--O 1.246 0.907 0 C-N-CA 126.996 2.119 . . . . 0.0 107.719 169.889 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.4 p . . . . . 0 CA--C 1.53 0.2 0 N-CA-C 106.314 -1.736 . . . . 0.0 106.314 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.75 170.31 18.56 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.595 1.558 . . . . 0.0 108.336 177.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.3 m -97.85 161.53 13.7 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 169.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.402 HG12 ' H ' ' A' ' 32' ' ' THR . 17.7 pt -120.2 174.37 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 125.127 1.371 . . . . 0.0 108.041 -179.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.51 88.15 1.69 Allowed 'General case' 0 C--O 1.232 0.173 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 169.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.7 p -134.02 155.76 40.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -171.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -175.91 -65.68 0.06 OUTLIER Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.782 -0.527 . . . . 0.0 111.782 170.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -83.0 39.15 2.73 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 124.341 0.972 . . . . 0.0 112.398 -174.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.1 p -148.36 71.44 10.89 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 126.617 1.967 . . . . 0.0 106.07 -169.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -52.61 -34.78 64.84 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 123.045 2.497 . . . . 0.0 114.128 -169.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -66.49 -36.9 83.88 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.938 0.399 . . . . 0.0 110.211 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -76.2 -25.27 54.99 Favored 'General case' 0 N--CA 1.454 -0.236 0 O-C-N 121.719 -0.613 . . . . 0.0 110.52 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 91.2 mt -61.27 -37.81 84.48 Favored 'General case' 0 C--O 1.227 -0.127 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 169.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -70.96 -49.85 40.92 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 119.083 0.856 . . . . 0.0 109.47 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -59.43 -48.19 82.61 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 117.834 0.288 . . . . 0.0 110.6 -178.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.0 mt -74.58 -33.75 62.73 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 118.356 -0.83 . . . . 0.0 110.296 -175.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -61.13 -37.95 84.64 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 120.102 1.319 . . . . 0.0 110.464 169.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -62.7 -45.73 91.43 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 119.788 1.176 . . . . 0.0 109.406 175.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -59.12 -28.68 66.76 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 118.818 -0.61 . . . . 0.0 112.304 175.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.33 -21.57 64.11 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.363 0.983 . . . . 0.0 112.771 175.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.41 -33.06 10.15 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 118.548 0.613 . . . . 0.0 110.454 169.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -67.46 -29.37 68.81 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 118.842 0.746 . . . . 0.0 111.08 -175.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -140.62 179.82 6.47 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.823 1.649 . . . . 0.0 109.775 -174.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -91.85 11.39 25.01 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.911 1.284 . . . . 0.0 112.105 -173.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.8 pt -61.97 156.02 4.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 124.423 1.089 . . . . 0.0 112.131 -171.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.1 ptm180 -107.12 74.77 0.99 Allowed 'General case' 0 C--O 1.235 0.319 0 C-N-CA 123.901 0.881 . . . . 0.0 109.263 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 29.8 m -54.5 139.57 13.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.056 178.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.402 ' H ' HG12 ' A' ' 8' ' ' ILE . 14.9 m -142.87 119.91 11.38 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 104.562 -2.385 . . . . 0.0 104.562 -175.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -114.58 111.04 20.73 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -169.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 9.7 m-90 -80.07 154.52 28.07 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.144 0.578 . . . . 0.0 110.037 175.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -86.81 40.09 3.08 Favored Glycine 0 CA--C 1.532 1.121 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 169.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.3 t70 . . . . . 0 C--O 1.248 0.999 0 C-N-CA 125.129 1.372 . . . . 0.0 111.192 -173.89 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.9 p . . . . . 0 CA--C 1.535 0.373 0 CA-C-O 121.683 0.754 . . . . 0.0 110.648 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -148.1 171.4 15.93 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 125.348 1.459 . . . . 0.0 109.263 -175.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.3 m -134.51 153.85 51.73 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 171.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.419 HG12 ' H ' ' A' ' 32' ' ' THR . 7.7 pt -129.3 167.51 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 125.713 1.605 . . . . 0.0 107.755 -175.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.31 39.56 0.91 Allowed 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.533 0.683 . . . . 0.0 110.603 175.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 28.3 m -69.03 144.87 13.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 O-C-N 121.289 -0.882 . . . . 0.0 109.866 176.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -172.1 147.6 10.15 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 106.632 -2.587 . . . . 0.0 106.632 172.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 55.06 24.58 35.77 Favored Glycine 0 CA--C 1.537 1.451 0 CA-C-N 117.797 0.799 . . . . 0.0 113.422 -170.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -140.63 61.12 14.98 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 125.289 1.436 . . . . 0.0 109.711 -171.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -62.27 -23.81 75.56 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.517 2.145 . . . . 0.0 112.711 -175.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -67.36 -19.22 65.4 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.033 0.933 . . . . 0.0 112.271 176.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -90.19 -26.14 20.27 Favored 'General case' 0 N--CA 1.465 0.275 0 O-C-N 121.392 -0.817 . . . . 0.0 110.174 -178.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 59.0 mt -55.05 -30.06 58.8 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 169.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -64.68 -23.71 67.34 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 119.051 -0.499 . . . . 0.0 112.041 -177.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -99.76 -45.6 5.69 Favored 'General case' 0 C--N 1.34 0.156 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 176.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 83.5 mt -72.4 -29.89 64.15 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 118.648 -0.691 . . . . 0.0 111.702 -169.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 27.0 mmtp -62.98 -38.35 90.79 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 119.578 1.081 . . . . 0.0 110.43 169.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -63.93 -45.99 86.77 Favored 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -59.82 -42.47 93.6 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.432 1.015 . . . . 0.0 111.036 177.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.91 -6.15 11.5 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.387 1.075 . . . . 0.0 113.889 177.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -121.57 -25.05 5.2 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.068 1.347 . . . . 0.0 110.052 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -70.15 -40.46 74.75 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 125.054 1.342 . . . . 0.0 108.837 172.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -134.97 166.23 23.51 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.714 1.206 . . . . 0.0 109.236 175.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -76.2 10.36 2.02 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.796 1.239 . . . . 0.0 112.954 -176.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.4 pp -62.17 153.4 6.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-O 122.093 0.949 . . . . 0.0 112.667 -169.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.93 144.26 47.38 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 124.14 0.976 . . . . 0.0 109.329 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.5 m -143.56 152.59 16.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 125.955 1.702 . . . . 0.0 106.497 169.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.419 ' H ' HG12 ' A' ' 8' ' ' ILE . 27.5 m -143.84 133.42 23.56 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 173.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -120.67 102.19 8.24 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -169.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 24.3 m-90 -75.87 155.19 35.52 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 171.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -66.88 -49.66 52.96 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 108.285 -1.926 . . . . 0.0 108.285 169.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.3 t70 . . . . . 0 C--O 1.246 0.881 0 C-N-CA 126.871 2.069 . . . . 0.0 107.797 169.919 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 32.6 m . . . . . 0 CA--C 1.536 0.428 0 N-CA-C 111.652 0.241 . . . . 0.0 111.652 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 69.9 mtm-85 -124.75 -31.69 3.16 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 118.487 -0.768 . . . . 0.0 112.951 176.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.4 m 64.61 151.84 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.032 1.333 . . . . 0.0 110.056 -169.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.402 HG12 ' H ' ' A' ' 32' ' ' THR . 8.0 pt -135.2 172.53 15.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 125.029 1.332 . . . . 0.0 108.615 -169.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.2 37.17 0.54 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.233 0.613 . . . . 0.0 110.962 177.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.1 m -67.33 153.44 8.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 O-C-N 121.069 -1.019 . . . . 0.0 112.47 -174.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 174.64 139.54 3.03 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 108.512 -1.835 . . . . 0.0 108.512 176.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 64.11 29.36 74.71 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-N 117.181 0.491 . . . . 0.0 111.92 -172.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.4 p -141.25 65.23 21.47 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 125.462 1.505 . . . . 0.0 108.286 -172.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.15 -23.89 31.15 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 124.078 3.185 . . . . 0.0 115.841 -169.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -102.41 -11.59 18.5 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.783 0.833 . . . . 0.0 111.429 -173.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -88.77 -40.39 13.24 Favored 'General case' 0 CA--C 1.519 -0.225 0 O-C-N 121.103 -0.998 . . . . 0.0 108.583 -176.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.4 pp -57.28 -25.69 59.64 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-O 118.535 -0.745 . . . . 0.0 110.989 169.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -73.09 -45.89 54.54 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.337 0.971 . . . . 0.0 110.023 177.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -63.21 -43.71 97.36 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 177.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.1 mt -68.64 -38.78 80.75 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 118.78 -0.628 . . . . 0.0 110.296 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -58.86 -41.5 87.15 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.579 1.081 . . . . 0.0 110.726 171.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -61.3 -41.98 97.89 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.9 0.773 . . . . 0.0 110.041 176.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -62.72 -38.53 90.83 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 119.419 1.009 . . . . 0.0 111.802 174.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.86 -30.83 71.88 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.972 0.806 . . . . 0.0 111.561 177.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -80.21 -35.85 35.65 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.222 0.609 . . . . 0.0 110.216 174.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -76.84 -40.63 47.1 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 118.574 0.625 . . . . 0.0 111.174 -173.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -132.08 175.14 9.49 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.835 1.254 . . . . 0.0 111.13 -169.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -65.35 -17.7 64.73 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.819 1.248 . . . . 0.0 113.541 -177.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.0 pp -55.79 144.89 6.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 123.9 0.88 . . . . 0.0 112.759 -169.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 8.4 ptm85 -83.9 161.58 20.8 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 121.181 0.515 . . . . 0.0 109.845 171.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.8 m -140.3 156.07 23.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 125.24 1.416 . . . . 0.0 108.158 171.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.402 ' H ' HG12 ' A' ' 8' ' ' ILE . 2.2 m -144.59 124.06 13.15 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 -177.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -119.19 83.89 2.11 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.223 0.609 . . . . 0.0 109.751 -169.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 13.5 m-90 -64.28 -42.68 96.3 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.46 173.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 65.3 29.35 75.06 Favored Glycine 0 CA--C 1.535 1.333 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 -169.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.9 t70 . . . . . 0 C--O 1.248 1.008 0 C-N-CA 125.075 1.35 . . . . 0.0 111.581 -175.388 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.0 t . . . . . 0 CA--C 1.535 0.397 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -149.27 174.35 12.5 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 124.909 1.284 . . . . 0.0 109.816 -174.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.9 m -108.15 160.3 15.92 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.563 1.545 . . . . 0.0 108.426 172.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.447 HG12 ' H ' ' A' ' 32' ' ' THR . 4.8 pt -131.95 163.66 36.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 169.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.78 73.18 1.33 Allowed 'General case' 0 C--O 1.233 0.21 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 175.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.3 m -125.52 162.13 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 121.876 0.846 . . . . 0.0 111.624 -173.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -176.71 165.58 35.88 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 126.12 1.819 . . . . 0.0 108.953 171.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 57.75 19.87 37.59 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 124.324 0.964 . . . . 0.0 114.7 173.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.2 m -140.74 73.01 29.03 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 118.325 1.062 . . . . 0.0 108.997 -171.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -44.02 -34.91 6.89 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.706 2.937 . . . . 0.0 113.644 173.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 51.3 mp0 -66.52 -9.68 37.13 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.43 1.892 . . . . 0.0 112.589 -176.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -130.15 -44.73 1.14 Allowed 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 125.219 1.408 . . . . 0.0 108.786 -178.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.1 pp -68.2 -27.23 66.21 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 119.888 1.222 . . . . 0.0 111.439 -175.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -68.0 -39.15 83.26 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 120.122 1.328 . . . . 0.0 110.417 171.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -68.63 -42.33 78.19 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 118.616 0.644 . . . . 0.0 109.736 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 79.3 mt -69.46 -34.82 74.94 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.458 0.572 . . . . 0.0 110.509 177.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -61.08 -42.8 99.18 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 119.285 0.948 . . . . 0.0 110.563 169.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -62.32 -38.19 88.46 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.76 0.709 . . . . 0.0 110.101 176.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -62.23 -41.71 98.65 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.174 0.99 . . . . 0.0 110.586 176.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.13 -45.76 91.91 Favored 'General case' 0 C--N 1.338 0.089 0 C-N-CA 122.869 0.467 . . . . 0.0 110.481 174.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -66.06 -32.77 74.44 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 119.038 -0.506 . . . . 0.0 111.161 177.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.2 ttpt -81.16 -49.19 11.12 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 118.955 0.798 . . . . 0.0 110.823 -173.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.99 7.33 21.55 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.137 0.975 . . . . 0.0 112.999 -169.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 54.5 t30 65.58 1.66 1.79 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.913 2.085 . . . . 0.0 114.094 -178.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.6 pp -63.23 147.49 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 121.626 0.727 . . . . 0.0 111.368 -172.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 43.1 ptt85 -67.59 149.41 50.12 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.572 175.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.6 m -144.08 152.8 15.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 125.323 1.449 . . . . 0.0 107.769 176.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.447 ' H ' HG12 ' A' ' 8' ' ' ILE . 10.9 m -140.85 127.29 19.95 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -178.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -121.05 102.09 8.1 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -170.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 1.9 m-90 -70.87 -34.45 71.63 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 123.558 0.743 . . . . 0.0 112.441 -175.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.16 27.26 72.81 Favored Glycine 0 CA--C 1.535 1.324 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 -169.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 22.8 t70 . . . . . 0 C--O 1.25 1.096 0 C-N-CA 125.083 1.353 . . . . 0.0 111.25 -177.759 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.9 p . . . . . 0 CA--C 1.537 0.474 0 CA-C-O 121.433 0.635 . . . . 0.0 111.372 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 40.4 ptt85 -147.81 174.8 11.48 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 125.19 1.396 . . . . 0.0 108.438 171.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 92.5 m -123.7 155.17 38.31 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 174.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.8 pt -128.41 172.75 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.865 1.666 . . . . 0.0 108.266 -169.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.63 35.67 0.71 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 118.505 0.593 . . . . 0.0 111.639 174.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.0 m -67.63 146.09 13.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 O-C-N 121.165 -0.959 . . . . 0.0 109.244 177.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -88.41 39.12 3.13 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.164 0.888 . . . . 0.0 110.913 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 54.81 33.12 55.71 Favored Glycine 0 CA--C 1.533 1.188 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 -169.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.14 125.37 85.27 Favored Pre-proline 0 N--CA 1.448 -0.53 0 C-N-CA 125.66 1.584 . . . . 0.0 110.078 -169.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -56.14 -15.41 14.14 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.621 2.881 . . . . 0.0 114.986 174.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -94.14 -15.72 24.41 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.574 1.15 . . . . 0.0 111.561 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -116.48 -35.42 4.27 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 121.44 -0.787 . . . . 0.0 111.043 -169.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 76.1 mt -51.51 -30.89 21.83 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.654 0.661 . . . . 0.0 110.97 170.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -58.0 -23.28 53.38 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 125.035 1.334 . . . . 0.0 112.835 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -113.2 -41.48 3.69 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 123.761 0.824 . . . . 0.0 109.537 176.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -64.32 -40.4 95.84 Favored 'General case' 0 N--CA 1.457 -0.088 0 C-N-CA 122.924 0.49 . . . . 0.0 112.023 -174.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -66.48 -37.64 85.55 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 118.86 0.754 . . . . 0.0 110.12 178.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -63.66 -47.63 80.49 Favored 'General case' 0 C--O 1.225 -0.217 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 175.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -59.6 -40.25 86.88 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.109 0.964 . . . . 0.0 111.051 -179.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.99 -43.61 70.13 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 124.172 0.989 . . . . 0.0 110.955 177.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -82.12 -34.24 29.31 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 119.302 -0.38 . . . . 0.0 111.151 177.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -71.29 -39.97 71.16 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 118.614 0.643 . . . . 0.0 110.717 -170.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -119.05 6.98 11.3 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.763 0.825 . . . . 0.0 112.082 -172.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 55.7 t30 62.39 1.01 0.67 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 127.07 2.148 . . . . 0.0 114.602 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.7 pp -62.56 152.95 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.517 1.127 . . . . 0.0 111.497 -174.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.07 152.1 44.34 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 172.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.8 m -141.22 149.17 20.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 169.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.5 m -143.18 132.82 23.74 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -122.78 105.19 9.82 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -169.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 13.6 m-90 -79.81 153.37 29.18 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 122.45 0.3 . . . . 0.0 110.396 -177.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -84.62 43.87 3.28 Favored Glycine 0 CA--C 1.532 1.107 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 169.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.0 t70 . . . . . 0 C--O 1.248 0.982 0 C-N-CA 125.066 1.346 . . . . 0.0 111.251 -173.478 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 C--O 1.234 0.287 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 29.4 ptt-85 -161.29 158.49 27.21 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 123.981 0.912 . . . . 0.0 109.005 -175.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.8 m -82.31 158.85 23.28 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 169.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.4 pt -125.99 168.42 18.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 125.141 1.376 . . . . 0.0 108.432 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.13 49.1 1.27 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.939 0.876 . . . . 0.0 110.118 176.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.1 t -60.38 134.08 25.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 169.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -147.92 -26.94 0.07 OUTLIER Glycine 0 CA--C 1.524 0.6 0 CA-C-O 119.482 -0.621 . . . . 0.0 114.175 -172.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -166.21 44.55 0.27 Allowed Glycine 0 CA--C 1.523 0.566 0 N-CA-C 108.249 -1.94 . . . . 0.0 108.249 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -138.58 78.03 32.68 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 125.663 1.585 . . . . 0.0 108.15 -168.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -63.16 -21.66 72.54 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 121.906 1.738 . . . . 0.0 112.093 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -66.53 -20.18 65.96 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.572 -0.705 . . . . 0.0 111.641 173.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -90.05 -38.15 13.78 Favored 'General case' 0 C--N 1.338 0.099 0 O-C-N 121.629 -0.669 . . . . 0.0 109.599 174.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.3 mt -55.59 -32.52 63.15 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.23 0.923 . . . . 0.0 110.433 169.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -64.48 -21.8 66.77 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.205 1.002 . . . . 0.0 112.499 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -126.91 -45.35 1.59 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 119.247 0.93 . . . . 0.0 111.969 -169.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 32.4 mt -70.85 -30.52 66.95 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 121.504 -0.747 . . . . 0.0 110.749 -174.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -62.31 -37.61 86.24 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.059 0.845 . . . . 0.0 111.003 170.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -68.23 -41.45 81.21 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 175.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -60.37 -37.42 80.69 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 121.387 -0.821 . . . . 0.0 111.317 178.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.99 -11.81 9.37 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.692 1.197 . . . . 0.0 113.707 174.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -118.18 -26.64 6.28 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.476 1.51 . . . . 0.0 109.75 -179.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -71.3 -37.8 71.81 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 123.623 0.769 . . . . 0.0 109.731 173.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -134.93 169.24 17.7 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 125.416 1.486 . . . . 0.0 109.249 -178.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -75.94 -1.46 25.67 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.37 1.068 . . . . 0.0 113.043 -176.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.3 pp -58.67 147.29 7.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 123.946 0.898 . . . . 0.0 111.638 -171.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 31.8 ptt-85 -75.06 153.61 38.32 Favored 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 123.142 0.577 . . . . 0.0 109.684 174.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.6 m -141.19 155.03 20.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 124.971 1.309 . . . . 0.0 107.647 171.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.0 m -149.38 141.17 23.64 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 173.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -130.32 110.45 11.53 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -169.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 18.4 m-90 -85.51 170.36 12.72 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.946 0.898 . . . . 0.0 109.778 172.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -130.57 65.45 0.59 Allowed Glycine 0 CA--C 1.524 0.602 0 N-CA-C 105.883 -2.887 . . . . 0.0 105.883 171.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.4 t70 . . . . . 0 C--O 1.247 0.962 0 C-N-CA 125.256 1.423 . . . . 0.0 111.582 -169.855 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.2 p . . . . . 0 CA--C 1.539 0.545 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -160.22 179.22 8.88 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 126.581 1.952 . . . . 0.0 108.566 177.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.9 m -123.63 156.88 35.0 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 126.33 1.852 . . . . 0.0 107.196 175.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.423 HG12 ' H ' ' A' ' 32' ' ' THR . 4.3 pt -118.5 167.42 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.671 1.189 . . . . 0.0 108.835 -174.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -147.0 69.85 1.18 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 174.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.5 m -118.31 158.09 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 122.999 0.52 . . . . 0.0 110.158 -177.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 173.97 150.14 7.44 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 108.291 -1.924 . . . . 0.0 108.291 178.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 61.78 31.02 76.66 Favored Glycine 0 CA--C 1.534 1.279 0 N-CA-C 111.77 -0.532 . . . . 0.0 111.77 -171.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.0 p -138.0 58.39 15.52 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 125.703 1.601 . . . . 0.0 108.995 -169.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -62.66 -20.42 70.87 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.027 2.485 . . . . 0.0 113.316 -169.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -87.91 -4.3 58.85 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.501 0.72 . . . . 0.0 112.155 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -127.69 -34.44 2.2 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.572 0.749 . . . . 0.0 110.692 -173.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.6 pp -62.31 -25.26 67.77 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-O 118.129 -0.938 . . . . 0.0 110.62 169.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.0 ptpp? -68.42 -37.67 80.51 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 119.987 1.267 . . . . 0.0 111.299 171.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -69.86 -43.45 71.86 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 72.3 mt -69.55 -34.08 73.69 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 118.986 -0.531 . . . . 0.0 110.546 177.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -62.32 -39.43 93.01 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.583 1.083 . . . . 0.0 111.297 171.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -59.9 -46.85 88.02 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.696 1.135 . . . . 0.0 109.141 172.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -57.25 -33.32 67.47 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.565 1.146 . . . . 0.0 111.517 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.77 -23.45 66.2 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.129 0.972 . . . . 0.0 112.771 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.36 -31.62 11.24 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 123.018 0.527 . . . . 0.0 110.28 171.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.2 ttmt -66.5 -36.43 82.7 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 118.602 0.637 . . . . 0.0 111.342 -176.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -134.82 176.22 8.84 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.743 1.217 . . . . 0.0 111.06 -169.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -80.32 1.76 27.44 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.68 1.192 . . . . 0.0 112.216 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.1 pp -59.98 158.86 1.94 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 124.0 0.92 . . . . 0.0 110.352 177.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -116.98 154.44 30.89 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 172.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 29.0 m -128.94 147.99 33.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 123.316 0.647 . . . . 0.0 110.14 -175.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.423 ' H ' HG12 ' A' ' 8' ' ' ILE . 16.0 m -144.76 131.23 19.8 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 176.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -123.51 110.23 14.8 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -169.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 11.3 m-90 -74.09 158.54 34.07 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.862 0.865 . . . . 0.0 109.652 172.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -65.57 -44.59 92.53 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 108.802 -1.719 . . . . 0.0 108.802 169.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.5 t70 . . . . . 0 C--O 1.246 0.887 0 C-N-CA 127.111 2.164 . . . . 0.0 107.676 169.806 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.5 t . . . . . 0 C--O 1.236 0.377 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 33.5 ptt-85 -155.74 157.07 35.96 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 124.386 1.074 . . . . 0.0 108.508 171.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.8 m -81.37 160.1 24.19 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 169.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.9 pt -122.66 167.45 16.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 125.0 1.32 . . . . 0.0 108.993 177.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.19 45.5 1.15 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 122.213 1.006 . . . . 0.0 108.503 170.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.2 p -70.72 144.02 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 O-C-N 121.444 -0.785 . . . . 0.0 110.737 -170.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -175.98 159.15 26.42 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 172.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 58.02 18.89 35.58 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.355 0.979 . . . . 0.0 113.915 -176.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.5 p -144.66 71.9 15.45 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 125.282 1.433 . . . . 0.0 108.178 -169.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -60.45 -24.02 76.7 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.296 1.997 . . . . 0.0 112.848 -176.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.5 mp0 -62.36 -39.52 93.44 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.602 0.761 . . . . 0.0 109.678 173.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -79.04 -24.14 43.8 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 121.476 -0.765 . . . . 0.0 110.775 -178.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.6 mt -60.92 -38.49 85.96 Favored 'General case' 0 CA--C 1.526 0.052 0 CA-C-N 119.65 1.114 . . . . 0.0 108.027 169.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -72.54 -49.46 32.53 Favored 'General case' 0 C--N 1.341 0.223 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -60.92 -45.94 92.67 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 118.596 0.635 . . . . 0.0 111.04 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 94.4 mt -72.93 -33.99 66.29 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 118.5 -0.762 . . . . 0.0 110.103 -177.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -60.99 -40.33 93.11 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.937 1.244 . . . . 0.0 110.315 169.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -62.11 -41.39 98.18 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.668 0.667 . . . . 0.0 109.941 177.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -63.45 -40.26 96.67 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 119.35 0.977 . . . . 0.0 111.628 175.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.8 -42.89 98.49 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 118.784 0.72 . . . . 0.0 110.404 176.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 42.2 mtpt -67.08 -37.28 83.72 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.979 -0.45 . . . . 0.0 110.941 175.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 66.3 tttm -80.44 -40.51 26.19 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 118.674 0.67 . . . . 0.0 111.851 -169.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -130.5 10.26 5.2 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.947 0.899 . . . . 0.0 113.076 -169.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 64.04 7.8 3.6 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.133 1.773 . . . . 0.0 114.05 177.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.5 pp -64.2 155.83 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 121.96 0.886 . . . . 0.0 112.551 -169.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 28.1 ttp-105 -62.44 134.25 56.17 Favored 'General case' 0 CA--C 1.527 0.073 0 C-N-CA 124.361 1.064 . . . . 0.0 109.28 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.6 m -139.56 144.29 29.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 172.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.2 m -140.2 110.24 6.51 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -99.56 84.86 3.02 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.48 0.712 . . . . 0.0 109.993 -169.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 14.0 m-90 -64.65 -47.86 76.93 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.32 169.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.91 -12.51 42.2 Favored Glycine 0 CA--C 1.536 1.364 0 CA-C-O 118.923 -0.931 . . . . 0.0 113.003 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.2 t0 . . . . . 0 C--O 1.248 0.996 0 C-N-CA 127.508 2.323 . . . . 0.0 112.123 -171.463 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.0 p . . . . . 0 C--O 1.234 0.277 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 71.6 mtt180 -140.67 177.19 8.2 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 125.309 1.444 . . . . 0.0 108.169 -177.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.0 m -144.08 149.13 36.11 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 169.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.429 HG12 ' H ' ' A' ' 32' ' ' THR . 17.3 pt -135.15 171.79 17.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 124.932 1.293 . . . . 0.0 108.406 -175.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.58 43.01 1.18 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.867 0.841 . . . . 0.0 109.826 176.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.9 p -73.37 148.47 8.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 O-C-N 121.437 -0.789 . . . . 0.0 109.804 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -173.39 166.89 39.43 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 108.378 -1.889 . . . . 0.0 108.378 169.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 54.5 21.26 20.11 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.069 1.319 . . . . 0.0 114.974 176.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.7 m -145.94 75.32 13.05 Favored Pre-proline 0 CA--C 1.538 0.497 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 -169.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -50.01 -34.52 38.2 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.434 2.756 . . . . 0.0 113.639 -177.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -68.25 -41.64 80.85 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.906 0.384 . . . . 0.0 110.15 -176.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -74.72 -36.18 62.68 Favored 'General case' 0 N--CA 1.436 -1.131 0 O-C-N 121.215 -0.928 . . . . 0.0 109.429 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.3 mt -57.26 -38.43 73.84 Favored 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 123.806 0.843 . . . . 0.0 109.721 172.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 43.1 mtpt -68.13 -49.13 63.08 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 118.741 0.7 . . . . 0.0 109.855 176.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -60.8 -43.82 97.66 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 118.797 0.726 . . . . 0.0 110.954 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 69.0 mt -74.64 -31.68 62.03 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 118.552 -0.737 . . . . 0.0 110.599 -178.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -62.07 -41.58 98.31 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.815 1.189 . . . . 0.0 110.254 169.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -63.38 -42.92 98.86 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.638 0.654 . . . . 0.0 109.617 176.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.0 tp10 -60.23 -39.26 86.04 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.055 -1.028 . . . . 0.0 111.037 176.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.14 -3.1 6.67 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.827 1.251 . . . . 0.0 113.798 174.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -118.2 -25.54 6.59 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.23 1.412 . . . . 0.0 110.036 174.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.4 ttpt -68.45 -41.6 80.02 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 123.791 0.836 . . . . 0.0 108.905 172.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -132.49 161.25 34.21 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.193 1.397 . . . . 0.0 109.205 175.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -74.31 -7.08 51.59 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.016 0.926 . . . . 0.0 113.341 -173.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.8 pp -51.76 145.6 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 125.251 1.421 . . . . 0.0 113.944 -169.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.9 ttp180 -59.37 143.98 48.03 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 124.776 1.23 . . . . 0.0 109.476 172.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.4 m -140.18 153.55 22.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 C-N-CA 125.607 1.563 . . . . 0.0 106.789 169.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.429 ' H ' HG12 ' A' ' 8' ' ' ILE . 1.9 m -141.46 128.24 20.43 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 -176.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -121.4 119.24 31.54 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -169.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 19.8 m-90 -94.73 157.43 15.95 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 169.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.61 -48.3 82.65 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 108.661 -1.776 . . . . 0.0 108.661 169.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.7 t70 . . . . . 0 C--O 1.247 0.961 0 C-N-CA 126.947 2.099 . . . . 0.0 107.73 169.721 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.3 t . . . . . 0 C--O 1.234 0.275 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 30.1 ptt-85 -155.43 -179.71 8.35 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 126.804 2.041 . . . . 0.0 106.599 -178.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.9 m -129.6 152.63 48.91 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 175.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.458 HG12 ' H ' ' A' ' 32' ' ' THR . 1.9 pt -117.07 167.13 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.765 1.226 . . . . 0.0 108.446 -171.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -144.52 36.08 1.19 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.775 0.83 . . . . 0.0 109.522 177.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.4 m -69.17 150.58 10.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 O-C-N 121.346 -0.846 . . . . 0.0 109.493 -178.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -81.97 42.27 2.83 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.548 1.071 . . . . 0.0 111.774 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 57.45 35.01 70.17 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 124.117 0.865 . . . . 0.0 111.691 -177.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.74 125.17 87.09 Favored Pre-proline 0 N--CA 1.45 -0.466 0 C-N-CA 124.615 1.166 . . . . 0.0 108.642 -174.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -65.39 -18.08 59.33 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 121.699 1.6 . . . . 0.0 111.475 175.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -77.75 -11.36 59.87 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.096 0.958 . . . . 0.0 111.085 178.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -125.58 -47.43 1.7 Allowed 'General case' 0 CA--C 1.519 -0.25 0 C-N-CA 123.281 0.632 . . . . 0.0 109.725 -169.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.4 pp -57.0 -27.9 61.98 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 118.77 0.714 . . . . 0.0 111.663 177.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -68.6 -13.88 62.64 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 118.703 -0.665 . . . . 0.0 112.736 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -111.43 -42.59 3.85 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.22 0.918 . . . . 0.0 109.074 173.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -62.96 -41.61 99.57 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.339 0.656 . . . . 0.0 111.518 -177.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.9 tptp -67.97 -31.77 71.73 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.186 0.903 . . . . 0.0 111.014 178.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -66.31 -46.17 77.83 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 172.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -60.77 -38.3 84.79 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.462 -0.774 . . . . 0.0 111.18 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.4 -15.78 40.04 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.483 1.113 . . . . 0.0 113.347 176.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -109.04 -27.17 9.79 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.886 1.274 . . . . 0.0 109.976 176.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -75.08 -35.94 61.77 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.932 0.893 . . . . 0.0 110.414 -179.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -140.03 169.91 16.84 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.329 1.452 . . . . 0.0 109.634 -177.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -76.75 15.47 0.64 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.901 1.28 . . . . 0.0 112.627 -174.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.4 pp -70.28 158.48 6.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 O-C-N 120.666 -1.271 . . . . 0.0 110.286 -174.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 41.8 ttm105 -98.93 147.29 25.13 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 29.9 m -136.67 154.58 32.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 170.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.458 ' H ' HG12 ' A' ' 8' ' ' ILE . 24.7 m -153.15 144.48 23.2 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 169.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -130.71 112.01 12.7 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -169.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 13.2 m-90 -93.84 150.7 20.16 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 122.887 0.475 . . . . 0.0 110.151 179.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -82.71 43.77 3.13 Favored Glycine 0 CA--C 1.532 1.154 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 169.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.1 t70 . . . . . 0 C--O 1.247 0.944 0 C-N-CA 125.075 1.35 . . . . 0.0 111.246 -173.924 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.234 0.263 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -160.33 158.93 30.56 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 125.998 1.719 . . . . 0.0 107.552 172.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.4 m -99.23 152.47 19.87 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 169.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.439 HG12 ' H ' ' A' ' 32' ' ' THR . 8.0 pt -113.38 173.81 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 124.365 1.066 . . . . 0.0 109.066 -176.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.92 72.31 1.17 Allowed 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 172.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.5 m -124.06 157.8 30.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 177.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -167.87 136.3 4.04 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 108.979 -1.649 . . . . 0.0 108.979 171.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 56.22 23.08 39.16 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 124.247 0.927 . . . . 0.0 114.19 179.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.0 p -68.58 150.23 97.73 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 119.072 1.436 . . . . 0.0 108.886 176.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.4 -25.99 29.74 Favored 'Trans proline' 0 CA--C 1.533 0.463 0 C-N-CA 121.965 1.777 . . . . 0.0 112.041 -172.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -159.52 -12.91 0.06 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.279 1.032 . . . . 0.0 112.019 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -66.21 -36.74 83.84 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 120.591 -1.318 . . . . 0.0 110.557 -173.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.6 pp -65.38 -21.67 66.71 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-O 118.424 -0.798 . . . . 0.0 112.16 172.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -77.85 -45.65 23.7 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 119.861 1.209 . . . . 0.0 108.935 175.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -58.44 -46.73 85.95 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.251 0.478 . . . . 0.0 110.316 173.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.0 mt -70.34 -34.48 72.71 Favored 'General case' 0 C--O 1.226 -0.154 0 CA-C-O 118.41 -0.805 . . . . 0.0 110.616 -178.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -60.19 -42.36 94.91 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 120.335 1.425 . . . . 0.0 110.799 169.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -61.52 -40.13 93.53 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 119.316 0.962 . . . . 0.0 110.174 175.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -62.23 -31.9 72.5 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.498 -0.751 . . . . 0.0 111.288 173.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.42 -28.72 67.33 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 120.162 1.346 . . . . 0.0 112.138 173.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -78.86 -33.1 46.11 Favored 'General case' 0 N--CA 1.463 0.19 0 O-C-N 121.82 -0.55 . . . . 0.0 109.998 172.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -90.5 -23.71 20.86 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -169.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -142.09 172.67 12.37 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.827 1.651 . . . . 0.0 109.931 -176.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -81.97 2.04 32.63 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.838 1.255 . . . . 0.0 112.982 -173.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.5 pt -53.18 151.05 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 125.635 1.574 . . . . 0.0 113.881 -169.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 34.2 ttp180 -94.34 75.39 3.92 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.426 1.49 . . . . 0.0 108.989 -177.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.5 m -62.93 139.66 20.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 171.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.439 ' H ' HG12 ' A' ' 8' ' ' ILE . 21.0 m -144.76 125.01 13.73 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 104.257 -2.497 . . . . 0.0 104.257 177.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -117.7 109.69 16.93 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -169.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 11.8 m-90 -72.24 165.2 24.9 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.993 0.917 . . . . 0.0 109.997 171.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -68.84 -45.4 64.57 Favored Glycine 0 CA--C 1.531 1.054 0 N-CA-C 108.328 -1.909 . . . . 0.0 108.328 169.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.3 t70 . . . . . 0 C--O 1.246 0.876 0 C-N-CA 127.111 2.165 . . . . 0.0 107.756 169.81 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 C--O 1.234 0.289 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 23.5 ptt-85 -152.25 165.66 34.18 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 126.978 2.111 . . . . 0.0 105.959 168.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.1 m -136.17 153.95 51.11 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -173.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.9 pt -127.33 169.15 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 125.002 1.321 . . . . 0.0 108.887 -169.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.07 37.14 0.94 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.514 0.726 . . . . 0.0 110.332 176.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.0 m -72.68 152.58 7.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 O-C-N 121.116 -0.99 . . . . 0.0 109.528 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -81.93 40.56 2.66 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.624 1.107 . . . . 0.0 111.727 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 53.76 34.4 50.7 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.32 0.962 . . . . 0.0 111.839 -171.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.3 m -61.89 124.42 81.62 Favored Pre-proline 0 N--CA 1.445 -0.715 0 C-N-CA 125.269 1.428 . . . . 0.0 108.68 -169.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -52.82 -27.49 34.8 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.801 2.334 . . . . 0.0 112.91 172.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -70.39 -26.44 63.7 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.63 0.772 . . . . 0.0 111.073 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -102.41 -37.06 8.19 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 124.363 1.065 . . . . 0.0 109.232 -171.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 65.5 mt -53.38 -19.2 3.19 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.257 1.023 . . . . 0.0 112.277 169.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -58.96 -28.54 66.4 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 118.945 0.793 . . . . 0.0 112.589 172.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -131.77 -37.08 1.19 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.008 0.822 . . . . 0.0 111.639 -173.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -61.57 -40.42 94.67 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 119.021 0.828 . . . . 0.0 111.374 -176.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.6 tptt -66.88 -32.58 73.94 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 119.303 -0.38 . . . . 0.0 111.005 177.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -69.0 -46.38 68.17 Favored 'General case' 0 C--O 1.224 -0.262 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 175.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -58.2 -40.17 80.87 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 119.168 0.895 . . . . 0.0 111.005 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.93 -15.66 33.61 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.138 0.975 . . . . 0.0 113.444 177.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -113.76 -29.83 6.97 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.993 1.317 . . . . 0.0 110.062 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -73.19 -34.55 66.04 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 123.873 0.869 . . . . 0.0 110.411 178.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -133.86 168.41 18.81 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.351 1.06 . . . . 0.0 110.654 -173.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -69.09 -9.52 53.07 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.023 1.729 . . . . 0.0 113.533 -177.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.6 pp -60.49 157.0 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.81 1.244 . . . . 0.0 111.952 -173.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 12.0 ptp85 -97.51 159.85 14.68 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.652 0.739 . . . . 0.0 109.648 174.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.3 m -139.22 155.01 25.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 171.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 38.9 m -149.43 144.21 26.21 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 170.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -129.96 107.23 9.2 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -169.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 13.3 m-90 -84.21 151.29 24.92 Favored 'General case' 0 N--CA 1.461 0.118 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 -179.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -83.03 45.57 3.47 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 169.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.9 t70 . . . . . 0 C--O 1.249 1.066 0 C-N-CA 125.089 1.356 . . . . 0.0 111.306 -174.177 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.2 t . . . . . 0 C--O 1.233 0.224 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -151.9 145.55 24.98 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 104.539 -2.393 . . . . 0.0 104.539 173.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.7 m -102.92 145.41 29.87 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 175.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.46 HG12 ' H ' ' A' ' 32' ' ' THR . 8.4 pt -101.87 174.83 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.226 1.01 . . . . 0.0 109.254 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.83 46.86 1.26 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.629 0.771 . . . . 0.0 109.004 170.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.2 p -80.64 145.98 8.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 O-C-N 121.277 -0.889 . . . . 0.0 109.073 -175.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -86.27 35.67 3.28 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.692 1.139 . . . . 0.0 112.395 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 56.07 41.96 86.41 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.275 0.941 . . . . 0.0 113.15 173.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.5 m -61.55 137.45 94.82 Favored Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 177.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -51.42 -27.23 23.67 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.37 2.713 . . . . 0.0 115.466 -177.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -93.89 -29.68 15.17 Favored 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 123.264 0.626 . . . . 0.0 110.858 -178.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -71.88 -33.45 68.38 Favored 'General case' 0 N--CA 1.462 0.169 0 O-C-N 121.256 -0.902 . . . . 0.0 108.829 175.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 76.6 mt -62.44 -5.09 2.23 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.713 1.205 . . . . 0.0 112.445 169.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.4 mttp -109.24 -56.08 2.33 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 119.287 0.949 . . . . 0.0 108.937 170.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -62.08 -49.87 74.21 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.162 0.585 . . . . 0.0 111.098 -174.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 25.8 mt -76.16 -29.31 57.69 Favored 'General case' 0 C--O 1.224 -0.244 0 O-C-N 122.008 -0.432 . . . . 0.0 109.969 -177.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.3 tptt -63.3 -39.47 94.65 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 119.125 0.875 . . . . 0.0 110.503 171.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -64.68 -44.1 91.4 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 173.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -56.7 -36.9 70.18 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.666 0.786 . . . . 0.0 111.115 175.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.28 -14.03 61.35 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.562 1.145 . . . . 0.0 113.385 177.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.1 mptp? -104.72 -33.7 8.37 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.219 1.008 . . . . 0.0 109.867 172.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 32.6 tttm -66.97 -37.57 84.5 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 123.396 0.679 . . . . 0.0 110.519 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -136.05 163.46 30.25 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 126.468 1.907 . . . . 0.0 108.646 -175.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -82.14 6.43 16.49 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.006 0.923 . . . . 0.0 112.771 -174.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.0 pp -59.73 156.04 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 124.528 1.131 . . . . 0.0 112.754 -172.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 33.1 ttp180 -98.89 81.28 2.6 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.806 1.243 . . . . 0.0 109.975 -169.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.4 m -63.21 139.55 21.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.324 169.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.46 ' H ' HG12 ' A' ' 8' ' ' ILE . 19.1 m -146.04 122.06 10.73 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 104.116 -2.55 . . . . 0.0 104.116 173.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -112.53 111.95 23.14 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -169.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 10.3 m-90 -83.07 147.03 28.37 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 174.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.98 -41.23 61.69 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 169.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.6 t70 . . . . . 0 C--O 1.246 0.889 0 C-N-CA 126.885 2.074 . . . . 0.0 107.867 170.004 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.303 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.6 m -60.58 154.82 20.15 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.221 1.008 . . . . 0.0 111.448 177.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -179.88 -179.03 48.78 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -63.79 -55.63 21.59 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 176.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.4 t -63.93 136.98 25.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-O 121.746 0.784 . . . . 0.0 109.371 -175.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -159.63 176.67 11.74 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 127.46 2.304 . . . . 0.0 106.826 -173.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.4 m -139.91 155.63 47.08 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 -176.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.447 HG12 ' H ' ' A' ' 32' ' ' THR . 2.9 pt -121.02 167.37 14.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 125.022 1.329 . . . . 0.0 108.792 -172.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.26 43.37 1.12 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.71 0.804 . . . . 0.0 109.35 173.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.2 m -75.27 150.39 6.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 O-C-N 121.189 -0.945 . . . . 0.0 110.319 -177.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -88.07 33.69 3.97 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 124.867 1.222 . . . . 0.0 112.271 178.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 61.37 38.52 95.86 Favored Glycine 0 CA--C 1.531 1.037 0 CA-C-N 117.576 0.688 . . . . 0.0 112.976 174.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.3 m -62.79 136.12 96.21 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 172.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -51.32 -32.88 43.44 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 122.766 2.311 . . . . 0.0 113.801 177.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -73.51 -39.19 65.0 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.702 0.401 . . . . 0.0 110.14 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -77.07 -36.15 56.1 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -177.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 34.2 mt -59.41 -26.61 65.3 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.419 1.088 . . . . 0.0 111.451 169.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -83.81 -63.94 1.26 Allowed 'General case' 0 C--N 1.339 0.147 0 CA-C-N 119.237 0.926 . . . . 0.0 109.046 174.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -61.81 -49.21 77.22 Favored 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 122.75 0.42 . . . . 0.0 111.466 -169.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 52.4 mt -75.8 -30.29 59.0 Favored 'General case' 0 C--O 1.226 -0.134 0 CA-C-O 119.124 -0.465 . . . . 0.0 110.255 -171.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -62.95 -38.76 92.36 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.225 0.921 . . . . 0.0 110.059 169.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -61.88 -42.87 99.58 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 118.762 0.71 . . . . 0.0 109.938 174.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -62.35 -39.31 92.72 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.361 0.982 . . . . 0.0 111.23 175.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.34 -46.34 90.27 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 118.771 0.714 . . . . 0.0 110.319 175.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 43.1 mtpt -66.75 -37.24 84.23 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 122.982 0.513 . . . . 0.0 110.904 177.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -83.7 -33.12 25.22 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 118.755 -0.641 . . . . 0.0 112.035 -170.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -128.52 5.65 5.66 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.858 0.863 . . . . 0.0 113.081 -169.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 64.84 3.64 2.12 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.555 1.942 . . . . 0.0 114.309 178.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.0 pp -65.11 156.4 5.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 123.777 0.831 . . . . 0.0 111.577 -173.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 51.5 mtt85 -71.1 143.59 50.58 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -176.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.9 m -141.13 141.76 30.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 169.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.447 ' H ' HG12 ' A' ' 8' ' ' ILE . 19.7 m -145.06 130.16 18.46 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 175.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -120.93 110.99 16.95 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 -169.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 11.9 m-90 -86.75 148.2 25.52 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -85.81 44.68 3.38 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 169.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.6 t70 . . . . . 0 C--O 1.25 1.086 0 C-N-CA 125.022 1.329 . . . . 0.0 111.397 -173.397 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.227 0 N-CA-C 111.181 -0.767 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.1 m -60.47 155.02 19.26 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.241 1.016 . . . . 0.0 111.36 177.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 179.8 -178.95 48.82 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -66.21 -38.45 87.99 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.114 0.566 . . . . 0.0 110.682 177.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.7 t -64.76 140.5 19.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 124.439 1.096 . . . . 0.0 108.867 179.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -149.13 178.84 8.37 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 124.443 1.097 . . . . 0.0 110.089 -174.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 38.3 m -132.28 153.4 50.71 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 169.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.406 HG12 ' H ' ' A' ' 32' ' ' THR . 5.3 pt -126.2 170.34 16.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 125.443 1.497 . . . . 0.0 108.109 -174.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.3 34.9 0.88 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.302 0.572 . . . . 0.0 111.092 174.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.3 m -74.33 158.37 5.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 O-C-N 121.205 -0.935 . . . . 0.0 109.769 176.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -169.72 154.97 24.55 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 108.521 -1.832 . . . . 0.0 108.521 169.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 51.54 28.76 22.52 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 124.385 0.993 . . . . 0.0 114.29 178.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 26.4 m -138.63 74.91 38.63 Favored Pre-proline 0 CA--C 1.537 0.446 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 -170.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -59.55 -27.51 85.15 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.327 2.018 . . . . 0.0 111.778 -177.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -63.6 -17.32 62.75 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.392 1.077 . . . . 0.0 112.168 -178.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -126.92 -34.56 2.35 Favored 'General case' 0 C--N 1.34 0.172 0 C-N-CA 123.453 0.701 . . . . 0.0 111.262 -177.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.16 -25.43 68.34 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 119.47 1.032 . . . . 0.0 110.155 173.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -68.47 -42.88 78.09 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.803 1.183 . . . . 0.0 110.79 173.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -75.29 -29.69 60.17 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.325 0.966 . . . . 0.0 111.536 178.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.0 mt -72.71 -34.87 67.41 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.445 1.021 . . . . 0.0 109.916 172.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.7 mmtt -60.02 -45.41 92.87 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 119.51 1.05 . . . . 0.0 109.829 169.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -57.82 -46.04 85.29 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.575 0.75 . . . . 0.0 109.717 177.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -60.73 -41.64 95.72 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.227 0.921 . . . . 0.0 110.704 176.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.95 -2.96 11.07 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 177.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -117.19 -26.12 6.88 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.978 1.311 . . . . 0.0 109.806 175.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.0 tttm -72.43 -39.95 67.46 Favored 'General case' 0 C--O 1.23 0.073 0 C-N-CA 124.844 1.258 . . . . 0.0 109.521 173.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -133.64 167.88 19.7 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.873 1.669 . . . . 0.0 108.954 178.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -78.82 4.04 15.08 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.722 1.209 . . . . 0.0 113.114 -174.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.1 pp -59.75 151.58 5.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 121.997 0.904 . . . . 0.0 112.978 -169.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.13 144.38 42.86 Favored 'General case' 0 C--O 1.23 0.076 0 C-N-CA 124.003 0.921 . . . . 0.0 109.05 178.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.1 m -143.46 153.76 16.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 125.79 1.636 . . . . 0.0 107.156 169.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.406 ' H ' HG12 ' A' ' 8' ' ' ILE . 25.6 m -146.75 141.65 26.95 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 173.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -128.39 111.83 13.75 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -169.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 18.6 m-90 -86.67 156.11 20.12 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 122.838 0.455 . . . . 0.0 110.679 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -83.46 48.49 4.05 Favored Glycine 0 CA--C 1.529 0.969 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 170.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.7 t70 . . . . . 0 C--O 1.247 0.942 0 C-N-CA 124.918 1.287 . . . . 0.0 111.513 -173.869 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.366 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.0 m -63.85 -24.77 67.88 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.322 1.049 . . . . 0.0 113.105 -176.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -178.72 -178.4 48.0 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 124.96 1.267 . . . . 0.0 109.935 178.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -70.33 -18.73 63.09 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.584 0.753 . . . . 0.0 111.857 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.7 t -59.76 142.97 14.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 O-C-N 121.419 -0.801 . . . . 0.0 109.818 -178.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.32 179.43 6.4 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.408 1.883 . . . . 0.0 106.945 170.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.8 m -140.05 152.27 46.07 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 126.456 1.902 . . . . 0.0 106.426 178.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.433 HG12 ' H ' ' A' ' 32' ' ' THR . 13.6 pt -128.33 170.82 17.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 125.052 1.341 . . . . 0.0 108.6 -170.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -150.89 37.88 0.65 Allowed 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 121.727 0.775 . . . . 0.0 110.335 176.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 27.2 m -68.75 152.36 9.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 O-C-N 121.325 -0.86 . . . . 0.0 111.42 -177.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -158.28 41.14 0.51 Allowed Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.071 1.32 . . . . 0.0 110.719 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 162.1 -170.49 37.77 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 108.979 -1.649 . . . . 0.0 108.979 -175.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.5 m 58.38 73.83 0.68 Allowed Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 124.954 1.301 . . . . 0.0 110.061 176.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -58.64 -23.37 65.23 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.396 2.064 . . . . 0.0 112.924 -177.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -62.7 -43.39 98.92 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.346 0.521 . . . . 0.0 110.191 172.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -74.92 -32.11 61.71 Favored 'General case' 0 N--CA 1.438 -1.069 0 C-N-CA 124.085 0.954 . . . . 0.0 109.721 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 78.3 mt -60.36 -43.67 96.32 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-N 120.086 1.312 . . . . 0.0 108.718 172.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -64.42 -47.23 79.92 Favored 'General case' 0 C--N 1.339 0.114 0 CA-C-O 119.212 -0.423 . . . . 0.0 110.323 176.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -63.18 -45.7 90.58 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.995 0.816 . . . . 0.0 111.091 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 73.2 mt -66.69 -37.23 84.31 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 118.815 0.734 . . . . 0.0 110.108 178.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -60.52 -41.06 93.64 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 119.194 0.906 . . . . 0.0 110.606 171.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -63.06 -40.89 99.02 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 118.707 0.685 . . . . 0.0 110.444 177.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -62.29 -41.57 98.61 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 119.472 1.033 . . . . 0.0 110.809 174.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.02 -45.34 95.18 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-N 118.623 0.647 . . . . 0.0 110.545 176.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -66.23 -35.55 80.71 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 119.072 -0.49 . . . . 0.0 111.044 177.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -81.64 -39.53 24.27 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.812 0.733 . . . . 0.0 111.748 -172.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -117.3 4.96 12.58 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.582 0.753 . . . . 0.0 112.855 -170.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 55.4 t30 65.54 1.32 1.66 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 127.141 2.177 . . . . 0.0 114.186 -178.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.7 pp -63.3 147.1 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 124.095 0.958 . . . . 0.0 111.079 -174.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -78.64 133.93 37.21 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.5 m -120.15 155.51 23.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 125.064 1.346 . . . . 0.0 108.396 173.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.433 ' H ' HG12 ' A' ' 8' ' ' ILE . 0.8 OUTLIER -137.94 92.57 2.68 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -169.728 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -92.43 93.98 8.87 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -175.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 5.9 m-90 -66.33 -46.31 77.29 Favored 'General case' 0 C--O 1.232 0.153 0 O-C-N 122.341 -0.224 . . . . 0.0 110.724 173.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.49 -50.14 3.14 Favored Glycine 0 CA--C 1.531 1.084 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -169.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.0 t70 . . . . . 0 C--O 1.249 1.037 0 C-N-CA 126.818 2.047 . . . . 0.0 108.259 169.52 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.252 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.8 m -143.91 164.8 29.53 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.124 1.37 . . . . 0.0 109.144 -177.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -177.71 177.95 48.37 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 30.1 tp60 -68.79 -27.97 66.36 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.265 0.626 . . . . 0.0 111.41 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.9 t -61.77 124.65 16.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 30.7 ptt-85 -160.58 -178.14 6.68 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.896 1.278 . . . . 0.0 108.704 -176.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.8 m -116.15 154.71 29.53 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 171.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 11.0 pt -120.99 174.98 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.985 1.314 . . . . 0.0 109.038 -171.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.9 68.31 0.88 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 175.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.8 m -122.33 166.04 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 177.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -169.25 -26.24 0.02 OUTLIER Glycine 0 CA--C 1.527 0.839 0 CA-C-N 115.623 -0.717 . . . . 0.0 113.879 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -157.95 38.61 0.53 Allowed Glycine 0 CA--C 1.527 0.798 0 C-N-CA 124.022 0.82 . . . . 0.0 111.274 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.5 p -68.33 159.72 79.31 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 123.806 0.842 . . . . 0.0 109.967 177.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -54.08 -41.73 73.05 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.783 2.322 . . . . 0.0 112.719 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -161.11 2.91 0.06 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.248 1.019 . . . . 0.0 112.692 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -68.95 -28.09 66.32 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 120.2 1.364 . . . . 0.0 110.501 -175.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.3 mt -51.18 -39.62 56.83 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 125.168 1.387 . . . . 0.0 109.755 169.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -71.43 -45.35 62.9 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-N 118.655 0.661 . . . . 0.0 109.46 -177.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.0 mmtt -64.0 -46.22 85.53 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -177.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 92.6 mt -73.08 -38.28 66.47 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 118.795 -0.621 . . . . 0.0 110.112 -176.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.9 tptt -59.84 -40.15 87.56 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.402 1.001 . . . . 0.0 110.848 170.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -63.7 -43.58 96.2 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 119.084 0.856 . . . . 0.0 110.077 176.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -60.7 -35.09 75.42 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 120.143 1.338 . . . . 0.0 111.686 177.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.78 -23.78 65.28 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.04 0.836 . . . . 0.0 112.099 173.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -104.84 -20.72 13.5 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.068 1.347 . . . . 0.0 111.776 -177.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -110.69 -20.34 12.55 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 119.324 0.965 . . . . 0.0 112.358 -173.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -129.97 0.06 4.75 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.231 1.412 . . . . 0.0 111.539 178.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 63.77 6.94 2.92 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 127.05 2.14 . . . . 0.0 114.316 177.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.3 pp -65.03 157.0 5.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 O-C-N 121.63 -0.668 . . . . 0.0 111.878 -171.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 96.9 mtt-85 -67.35 142.11 56.89 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 22.6 m -137.61 151.96 26.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 173.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.8 m -146.18 130.91 17.97 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -125.16 112.48 16.5 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -169.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 8.2 m-90 -78.29 158.31 28.93 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.889 0.876 . . . . 0.0 110.533 178.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -82.53 48.06 3.89 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 109.866 -1.293 . . . . 0.0 109.866 169.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.2 t70 . . . . . 0 C--O 1.247 0.935 0 C-N-CA 124.914 1.286 . . . . 0.0 111.363 -174.228 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.337 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.8 p -66.14 -29.5 69.81 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.353 1.061 . . . . 0.0 112.351 178.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 171.35 -168.46 41.59 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -71.02 25.06 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.481 1.513 . . . . 0.0 113.677 178.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.1 t -61.27 147.25 10.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 125.708 1.603 . . . . 0.0 110.111 -174.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -151.41 174.94 12.76 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 126.196 1.798 . . . . 0.0 108.69 -174.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.8 m -136.69 147.74 46.96 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 169.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.7 pt -126.68 163.5 28.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 123.638 0.775 . . . . 0.0 108.936 -169.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.28 40.77 0.87 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.669 0.788 . . . . 0.0 109.254 176.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 27.5 m -67.07 133.18 31.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 O-C-N 121.243 -0.91 . . . . 0.0 108.584 177.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.46 -52.58 42.13 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 171.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 160.12 41.91 0.02 OUTLIER Glycine 0 CA--C 1.526 0.763 0 CA-C-O 119.086 -0.841 . . . . 0.0 112.923 176.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.7 m -67.05 123.17 85.58 Favored Pre-proline 0 N--CA 1.454 -0.227 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 176.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -50.91 -34.77 47.0 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.274 1.983 . . . . 0.0 113.218 -178.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -74.48 -36.29 63.28 Favored 'General case' 0 N--CA 1.456 -0.148 0 O-C-N 122.121 -0.362 . . . . 0.0 110.161 -175.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -80.6 -35.88 33.52 Favored 'General case' 0 CA--C 1.521 -0.142 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -177.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 88.0 mt -56.62 -41.87 77.84 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 169.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -66.77 -56.45 10.44 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 118.544 0.611 . . . . 0.0 109.907 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -61.94 -45.35 94.05 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 118.495 0.589 . . . . 0.0 111.083 -175.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.4 mt -74.62 -35.08 62.92 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 118.517 -0.754 . . . . 0.0 110.382 -174.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.4 tptt -61.76 -39.87 93.16 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 119.935 1.243 . . . . 0.0 110.092 169.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -63.06 -39.14 93.84 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.95 0.795 . . . . 0.0 110.407 178.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -63.9 -40.43 96.49 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 119.866 1.212 . . . . 0.0 111.336 172.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.7 -23.99 66.89 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.048 0.84 . . . . 0.0 112.343 177.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 41.4 mtpt -84.35 -38.09 20.77 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.643 0.777 . . . . 0.0 110.11 172.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -70.47 -42.21 71.74 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.883 0.873 . . . . 0.0 110.426 -174.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -135.84 165.71 25.0 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.064 1.346 . . . . 0.0 109.738 -173.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -71.03 7.04 1.31 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.064 1.346 . . . . 0.0 113.535 -175.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.0 pp -64.42 154.66 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 124.294 1.038 . . . . 0.0 111.347 -171.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -89.95 152.15 21.35 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.014 0.435 . . . . 0.0 110.307 178.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.0 m -142.89 157.07 17.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 125.9 1.68 . . . . 0.0 107.568 174.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 32.2 m -149.41 133.53 17.23 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 173.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -121.76 110.45 15.94 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 -169.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -70.68 -32.7 70.05 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -170.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 64.49 39.9 97.23 Favored Glycine 0 CA--C 1.532 1.113 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -172.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.5 t70 . . . . . 0 C--O 1.248 0.989 0 C-N-CA 125.037 1.335 . . . . 0.0 111.298 -176.682 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.3 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.1 m -64.13 -24.67 67.78 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.219 1.008 . . . . 0.0 113.078 -176.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -178.68 -178.51 48.05 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 109.914 -1.275 . . . . 0.0 109.914 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -139.88 18.1 2.48 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.388 1.075 . . . . 0.0 111.699 -177.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.2 t -59.54 139.9 18.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 123.617 0.767 . . . . 0.0 109.583 -176.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 33.0 ptt85 -144.28 167.36 22.63 Favored 'General case' 0 C--O 1.231 0.1 0 C-N-CA 125.495 1.518 . . . . 0.0 107.691 175.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.3 m -126.99 153.57 45.73 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.428 HG12 ' H ' ' A' ' 32' ' ' THR . 10.5 pt -126.78 170.56 16.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 124.658 1.183 . . . . 0.0 108.163 -173.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.13 75.68 1.45 Allowed 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 -178.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.7 m -125.08 153.53 32.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 C-N-CA 123.434 0.694 . . . . 0.0 109.713 -173.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -81.68 33.34 2.58 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 124.477 1.037 . . . . 0.0 112.574 -177.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 54.81 39.01 66.04 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-N 118.084 0.942 . . . . 0.0 111.428 -172.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -60.59 126.69 85.51 Favored Pre-proline 0 N--CA 1.451 -0.414 0 C-N-CA 125.038 1.335 . . . . 0.0 109.459 -169.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -53.59 -23.24 24.84 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.187 2.591 . . . . 0.0 113.91 173.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -92.37 -4.18 54.22 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.246 1.018 . . . . 0.0 111.878 -177.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -117.45 -36.69 3.66 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 123.763 0.825 . . . . 0.0 109.424 -178.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 28.4 mt -47.05 -34.65 6.01 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.523 1.129 . . . . 0.0 111.481 169.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.4 mttp -56.62 -25.66 53.76 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -118.53 -38.56 3.12 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 118.97 0.804 . . . . 0.0 110.303 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -68.39 -41.07 81.04 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-N 118.468 0.576 . . . . 0.0 111.277 -175.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 48.9 tptt -68.92 -34.74 75.88 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 118.499 0.591 . . . . 0.0 110.092 176.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -63.62 -45.39 90.52 Favored 'General case' 0 C--O 1.222 -0.367 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 175.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -60.1 -41.6 92.86 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 119.287 0.949 . . . . 0.0 110.516 178.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.13 -2.59 4.34 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.485 1.114 . . . . 0.0 113.829 176.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -121.72 -27.4 4.7 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.226 1.41 . . . . 0.0 110.308 175.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -70.41 -39.94 74.14 Favored 'General case' 0 C--N 1.338 0.107 0 C-N-CA 124.109 0.963 . . . . 0.0 109.343 175.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -122.84 166.58 14.76 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.729 1.211 . . . . 0.0 109.195 178.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -73.23 -1.31 17.25 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.632 1.173 . . . . 0.0 113.014 -178.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.2 pp -61.39 162.61 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 124.669 1.188 . . . . 0.0 110.83 -178.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.48 147.66 52.57 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.0 m -127.07 167.54 21.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 124.853 1.261 . . . . 0.0 110.173 -169.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.428 ' H ' HG12 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -129.69 125.19 35.4 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.277 1.431 . . . . 0.0 108.657 -169.727 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -128.56 94.83 3.97 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 -175.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -71.75 -24.7 61.82 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -171.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.16 25.75 68.54 Favored Glycine 0 CA--C 1.537 1.465 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 -169.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.5 t70 . . . . . 0 C--O 1.249 1.038 0 C-N-CA 125.394 1.478 . . . . 0.0 111.48 -177.439 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.293 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.2 m -143.48 161.01 39.54 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.173 1.389 . . . . 0.0 109.048 -177.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -151.34 23.99 0.97 Allowed Glycine 0 CA--C 1.529 0.924 0 C-N-CA 123.636 0.636 . . . . 0.0 112.71 -175.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -61.77 149.4 40.02 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 117.946 0.873 . . . . 0.0 108.77 171.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.9 t -138.51 135.64 43.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 172.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 36.9 mtp180 -144.64 160.6 40.92 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 129.171 2.989 . . . . 0.0 104.146 170.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.5 m -139.84 151.84 46.01 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 169.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.479 HG12 ' H ' ' A' ' 32' ' ' THR . 2.5 pt -127.2 165.89 25.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.216 1.006 . . . . 0.0 109.007 -169.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -142.91 40.85 1.53 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.804 0.842 . . . . 0.0 109.593 -178.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 34.6 m -69.25 144.1 14.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 O-C-N 121.425 -0.797 . . . . 0.0 109.365 178.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -166.48 30.93 0.2 Allowed Glycine 0 CA--C 1.528 0.878 0 C-N-CA 123.573 0.606 . . . . 0.0 112.591 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -176.32 27.02 0.07 OUTLIER Glycine 0 CA--C 1.529 0.911 0 CA-C-N 117.705 0.753 . . . . 0.0 112.644 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.0 p -143.83 59.68 7.45 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 125.304 1.442 . . . . 0.0 108.226 -169.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -62.42 -26.05 76.44 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.6 2.2 . . . . 0.0 113.11 -169.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -71.27 -30.82 66.75 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.454 0.57 . . . . 0.0 110.96 177.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -75.64 -19.4 59.22 Favored 'General case' 0 N--CA 1.462 0.144 0 O-C-N 121.262 -0.899 . . . . 0.0 111.358 -176.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.0 mt -52.54 -31.21 34.55 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.116 0.966 . . . . 0.0 110.613 169.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 42.0 mtmt -62.66 -32.23 73.26 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 118.837 0.744 . . . . 0.0 111.444 177.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -85.39 -48.89 8.58 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 177.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -64.66 -40.84 96.13 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.309 0.644 . . . . 0.0 111.478 -170.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -64.7 -31.46 72.69 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 119.012 -0.518 . . . . 0.0 111.14 175.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -68.82 -46.58 68.21 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 118.921 0.782 . . . . 0.0 109.1 174.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -59.07 -37.75 77.82 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 119.451 1.023 . . . . 0.0 111.062 177.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.25 -13.89 21.96 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.253 1.021 . . . . 0.0 113.572 176.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -117.38 -30.49 5.55 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 125.052 1.341 . . . . 0.0 110.291 -179.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -77.66 -24.32 49.44 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 123.967 0.907 . . . . 0.0 111.109 177.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -138.83 168.72 19.19 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.69 1.196 . . . . 0.0 110.303 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -71.78 -10.35 59.64 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.423 1.489 . . . . 0.0 113.359 -177.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.8 pp -58.15 151.32 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 124.458 1.103 . . . . 0.0 113.547 -169.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 43.7 ttm105 -83.67 150.16 26.04 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 174.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.6 m -135.85 149.06 27.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 107.273 -1.381 . . . . 0.0 107.273 169.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.479 ' H ' HG12 ' A' ' 8' ' ' ILE . 2.6 m -144.66 139.75 28.2 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 178.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -131.12 118.26 20.26 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 -169.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 12.9 m-90 -95.82 151.24 19.57 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 122.907 0.483 . . . . 0.0 109.955 173.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -72.96 -41.77 47.34 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 108.928 -1.669 . . . . 0.0 108.928 169.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.3 t70 . . . . . 0 C--O 1.246 0.907 0 C-N-CA 126.996 2.119 . . . . 0.0 107.719 169.889 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.387 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.9 m -64.18 -23.96 67.51 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.229 1.011 . . . . 0.0 113.157 -176.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -177.27 179.9 47.86 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 109.859 -1.297 . . . . 0.0 109.859 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -155.07 164.17 39.25 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.983 1.313 . . . . 0.0 109.047 177.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.4 p -143.74 127.53 13.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 106.314 -1.736 . . . . 0.0 106.314 169.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.75 170.31 18.56 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.595 1.558 . . . . 0.0 108.336 177.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.3 m -97.85 161.53 13.7 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 169.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.402 HG12 ' H ' ' A' ' 32' ' ' THR . 17.7 pt -120.2 174.37 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 125.127 1.371 . . . . 0.0 108.041 -179.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.51 88.15 1.69 Allowed 'General case' 0 C--O 1.232 0.173 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 169.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.7 p -134.02 155.76 40.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -171.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -175.91 -65.68 0.06 OUTLIER Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.782 -0.527 . . . . 0.0 111.782 170.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -83.0 39.15 2.73 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 124.341 0.972 . . . . 0.0 112.398 -174.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.1 p -148.36 71.44 10.89 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 126.617 1.967 . . . . 0.0 106.07 -169.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -52.61 -34.78 64.84 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 123.045 2.497 . . . . 0.0 114.128 -169.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -66.49 -36.9 83.88 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.938 0.399 . . . . 0.0 110.211 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -76.2 -25.27 54.99 Favored 'General case' 0 N--CA 1.454 -0.236 0 O-C-N 121.719 -0.613 . . . . 0.0 110.52 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 91.2 mt -61.27 -37.81 84.48 Favored 'General case' 0 C--O 1.227 -0.127 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 169.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -70.96 -49.85 40.92 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 119.083 0.856 . . . . 0.0 109.47 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -59.43 -48.19 82.61 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 117.834 0.288 . . . . 0.0 110.6 -178.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.0 mt -74.58 -33.75 62.73 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 118.356 -0.83 . . . . 0.0 110.296 -175.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -61.13 -37.95 84.64 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 120.102 1.319 . . . . 0.0 110.464 169.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -62.7 -45.73 91.43 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 119.788 1.176 . . . . 0.0 109.406 175.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -59.12 -28.68 66.76 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 118.818 -0.61 . . . . 0.0 112.304 175.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.33 -21.57 64.11 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.363 0.983 . . . . 0.0 112.771 175.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.41 -33.06 10.15 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 118.548 0.613 . . . . 0.0 110.454 169.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -67.46 -29.37 68.81 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 118.842 0.746 . . . . 0.0 111.08 -175.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -140.62 179.82 6.47 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.823 1.649 . . . . 0.0 109.775 -174.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -91.85 11.39 25.01 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.911 1.284 . . . . 0.0 112.105 -173.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.8 pt -61.97 156.02 4.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 124.423 1.089 . . . . 0.0 112.131 -171.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.1 ptm180 -107.12 74.77 0.99 Allowed 'General case' 0 C--O 1.235 0.319 0 C-N-CA 123.901 0.881 . . . . 0.0 109.263 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 29.8 m -54.5 139.57 13.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.056 178.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.402 ' H ' HG12 ' A' ' 8' ' ' ILE . 14.9 m -142.87 119.91 11.38 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 104.562 -2.385 . . . . 0.0 104.562 -175.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -114.58 111.04 20.73 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -169.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 9.7 m-90 -80.07 154.52 28.07 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.144 0.578 . . . . 0.0 110.037 175.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -86.81 40.09 3.08 Favored Glycine 0 CA--C 1.532 1.121 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 169.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.3 t70 . . . . . 0 C--O 1.248 0.999 0 C-N-CA 125.129 1.372 . . . . 0.0 111.192 -173.89 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.358 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.9 m -143.79 164.39 30.64 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.078 1.351 . . . . 0.0 109.26 -177.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -178.97 179.82 48.82 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 178.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -66.54 -35.66 80.78 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.093 0.557 . . . . 0.0 110.951 178.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.9 p -61.63 147.35 11.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 123.743 0.817 . . . . 0.0 110.648 -177.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -148.1 171.4 15.93 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 125.348 1.459 . . . . 0.0 109.263 -175.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.3 m -134.51 153.85 51.73 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 171.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.419 HG12 ' H ' ' A' ' 32' ' ' THR . 7.7 pt -129.3 167.51 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 125.713 1.605 . . . . 0.0 107.755 -175.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.31 39.56 0.91 Allowed 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.533 0.683 . . . . 0.0 110.603 175.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 28.3 m -69.03 144.87 13.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 O-C-N 121.289 -0.882 . . . . 0.0 109.866 176.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -172.1 147.6 10.15 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 106.632 -2.587 . . . . 0.0 106.632 172.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 55.06 24.58 35.77 Favored Glycine 0 CA--C 1.537 1.451 0 CA-C-N 117.797 0.799 . . . . 0.0 113.422 -170.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -140.63 61.12 14.98 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 125.289 1.436 . . . . 0.0 109.711 -171.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -62.27 -23.81 75.56 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.517 2.145 . . . . 0.0 112.711 -175.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -67.36 -19.22 65.4 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.033 0.933 . . . . 0.0 112.271 176.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -90.19 -26.14 20.27 Favored 'General case' 0 N--CA 1.465 0.275 0 O-C-N 121.392 -0.817 . . . . 0.0 110.174 -178.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 59.0 mt -55.05 -30.06 58.8 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 169.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -64.68 -23.71 67.34 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 119.051 -0.499 . . . . 0.0 112.041 -177.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -99.76 -45.6 5.69 Favored 'General case' 0 C--N 1.34 0.156 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 176.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 83.5 mt -72.4 -29.89 64.15 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 118.648 -0.691 . . . . 0.0 111.702 -169.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 27.0 mmtp -62.98 -38.35 90.79 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 119.578 1.081 . . . . 0.0 110.43 169.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -63.93 -45.99 86.77 Favored 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -59.82 -42.47 93.6 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.432 1.015 . . . . 0.0 111.036 177.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.91 -6.15 11.5 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.387 1.075 . . . . 0.0 113.889 177.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -121.57 -25.05 5.2 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.068 1.347 . . . . 0.0 110.052 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -70.15 -40.46 74.75 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 125.054 1.342 . . . . 0.0 108.837 172.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -134.97 166.23 23.51 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.714 1.206 . . . . 0.0 109.236 175.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -76.2 10.36 2.02 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.796 1.239 . . . . 0.0 112.954 -176.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.4 pp -62.17 153.4 6.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-O 122.093 0.949 . . . . 0.0 112.667 -169.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.93 144.26 47.38 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 124.14 0.976 . . . . 0.0 109.329 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.5 m -143.56 152.59 16.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 125.955 1.702 . . . . 0.0 106.497 169.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.419 ' H ' HG12 ' A' ' 8' ' ' ILE . 27.5 m -143.84 133.42 23.56 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 173.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -120.67 102.19 8.24 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -169.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 24.3 m-90 -75.87 155.19 35.52 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 171.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -66.88 -49.66 52.96 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 108.285 -1.926 . . . . 0.0 108.285 169.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.3 t70 . . . . . 0 C--O 1.246 0.881 0 C-N-CA 126.871 2.069 . . . . 0.0 107.797 169.919 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.253 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.4 m -59.04 149.87 26.38 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.275 1.03 . . . . 0.0 111.309 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 177.09 -172.41 45.32 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.0 tp60 64.51 -9.74 0.17 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 127.329 2.252 . . . . 0.0 115.268 174.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 32.6 m -52.12 141.85 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 120.112 1.324 . . . . 0.0 111.652 -175.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 69.9 mtm-85 -124.75 -31.69 3.16 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 118.487 -0.768 . . . . 0.0 112.951 176.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.4 m 64.61 151.84 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.032 1.333 . . . . 0.0 110.056 -169.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.402 HG12 ' H ' ' A' ' 32' ' ' THR . 8.0 pt -135.2 172.53 15.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 125.029 1.332 . . . . 0.0 108.615 -169.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.2 37.17 0.54 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.233 0.613 . . . . 0.0 110.962 177.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.1 m -67.33 153.44 8.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 O-C-N 121.069 -1.019 . . . . 0.0 112.47 -174.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 174.64 139.54 3.03 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 108.512 -1.835 . . . . 0.0 108.512 176.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 64.11 29.36 74.71 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-N 117.181 0.491 . . . . 0.0 111.92 -172.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.4 p -141.25 65.23 21.47 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 125.462 1.505 . . . . 0.0 108.286 -172.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.15 -23.89 31.15 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 124.078 3.185 . . . . 0.0 115.841 -169.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -102.41 -11.59 18.5 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.783 0.833 . . . . 0.0 111.429 -173.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -88.77 -40.39 13.24 Favored 'General case' 0 CA--C 1.519 -0.225 0 O-C-N 121.103 -0.998 . . . . 0.0 108.583 -176.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.4 pp -57.28 -25.69 59.64 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-O 118.535 -0.745 . . . . 0.0 110.989 169.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -73.09 -45.89 54.54 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.337 0.971 . . . . 0.0 110.023 177.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -63.21 -43.71 97.36 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 177.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.1 mt -68.64 -38.78 80.75 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 118.78 -0.628 . . . . 0.0 110.296 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -58.86 -41.5 87.15 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.579 1.081 . . . . 0.0 110.726 171.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -61.3 -41.98 97.89 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.9 0.773 . . . . 0.0 110.041 176.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -62.72 -38.53 90.83 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 119.419 1.009 . . . . 0.0 111.802 174.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.86 -30.83 71.88 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.972 0.806 . . . . 0.0 111.561 177.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -80.21 -35.85 35.65 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.222 0.609 . . . . 0.0 110.216 174.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -76.84 -40.63 47.1 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 118.574 0.625 . . . . 0.0 111.174 -173.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -132.08 175.14 9.49 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.835 1.254 . . . . 0.0 111.13 -169.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -65.35 -17.7 64.73 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.819 1.248 . . . . 0.0 113.541 -177.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.0 pp -55.79 144.89 6.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 123.9 0.88 . . . . 0.0 112.759 -169.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 8.4 ptm85 -83.9 161.58 20.8 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 121.181 0.515 . . . . 0.0 109.845 171.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.8 m -140.3 156.07 23.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 125.24 1.416 . . . . 0.0 108.158 171.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.402 ' H ' HG12 ' A' ' 8' ' ' ILE . 2.2 m -144.59 124.06 13.15 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 -177.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -119.19 83.89 2.11 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.223 0.609 . . . . 0.0 109.751 -169.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 13.5 m-90 -64.28 -42.68 96.3 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.46 173.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 65.3 29.35 75.06 Favored Glycine 0 CA--C 1.535 1.333 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 -169.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.9 t70 . . . . . 0 C--O 1.248 1.008 0 C-N-CA 125.075 1.35 . . . . 0.0 111.581 -175.388 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.351 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.8 m -57.18 -26.06 59.99 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.779 1.231 . . . . 0.0 113.62 -173.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -59.53 -19.64 48.75 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 123.879 0.752 . . . . 0.0 113.562 176.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 18.9 tp60 -66.19 -27.42 67.98 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.691 1.246 . . . . 0.0 111.784 175.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.0 t -63.57 138.99 22.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -149.27 174.35 12.5 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 124.909 1.284 . . . . 0.0 109.816 -174.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.9 m -108.15 160.3 15.92 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.563 1.545 . . . . 0.0 108.426 172.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.447 HG12 ' H ' ' A' ' 32' ' ' THR . 4.8 pt -131.95 163.66 36.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 169.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.78 73.18 1.33 Allowed 'General case' 0 C--O 1.233 0.21 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 175.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.3 m -125.52 162.13 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 121.876 0.846 . . . . 0.0 111.624 -173.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -176.71 165.58 35.88 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 126.12 1.819 . . . . 0.0 108.953 171.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 57.75 19.87 37.59 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 124.324 0.964 . . . . 0.0 114.7 173.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.2 m -140.74 73.01 29.03 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 118.325 1.062 . . . . 0.0 108.997 -171.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -44.02 -34.91 6.89 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.706 2.937 . . . . 0.0 113.644 173.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 51.3 mp0 -66.52 -9.68 37.13 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.43 1.892 . . . . 0.0 112.589 -176.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -130.15 -44.73 1.14 Allowed 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 125.219 1.408 . . . . 0.0 108.786 -178.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.1 pp -68.2 -27.23 66.21 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 119.888 1.222 . . . . 0.0 111.439 -175.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -68.0 -39.15 83.26 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 120.122 1.328 . . . . 0.0 110.417 171.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -68.63 -42.33 78.19 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 118.616 0.644 . . . . 0.0 109.736 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 79.3 mt -69.46 -34.82 74.94 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.458 0.572 . . . . 0.0 110.509 177.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -61.08 -42.8 99.18 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 119.285 0.948 . . . . 0.0 110.563 169.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -62.32 -38.19 88.46 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.76 0.709 . . . . 0.0 110.101 176.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -62.23 -41.71 98.65 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.174 0.99 . . . . 0.0 110.586 176.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.13 -45.76 91.91 Favored 'General case' 0 C--N 1.338 0.089 0 C-N-CA 122.869 0.467 . . . . 0.0 110.481 174.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -66.06 -32.77 74.44 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 119.038 -0.506 . . . . 0.0 111.161 177.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.2 ttpt -81.16 -49.19 11.12 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 118.955 0.798 . . . . 0.0 110.823 -173.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.99 7.33 21.55 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.137 0.975 . . . . 0.0 112.999 -169.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 54.5 t30 65.58 1.66 1.79 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.913 2.085 . . . . 0.0 114.094 -178.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.6 pp -63.23 147.49 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 121.626 0.727 . . . . 0.0 111.368 -172.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 43.1 ptt85 -67.59 149.41 50.12 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.572 175.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.6 m -144.08 152.8 15.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 125.323 1.449 . . . . 0.0 107.769 176.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.447 ' H ' HG12 ' A' ' 8' ' ' ILE . 10.9 m -140.85 127.29 19.95 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -178.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -121.05 102.09 8.1 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -170.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 1.9 m-90 -70.87 -34.45 71.63 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 123.558 0.743 . . . . 0.0 112.441 -175.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.16 27.26 72.81 Favored Glycine 0 CA--C 1.535 1.324 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 -169.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 22.8 t70 . . . . . 0 C--O 1.25 1.096 0 C-N-CA 125.083 1.353 . . . . 0.0 111.25 -177.759 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.288 0 N-CA-C 111.707 -0.557 . . . . 0.0 111.707 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.9 p -66.74 -30.48 70.71 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.406 1.082 . . . . 0.0 112.287 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 70.04 -160.03 53.34 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 -177.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.6 pm0 -68.55 1.4 3.15 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.644 1.578 . . . . 0.0 114.676 -173.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.9 p -55.51 145.62 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 124.134 0.974 . . . . 0.0 111.372 -177.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 40.4 ptt85 -147.81 174.8 11.48 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 125.19 1.396 . . . . 0.0 108.438 171.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 92.5 m -123.7 155.17 38.31 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 174.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.8 pt -128.41 172.75 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.865 1.666 . . . . 0.0 108.266 -169.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.63 35.67 0.71 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 118.505 0.593 . . . . 0.0 111.639 174.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.0 m -67.63 146.09 13.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 O-C-N 121.165 -0.959 . . . . 0.0 109.244 177.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -88.41 39.12 3.13 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.164 0.888 . . . . 0.0 110.913 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 54.81 33.12 55.71 Favored Glycine 0 CA--C 1.533 1.188 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 -169.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.14 125.37 85.27 Favored Pre-proline 0 N--CA 1.448 -0.53 0 C-N-CA 125.66 1.584 . . . . 0.0 110.078 -169.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -56.14 -15.41 14.14 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.621 2.881 . . . . 0.0 114.986 174.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -94.14 -15.72 24.41 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.574 1.15 . . . . 0.0 111.561 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -116.48 -35.42 4.27 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 121.44 -0.787 . . . . 0.0 111.043 -169.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 76.1 mt -51.51 -30.89 21.83 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.654 0.661 . . . . 0.0 110.97 170.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -58.0 -23.28 53.38 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 125.035 1.334 . . . . 0.0 112.835 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -113.2 -41.48 3.69 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 123.761 0.824 . . . . 0.0 109.537 176.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -64.32 -40.4 95.84 Favored 'General case' 0 N--CA 1.457 -0.088 0 C-N-CA 122.924 0.49 . . . . 0.0 112.023 -174.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -66.48 -37.64 85.55 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 118.86 0.754 . . . . 0.0 110.12 178.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -63.66 -47.63 80.49 Favored 'General case' 0 C--O 1.225 -0.217 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 175.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -59.6 -40.25 86.88 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.109 0.964 . . . . 0.0 111.051 -179.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.99 -43.61 70.13 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 124.172 0.989 . . . . 0.0 110.955 177.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -82.12 -34.24 29.31 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 119.302 -0.38 . . . . 0.0 111.151 177.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -71.29 -39.97 71.16 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 118.614 0.643 . . . . 0.0 110.717 -170.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -119.05 6.98 11.3 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.763 0.825 . . . . 0.0 112.082 -172.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 55.7 t30 62.39 1.01 0.67 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 127.07 2.148 . . . . 0.0 114.602 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.7 pp -62.56 152.95 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.517 1.127 . . . . 0.0 111.497 -174.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.07 152.1 44.34 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 172.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.8 m -141.22 149.17 20.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 169.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.5 m -143.18 132.82 23.74 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -122.78 105.19 9.82 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -169.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 13.6 m-90 -79.81 153.37 29.18 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 122.45 0.3 . . . . 0.0 110.396 -177.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -84.62 43.87 3.28 Favored Glycine 0 CA--C 1.532 1.107 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 169.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.0 t70 . . . . . 0 C--O 1.248 0.982 0 C-N-CA 125.066 1.346 . . . . 0.0 111.251 -173.478 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.341 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.6 m -60.39 154.76 19.63 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.262 1.025 . . . . 0.0 111.401 178.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 178.22 -178.21 48.52 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 179.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 41.3 tp60 -65.65 -33.51 76.07 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 122.961 0.504 . . . . 0.0 110.83 177.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -61.63 123.5 14.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 C-N-CA 123.62 0.768 . . . . 0.0 109.422 176.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 29.4 ptt-85 -161.29 158.49 27.21 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 123.981 0.912 . . . . 0.0 109.005 -175.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.8 m -82.31 158.85 23.28 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 169.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.4 pt -125.99 168.42 18.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 125.141 1.376 . . . . 0.0 108.432 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.13 49.1 1.27 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.939 0.876 . . . . 0.0 110.118 176.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.1 t -60.38 134.08 25.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 169.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -147.92 -26.94 0.07 OUTLIER Glycine 0 CA--C 1.524 0.6 0 CA-C-O 119.482 -0.621 . . . . 0.0 114.175 -172.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -166.21 44.55 0.27 Allowed Glycine 0 CA--C 1.523 0.566 0 N-CA-C 108.249 -1.94 . . . . 0.0 108.249 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -138.58 78.03 32.68 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 125.663 1.585 . . . . 0.0 108.15 -168.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -63.16 -21.66 72.54 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 121.906 1.738 . . . . 0.0 112.093 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -66.53 -20.18 65.96 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.572 -0.705 . . . . 0.0 111.641 173.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -90.05 -38.15 13.78 Favored 'General case' 0 C--N 1.338 0.099 0 O-C-N 121.629 -0.669 . . . . 0.0 109.599 174.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.3 mt -55.59 -32.52 63.15 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.23 0.923 . . . . 0.0 110.433 169.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -64.48 -21.8 66.77 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.205 1.002 . . . . 0.0 112.499 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -126.91 -45.35 1.59 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 119.247 0.93 . . . . 0.0 111.969 -169.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 32.4 mt -70.85 -30.52 66.95 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 121.504 -0.747 . . . . 0.0 110.749 -174.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -62.31 -37.61 86.24 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.059 0.845 . . . . 0.0 111.003 170.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -68.23 -41.45 81.21 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 175.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -60.37 -37.42 80.69 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 121.387 -0.821 . . . . 0.0 111.317 178.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.99 -11.81 9.37 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.692 1.197 . . . . 0.0 113.707 174.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -118.18 -26.64 6.28 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.476 1.51 . . . . 0.0 109.75 -179.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -71.3 -37.8 71.81 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 123.623 0.769 . . . . 0.0 109.731 173.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -134.93 169.24 17.7 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 125.416 1.486 . . . . 0.0 109.249 -178.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -75.94 -1.46 25.67 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.37 1.068 . . . . 0.0 113.043 -176.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.3 pp -58.67 147.29 7.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 123.946 0.898 . . . . 0.0 111.638 -171.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 31.8 ptt-85 -75.06 153.61 38.32 Favored 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 123.142 0.577 . . . . 0.0 109.684 174.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.6 m -141.19 155.03 20.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 124.971 1.309 . . . . 0.0 107.647 171.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.0 m -149.38 141.17 23.64 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 173.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -130.32 110.45 11.53 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -169.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 18.4 m-90 -85.51 170.36 12.72 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.946 0.898 . . . . 0.0 109.778 172.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -130.57 65.45 0.59 Allowed Glycine 0 CA--C 1.524 0.602 0 N-CA-C 105.883 -2.887 . . . . 0.0 105.883 171.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.4 t70 . . . . . 0 C--O 1.247 0.962 0 C-N-CA 125.256 1.423 . . . . 0.0 111.582 -169.855 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.306 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.4 p -66.88 -28.75 68.58 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.099 0.96 . . . . 0.0 112.337 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 56.71 41.93 90.69 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 123.886 0.755 . . . . 0.0 111.832 -178.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 51.21 20.93 0.98 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 127.827 2.451 . . . . 0.0 115.291 -177.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.2 p -45.93 134.74 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 125.412 1.485 . . . . 0.0 113.464 -171.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -160.22 179.22 8.88 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 126.581 1.952 . . . . 0.0 108.566 177.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.9 m -123.63 156.88 35.0 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 126.33 1.852 . . . . 0.0 107.196 175.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.423 HG12 ' H ' ' A' ' 32' ' ' THR . 4.3 pt -118.5 167.42 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.671 1.189 . . . . 0.0 108.835 -174.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -147.0 69.85 1.18 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 174.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.5 m -118.31 158.09 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 122.999 0.52 . . . . 0.0 110.158 -177.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 173.97 150.14 7.44 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 108.291 -1.924 . . . . 0.0 108.291 178.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 61.78 31.02 76.66 Favored Glycine 0 CA--C 1.534 1.279 0 N-CA-C 111.77 -0.532 . . . . 0.0 111.77 -171.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.0 p -138.0 58.39 15.52 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 125.703 1.601 . . . . 0.0 108.995 -169.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -62.66 -20.42 70.87 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.027 2.485 . . . . 0.0 113.316 -169.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -87.91 -4.3 58.85 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.501 0.72 . . . . 0.0 112.155 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -127.69 -34.44 2.2 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.572 0.749 . . . . 0.0 110.692 -173.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.6 pp -62.31 -25.26 67.77 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-O 118.129 -0.938 . . . . 0.0 110.62 169.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.0 ptpp? -68.42 -37.67 80.51 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 119.987 1.267 . . . . 0.0 111.299 171.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -69.86 -43.45 71.86 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 72.3 mt -69.55 -34.08 73.69 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 118.986 -0.531 . . . . 0.0 110.546 177.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -62.32 -39.43 93.01 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.583 1.083 . . . . 0.0 111.297 171.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -59.9 -46.85 88.02 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.696 1.135 . . . . 0.0 109.141 172.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -57.25 -33.32 67.47 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.565 1.146 . . . . 0.0 111.517 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.77 -23.45 66.2 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.129 0.972 . . . . 0.0 112.771 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.36 -31.62 11.24 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 123.018 0.527 . . . . 0.0 110.28 171.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.2 ttmt -66.5 -36.43 82.7 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 118.602 0.637 . . . . 0.0 111.342 -176.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -134.82 176.22 8.84 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.743 1.217 . . . . 0.0 111.06 -169.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -80.32 1.76 27.44 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.68 1.192 . . . . 0.0 112.216 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.1 pp -59.98 158.86 1.94 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 124.0 0.92 . . . . 0.0 110.352 177.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -116.98 154.44 30.89 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 172.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 29.0 m -128.94 147.99 33.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 123.316 0.647 . . . . 0.0 110.14 -175.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.423 ' H ' HG12 ' A' ' 8' ' ' ILE . 16.0 m -144.76 131.23 19.8 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 176.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -123.51 110.23 14.8 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -169.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 11.3 m-90 -74.09 158.54 34.07 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.862 0.865 . . . . 0.0 109.652 172.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -65.57 -44.59 92.53 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 108.802 -1.719 . . . . 0.0 108.802 169.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.5 t70 . . . . . 0 C--O 1.246 0.887 0 C-N-CA 127.111 2.164 . . . . 0.0 107.676 169.806 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.299 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.2 m -143.57 162.94 34.57 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.1 1.36 . . . . 0.0 109.198 -177.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 177.91 -178.31 48.45 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.07 24.3 2.35 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.176 0.99 . . . . 0.0 111.566 -178.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.5 t -64.92 132.16 30.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 33.5 ptt-85 -155.74 157.07 35.96 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 124.386 1.074 . . . . 0.0 108.508 171.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.8 m -81.37 160.1 24.19 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 169.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.9 pt -122.66 167.45 16.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 125.0 1.32 . . . . 0.0 108.993 177.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.19 45.5 1.15 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 122.213 1.006 . . . . 0.0 108.503 170.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.2 p -70.72 144.02 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 O-C-N 121.444 -0.785 . . . . 0.0 110.737 -170.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -175.98 159.15 26.42 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 172.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 58.02 18.89 35.58 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.355 0.979 . . . . 0.0 113.915 -176.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.5 p -144.66 71.9 15.45 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 125.282 1.433 . . . . 0.0 108.178 -169.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -60.45 -24.02 76.7 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.296 1.997 . . . . 0.0 112.848 -176.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.5 mp0 -62.36 -39.52 93.44 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.602 0.761 . . . . 0.0 109.678 173.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -79.04 -24.14 43.8 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 121.476 -0.765 . . . . 0.0 110.775 -178.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.6 mt -60.92 -38.49 85.96 Favored 'General case' 0 CA--C 1.526 0.052 0 CA-C-N 119.65 1.114 . . . . 0.0 108.027 169.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -72.54 -49.46 32.53 Favored 'General case' 0 C--N 1.341 0.223 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -60.92 -45.94 92.67 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 118.596 0.635 . . . . 0.0 111.04 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 94.4 mt -72.93 -33.99 66.29 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 118.5 -0.762 . . . . 0.0 110.103 -177.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -60.99 -40.33 93.11 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.937 1.244 . . . . 0.0 110.315 169.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -62.11 -41.39 98.18 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.668 0.667 . . . . 0.0 109.941 177.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -63.45 -40.26 96.67 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 119.35 0.977 . . . . 0.0 111.628 175.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.8 -42.89 98.49 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 118.784 0.72 . . . . 0.0 110.404 176.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 42.2 mtpt -67.08 -37.28 83.72 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.979 -0.45 . . . . 0.0 110.941 175.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 66.3 tttm -80.44 -40.51 26.19 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 118.674 0.67 . . . . 0.0 111.851 -169.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -130.5 10.26 5.2 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.947 0.899 . . . . 0.0 113.076 -169.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 64.04 7.8 3.6 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.133 1.773 . . . . 0.0 114.05 177.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.5 pp -64.2 155.83 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 121.96 0.886 . . . . 0.0 112.551 -169.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 28.1 ttp-105 -62.44 134.25 56.17 Favored 'General case' 0 CA--C 1.527 0.073 0 C-N-CA 124.361 1.064 . . . . 0.0 109.28 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.6 m -139.56 144.29 29.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 172.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.2 m -140.2 110.24 6.51 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -99.56 84.86 3.02 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.48 0.712 . . . . 0.0 109.993 -169.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 14.0 m-90 -64.65 -47.86 76.93 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.32 169.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.91 -12.51 42.2 Favored Glycine 0 CA--C 1.536 1.364 0 CA-C-O 118.923 -0.931 . . . . 0.0 113.003 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.2 t0 . . . . . 0 C--O 1.248 0.996 0 C-N-CA 127.508 2.323 . . . . 0.0 112.123 -171.463 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.319 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.6 m -62.6 -30.44 71.34 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.302 1.041 . . . . 0.0 112.914 -175.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 151.45 -29.75 0.95 Allowed Glycine 0 CA--C 1.529 0.926 0 C-N-CA 124.568 1.08 . . . . 0.0 111.583 178.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -150.77 154.35 37.17 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 126.06 1.744 . . . . 0.0 107.028 176.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.0 p -151.27 152.6 11.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 169.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 71.6 mtt180 -140.67 177.19 8.2 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 125.309 1.444 . . . . 0.0 108.169 -177.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.0 m -144.08 149.13 36.11 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 169.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.429 HG12 ' H ' ' A' ' 32' ' ' THR . 17.3 pt -135.15 171.79 17.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 124.932 1.293 . . . . 0.0 108.406 -175.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.58 43.01 1.18 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.867 0.841 . . . . 0.0 109.826 176.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.9 p -73.37 148.47 8.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 O-C-N 121.437 -0.789 . . . . 0.0 109.804 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -173.39 166.89 39.43 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 108.378 -1.889 . . . . 0.0 108.378 169.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 54.5 21.26 20.11 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.069 1.319 . . . . 0.0 114.974 176.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.7 m -145.94 75.32 13.05 Favored Pre-proline 0 CA--C 1.538 0.497 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 -169.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -50.01 -34.52 38.2 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.434 2.756 . . . . 0.0 113.639 -177.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -68.25 -41.64 80.85 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.906 0.384 . . . . 0.0 110.15 -176.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -74.72 -36.18 62.68 Favored 'General case' 0 N--CA 1.436 -1.131 0 O-C-N 121.215 -0.928 . . . . 0.0 109.429 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.3 mt -57.26 -38.43 73.84 Favored 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 123.806 0.843 . . . . 0.0 109.721 172.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 43.1 mtpt -68.13 -49.13 63.08 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 118.741 0.7 . . . . 0.0 109.855 176.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -60.8 -43.82 97.66 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 118.797 0.726 . . . . 0.0 110.954 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 69.0 mt -74.64 -31.68 62.03 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 118.552 -0.737 . . . . 0.0 110.599 -178.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -62.07 -41.58 98.31 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.815 1.189 . . . . 0.0 110.254 169.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -63.38 -42.92 98.86 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.638 0.654 . . . . 0.0 109.617 176.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.0 tp10 -60.23 -39.26 86.04 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.055 -1.028 . . . . 0.0 111.037 176.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.14 -3.1 6.67 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.827 1.251 . . . . 0.0 113.798 174.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -118.2 -25.54 6.59 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.23 1.412 . . . . 0.0 110.036 174.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.4 ttpt -68.45 -41.6 80.02 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 123.791 0.836 . . . . 0.0 108.905 172.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -132.49 161.25 34.21 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.193 1.397 . . . . 0.0 109.205 175.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -74.31 -7.08 51.59 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.016 0.926 . . . . 0.0 113.341 -173.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.8 pp -51.76 145.6 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 125.251 1.421 . . . . 0.0 113.944 -169.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.9 ttp180 -59.37 143.98 48.03 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 124.776 1.23 . . . . 0.0 109.476 172.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.4 m -140.18 153.55 22.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 C-N-CA 125.607 1.563 . . . . 0.0 106.789 169.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.429 ' H ' HG12 ' A' ' 8' ' ' ILE . 1.9 m -141.46 128.24 20.43 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 -176.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -121.4 119.24 31.54 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -169.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 19.8 m-90 -94.73 157.43 15.95 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 169.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.61 -48.3 82.65 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 108.661 -1.776 . . . . 0.0 108.661 169.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.7 t70 . . . . . 0 C--O 1.247 0.961 0 C-N-CA 126.947 2.099 . . . . 0.0 107.73 169.721 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.343 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.5 m -60.24 155.19 18.13 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.264 1.026 . . . . 0.0 111.426 178.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 179.14 -179.24 48.92 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 179.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -141.31 31.06 1.73 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.524 1.129 . . . . 0.0 110.937 -178.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.3 t -58.83 124.38 12.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 172.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 30.1 ptt-85 -155.43 -179.71 8.35 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 126.804 2.041 . . . . 0.0 106.599 -178.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.9 m -129.6 152.63 48.91 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 175.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.458 HG12 ' H ' ' A' ' 32' ' ' THR . 1.9 pt -117.07 167.13 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.765 1.226 . . . . 0.0 108.446 -171.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -144.52 36.08 1.19 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.775 0.83 . . . . 0.0 109.522 177.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.4 m -69.17 150.58 10.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 O-C-N 121.346 -0.846 . . . . 0.0 109.493 -178.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -81.97 42.27 2.83 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.548 1.071 . . . . 0.0 111.774 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 57.45 35.01 70.17 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 124.117 0.865 . . . . 0.0 111.691 -177.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.74 125.17 87.09 Favored Pre-proline 0 N--CA 1.45 -0.466 0 C-N-CA 124.615 1.166 . . . . 0.0 108.642 -174.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -65.39 -18.08 59.33 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 121.699 1.6 . . . . 0.0 111.475 175.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -77.75 -11.36 59.87 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.096 0.958 . . . . 0.0 111.085 178.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -125.58 -47.43 1.7 Allowed 'General case' 0 CA--C 1.519 -0.25 0 C-N-CA 123.281 0.632 . . . . 0.0 109.725 -169.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.4 pp -57.0 -27.9 61.98 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 118.77 0.714 . . . . 0.0 111.663 177.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -68.6 -13.88 62.64 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 118.703 -0.665 . . . . 0.0 112.736 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -111.43 -42.59 3.85 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.22 0.918 . . . . 0.0 109.074 173.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -62.96 -41.61 99.57 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.339 0.656 . . . . 0.0 111.518 -177.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.9 tptp -67.97 -31.77 71.73 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.186 0.903 . . . . 0.0 111.014 178.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -66.31 -46.17 77.83 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 172.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -60.77 -38.3 84.79 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.462 -0.774 . . . . 0.0 111.18 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.4 -15.78 40.04 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.483 1.113 . . . . 0.0 113.347 176.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -109.04 -27.17 9.79 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.886 1.274 . . . . 0.0 109.976 176.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -75.08 -35.94 61.77 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.932 0.893 . . . . 0.0 110.414 -179.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -140.03 169.91 16.84 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.329 1.452 . . . . 0.0 109.634 -177.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -76.75 15.47 0.64 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.901 1.28 . . . . 0.0 112.627 -174.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.4 pp -70.28 158.48 6.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 O-C-N 120.666 -1.271 . . . . 0.0 110.286 -174.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 41.8 ttm105 -98.93 147.29 25.13 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 29.9 m -136.67 154.58 32.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 170.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.458 ' H ' HG12 ' A' ' 8' ' ' ILE . 24.7 m -153.15 144.48 23.2 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 169.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -130.71 112.01 12.7 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -169.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 13.2 m-90 -93.84 150.7 20.16 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 122.887 0.475 . . . . 0.0 110.151 179.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -82.71 43.77 3.13 Favored Glycine 0 CA--C 1.532 1.154 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 169.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.1 t70 . . . . . 0 C--O 1.247 0.944 0 C-N-CA 125.075 1.35 . . . . 0.0 111.246 -173.924 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.303 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.3 m -60.27 153.56 22.14 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.295 1.038 . . . . 0.0 111.275 178.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 177.1 -178.33 48.22 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -151.67 164.46 36.87 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.041 1.337 . . . . 0.0 108.947 176.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -138.64 131.37 38.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 176.067 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -160.33 158.93 30.56 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 125.998 1.719 . . . . 0.0 107.552 172.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.4 m -99.23 152.47 19.87 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 169.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.439 HG12 ' H ' ' A' ' 32' ' ' THR . 8.0 pt -113.38 173.81 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 124.365 1.066 . . . . 0.0 109.066 -176.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.92 72.31 1.17 Allowed 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 172.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.5 m -124.06 157.8 30.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 177.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -167.87 136.3 4.04 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 108.979 -1.649 . . . . 0.0 108.979 171.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 56.22 23.08 39.16 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 124.247 0.927 . . . . 0.0 114.19 179.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.0 p -68.58 150.23 97.73 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 119.072 1.436 . . . . 0.0 108.886 176.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.4 -25.99 29.74 Favored 'Trans proline' 0 CA--C 1.533 0.463 0 C-N-CA 121.965 1.777 . . . . 0.0 112.041 -172.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -159.52 -12.91 0.06 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.279 1.032 . . . . 0.0 112.019 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -66.21 -36.74 83.84 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 120.591 -1.318 . . . . 0.0 110.557 -173.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.6 pp -65.38 -21.67 66.71 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-O 118.424 -0.798 . . . . 0.0 112.16 172.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -77.85 -45.65 23.7 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 119.861 1.209 . . . . 0.0 108.935 175.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -58.44 -46.73 85.95 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.251 0.478 . . . . 0.0 110.316 173.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.0 mt -70.34 -34.48 72.71 Favored 'General case' 0 C--O 1.226 -0.154 0 CA-C-O 118.41 -0.805 . . . . 0.0 110.616 -178.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -60.19 -42.36 94.91 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 120.335 1.425 . . . . 0.0 110.799 169.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -61.52 -40.13 93.53 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 119.316 0.962 . . . . 0.0 110.174 175.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -62.23 -31.9 72.5 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.498 -0.751 . . . . 0.0 111.288 173.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.42 -28.72 67.33 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 120.162 1.346 . . . . 0.0 112.138 173.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -78.86 -33.1 46.11 Favored 'General case' 0 N--CA 1.463 0.19 0 O-C-N 121.82 -0.55 . . . . 0.0 109.998 172.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -90.5 -23.71 20.86 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -169.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -142.09 172.67 12.37 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.827 1.651 . . . . 0.0 109.931 -176.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -81.97 2.04 32.63 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.838 1.255 . . . . 0.0 112.982 -173.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.5 pt -53.18 151.05 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 125.635 1.574 . . . . 0.0 113.881 -169.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 34.2 ttp180 -94.34 75.39 3.92 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.426 1.49 . . . . 0.0 108.989 -177.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.5 m -62.93 139.66 20.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 171.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.439 ' H ' HG12 ' A' ' 8' ' ' ILE . 21.0 m -144.76 125.01 13.73 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 104.257 -2.497 . . . . 0.0 104.257 177.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -117.7 109.69 16.93 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -169.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 11.8 m-90 -72.24 165.2 24.9 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.993 0.917 . . . . 0.0 109.997 171.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -68.84 -45.4 64.57 Favored Glycine 0 CA--C 1.531 1.054 0 N-CA-C 108.328 -1.909 . . . . 0.0 108.328 169.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.3 t70 . . . . . 0 C--O 1.246 0.876 0 C-N-CA 127.111 2.165 . . . . 0.0 107.756 169.81 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.287 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.1 m -65.15 -21.93 66.85 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.285 1.034 . . . . 0.0 113.275 -176.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -178.73 -173.19 43.85 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 125.021 1.296 . . . . 0.0 109.995 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -145.21 153.03 40.9 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.072 1.349 . . . . 0.0 108.475 176.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.3 t -146.01 140.78 21.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 174.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 23.5 ptt-85 -152.25 165.66 34.18 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 126.978 2.111 . . . . 0.0 105.959 168.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.1 m -136.17 153.95 51.11 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -173.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.9 pt -127.33 169.15 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 125.002 1.321 . . . . 0.0 108.887 -169.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.07 37.14 0.94 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.514 0.726 . . . . 0.0 110.332 176.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.0 m -72.68 152.58 7.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 O-C-N 121.116 -0.99 . . . . 0.0 109.528 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -81.93 40.56 2.66 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.624 1.107 . . . . 0.0 111.727 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 53.76 34.4 50.7 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.32 0.962 . . . . 0.0 111.839 -171.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.3 m -61.89 124.42 81.62 Favored Pre-proline 0 N--CA 1.445 -0.715 0 C-N-CA 125.269 1.428 . . . . 0.0 108.68 -169.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -52.82 -27.49 34.8 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.801 2.334 . . . . 0.0 112.91 172.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -70.39 -26.44 63.7 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.63 0.772 . . . . 0.0 111.073 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -102.41 -37.06 8.19 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 124.363 1.065 . . . . 0.0 109.232 -171.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 65.5 mt -53.38 -19.2 3.19 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.257 1.023 . . . . 0.0 112.277 169.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -58.96 -28.54 66.4 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 118.945 0.793 . . . . 0.0 112.589 172.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -131.77 -37.08 1.19 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.008 0.822 . . . . 0.0 111.639 -173.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -61.57 -40.42 94.67 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 119.021 0.828 . . . . 0.0 111.374 -176.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.6 tptt -66.88 -32.58 73.94 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 119.303 -0.38 . . . . 0.0 111.005 177.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -69.0 -46.38 68.17 Favored 'General case' 0 C--O 1.224 -0.262 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 175.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -58.2 -40.17 80.87 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 119.168 0.895 . . . . 0.0 111.005 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.93 -15.66 33.61 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.138 0.975 . . . . 0.0 113.444 177.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -113.76 -29.83 6.97 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.993 1.317 . . . . 0.0 110.062 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -73.19 -34.55 66.04 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 123.873 0.869 . . . . 0.0 110.411 178.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -133.86 168.41 18.81 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.351 1.06 . . . . 0.0 110.654 -173.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -69.09 -9.52 53.07 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.023 1.729 . . . . 0.0 113.533 -177.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.6 pp -60.49 157.0 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.81 1.244 . . . . 0.0 111.952 -173.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 12.0 ptp85 -97.51 159.85 14.68 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.652 0.739 . . . . 0.0 109.648 174.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.3 m -139.22 155.01 25.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 171.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 38.9 m -149.43 144.21 26.21 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 170.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -129.96 107.23 9.2 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -169.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 13.3 m-90 -84.21 151.29 24.92 Favored 'General case' 0 N--CA 1.461 0.118 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 -179.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -83.03 45.57 3.47 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 169.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.9 t70 . . . . . 0 C--O 1.249 1.066 0 C-N-CA 125.089 1.356 . . . . 0.0 111.306 -174.177 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.397 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.2 p -63.89 -23.56 67.4 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.297 1.039 . . . . 0.0 111.939 173.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -152.51 -175.29 23.91 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 126.473 1.987 . . . . 0.0 108.499 169.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.91 140.65 23.6 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 125.475 1.51 . . . . 0.0 107.332 -177.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.2 t -136.04 136.11 49.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -176.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -151.9 145.55 24.98 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 104.539 -2.393 . . . . 0.0 104.539 173.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.7 m -102.92 145.41 29.87 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 175.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.46 HG12 ' H ' ' A' ' 32' ' ' THR . 8.4 pt -101.87 174.83 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.226 1.01 . . . . 0.0 109.254 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.83 46.86 1.26 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.629 0.771 . . . . 0.0 109.004 170.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.2 p -80.64 145.98 8.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 O-C-N 121.277 -0.889 . . . . 0.0 109.073 -175.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -86.27 35.67 3.28 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.692 1.139 . . . . 0.0 112.395 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 56.07 41.96 86.41 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.275 0.941 . . . . 0.0 113.15 173.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.5 m -61.55 137.45 94.82 Favored Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 177.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -51.42 -27.23 23.67 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.37 2.713 . . . . 0.0 115.466 -177.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -93.89 -29.68 15.17 Favored 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 123.264 0.626 . . . . 0.0 110.858 -178.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -71.88 -33.45 68.38 Favored 'General case' 0 N--CA 1.462 0.169 0 O-C-N 121.256 -0.902 . . . . 0.0 108.829 175.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 76.6 mt -62.44 -5.09 2.23 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.713 1.205 . . . . 0.0 112.445 169.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.4 mttp -109.24 -56.08 2.33 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 119.287 0.949 . . . . 0.0 108.937 170.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -62.08 -49.87 74.21 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.162 0.585 . . . . 0.0 111.098 -174.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 25.8 mt -76.16 -29.31 57.69 Favored 'General case' 0 C--O 1.224 -0.244 0 O-C-N 122.008 -0.432 . . . . 0.0 109.969 -177.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.3 tptt -63.3 -39.47 94.65 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 119.125 0.875 . . . . 0.0 110.503 171.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -64.68 -44.1 91.4 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 173.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -56.7 -36.9 70.18 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.666 0.786 . . . . 0.0 111.115 175.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.28 -14.03 61.35 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.562 1.145 . . . . 0.0 113.385 177.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.1 mptp? -104.72 -33.7 8.37 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.219 1.008 . . . . 0.0 109.867 172.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 32.6 tttm -66.97 -37.57 84.5 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 123.396 0.679 . . . . 0.0 110.519 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -136.05 163.46 30.25 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 126.468 1.907 . . . . 0.0 108.646 -175.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -82.14 6.43 16.49 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.006 0.923 . . . . 0.0 112.771 -174.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.0 pp -59.73 156.04 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 124.528 1.131 . . . . 0.0 112.754 -172.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 33.1 ttp180 -98.89 81.28 2.6 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.806 1.243 . . . . 0.0 109.975 -169.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.4 m -63.21 139.55 21.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.324 169.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.46 ' H ' HG12 ' A' ' 8' ' ' ILE . 19.1 m -146.04 122.06 10.73 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 104.116 -2.55 . . . . 0.0 104.116 173.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -112.53 111.95 23.14 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -169.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 10.3 m-90 -83.07 147.03 28.37 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 174.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.98 -41.23 61.69 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 169.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.6 t70 . . . . . 0 C--O 1.246 0.889 0 C-N-CA 126.885 2.074 . . . . 0.0 107.867 170.004 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.4 t . . . . . 0 C--O 1.235 0.301 0 CA-C-O 121.746 0.784 . . . . 0.0 109.371 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -159.63 176.67 11.74 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 127.46 2.304 . . . . 0.0 106.826 -173.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.4 m -139.91 155.63 47.08 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 -176.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.468 HG12 ' H ' ' A' ' 32' ' ' THR . 2.9 pt -121.02 167.37 14.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 125.022 1.329 . . . . 0.0 108.792 -172.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.26 43.37 1.12 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.71 0.804 . . . . 0.0 109.35 173.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.2 m -75.27 150.39 6.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 O-C-N 121.189 -0.945 . . . . 0.0 110.319 -177.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -88.07 33.69 3.97 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 124.867 1.222 . . . . 0.0 112.271 178.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 61.37 38.52 95.86 Favored Glycine 0 CA--C 1.531 1.037 0 CA-C-N 117.576 0.688 . . . . 0.0 112.976 174.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.3 m -62.79 136.12 96.21 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 172.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -51.32 -32.88 43.44 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 122.766 2.311 . . . . 0.0 113.801 177.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -73.51 -39.19 65.0 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.702 0.401 . . . . 0.0 110.14 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -77.07 -36.15 56.1 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -177.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 34.2 mt -59.41 -26.61 65.3 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.419 1.088 . . . . 0.0 111.451 169.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -83.81 -63.94 1.26 Allowed 'General case' 0 C--N 1.339 0.147 0 CA-C-N 119.237 0.926 . . . . 0.0 109.046 174.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -61.81 -49.21 77.22 Favored 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 122.75 0.42 . . . . 0.0 111.466 -169.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 52.4 mt -75.8 -30.29 59.0 Favored 'General case' 0 C--O 1.226 -0.134 0 CA-C-O 119.124 -0.465 . . . . 0.0 110.255 -171.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -62.95 -38.76 92.36 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.225 0.921 . . . . 0.0 110.059 169.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -61.88 -42.87 99.58 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 118.762 0.71 . . . . 0.0 109.938 174.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -62.35 -39.31 92.72 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.361 0.982 . . . . 0.0 111.23 175.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.34 -46.34 90.27 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 118.771 0.714 . . . . 0.0 110.319 175.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 43.1 mtpt -66.75 -37.24 84.23 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 122.982 0.513 . . . . 0.0 110.904 177.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -83.7 -33.12 25.22 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 118.755 -0.641 . . . . 0.0 112.035 -170.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -128.52 5.65 5.66 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.858 0.863 . . . . 0.0 113.081 -169.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 64.84 3.64 2.12 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.555 1.942 . . . . 0.0 114.309 178.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.0 pp -65.11 156.4 5.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 123.777 0.831 . . . . 0.0 111.577 -173.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 51.5 mtt85 -71.1 143.59 50.58 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -176.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.9 m -141.13 141.76 30.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 169.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.468 ' H ' HG12 ' A' ' 8' ' ' ILE . 19.7 m -145.06 130.16 18.46 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 175.311 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -120.93 110.99 16.95 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 -169.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 11.9 m-90 -86.75 148.2 25.52 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -85.81 44.68 3.38 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 169.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.6 t70 . . . . . 0 C--O 1.25 1.086 0 C-N-CA 125.022 1.329 . . . . 0.0 111.397 -173.397 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.7 t . . . . . 0 C--O 1.235 0.31 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -149.13 178.84 8.37 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 124.443 1.097 . . . . 0.0 110.089 -174.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 38.3 m -132.28 153.4 50.71 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 169.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.41 HG12 ' H ' ' A' ' 32' ' ' THR . 5.3 pt -126.2 170.34 16.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 125.443 1.497 . . . . 0.0 108.109 -174.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.3 34.9 0.88 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.302 0.572 . . . . 0.0 111.092 174.075 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.3 m -74.33 158.37 5.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 O-C-N 121.205 -0.935 . . . . 0.0 109.769 176.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -169.72 154.97 24.55 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 108.521 -1.832 . . . . 0.0 108.521 169.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 51.54 28.76 22.52 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 124.385 0.993 . . . . 0.0 114.29 178.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 26.4 m -138.63 74.91 38.63 Favored Pre-proline 0 CA--C 1.537 0.446 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 -170.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -59.55 -27.51 85.15 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.327 2.018 . . . . 0.0 111.778 -177.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -63.6 -17.32 62.75 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.392 1.077 . . . . 0.0 112.168 -178.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -126.92 -34.56 2.35 Favored 'General case' 0 C--N 1.34 0.172 0 C-N-CA 123.453 0.701 . . . . 0.0 111.262 -177.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.16 -25.43 68.34 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 119.47 1.032 . . . . 0.0 110.155 173.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -68.47 -42.88 78.09 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.803 1.183 . . . . 0.0 110.79 173.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -75.29 -29.69 60.17 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.325 0.966 . . . . 0.0 111.536 178.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.0 mt -72.71 -34.87 67.41 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.445 1.021 . . . . 0.0 109.916 172.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.7 mmtt -60.02 -45.41 92.87 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 119.51 1.05 . . . . 0.0 109.829 169.168 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -57.82 -46.04 85.29 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.575 0.75 . . . . 0.0 109.717 177.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -60.73 -41.64 95.72 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.227 0.921 . . . . 0.0 110.704 176.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.95 -2.96 11.07 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 177.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -117.19 -26.12 6.88 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.978 1.311 . . . . 0.0 109.806 175.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.0 tttm -72.43 -39.95 67.46 Favored 'General case' 0 C--O 1.23 0.073 0 C-N-CA 124.844 1.258 . . . . 0.0 109.521 173.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -133.64 167.88 19.7 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.873 1.669 . . . . 0.0 108.954 178.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -78.82 4.04 15.08 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.722 1.209 . . . . 0.0 113.114 -174.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.1 pp -59.75 151.58 5.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 121.997 0.904 . . . . 0.0 112.978 -169.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.13 144.38 42.86 Favored 'General case' 0 C--O 1.23 0.076 0 C-N-CA 124.003 0.921 . . . . 0.0 109.05 178.031 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.1 m -143.46 153.76 16.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 125.79 1.636 . . . . 0.0 107.156 169.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.41 ' H ' HG12 ' A' ' 8' ' ' ILE . 25.6 m -146.75 141.65 26.95 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 173.151 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -128.39 111.83 13.75 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -169.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 18.6 m-90 -86.67 156.11 20.12 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 122.838 0.455 . . . . 0.0 110.679 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -83.46 48.49 4.05 Favored Glycine 0 CA--C 1.529 0.969 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 170.021 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.7 t70 . . . . . 0 C--O 1.247 0.942 0 C-N-CA 124.918 1.287 . . . . 0.0 111.513 -173.869 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.7 t . . . . . 0 CA--C 1.538 0.519 0 CA-C-O 121.574 0.702 . . . . 0.0 109.818 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.32 179.43 6.4 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.408 1.883 . . . . 0.0 106.945 170.168 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.8 m -140.05 152.27 46.07 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 126.456 1.902 . . . . 0.0 106.426 178.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 13.6 pt -128.33 170.82 17.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 125.052 1.341 . . . . 0.0 108.6 -170.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -150.89 37.88 0.65 Allowed 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 121.727 0.775 . . . . 0.0 110.335 176.116 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 27.2 m -68.75 152.36 9.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 O-C-N 121.325 -0.86 . . . . 0.0 111.42 -177.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -158.28 41.14 0.51 Allowed Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.071 1.32 . . . . 0.0 110.719 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 162.1 -170.49 37.77 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 108.979 -1.649 . . . . 0.0 108.979 -175.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.5 m 58.38 73.83 0.68 Allowed Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 124.954 1.301 . . . . 0.0 110.061 176.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -58.64 -23.37 65.23 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.396 2.064 . . . . 0.0 112.924 -177.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -62.7 -43.39 98.92 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.346 0.521 . . . . 0.0 110.191 172.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -74.92 -32.11 61.71 Favored 'General case' 0 N--CA 1.438 -1.069 0 C-N-CA 124.085 0.954 . . . . 0.0 109.721 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 78.3 mt -60.36 -43.67 96.32 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-N 120.086 1.312 . . . . 0.0 108.718 172.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -64.42 -47.23 79.92 Favored 'General case' 0 C--N 1.339 0.114 0 CA-C-O 119.212 -0.423 . . . . 0.0 110.323 176.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -63.18 -45.7 90.58 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.995 0.816 . . . . 0.0 111.091 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 73.2 mt -66.69 -37.23 84.31 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 118.815 0.734 . . . . 0.0 110.108 178.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -60.52 -41.06 93.64 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 119.194 0.906 . . . . 0.0 110.606 171.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -63.06 -40.89 99.02 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 118.707 0.685 . . . . 0.0 110.444 177.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -62.29 -41.57 98.61 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 119.472 1.033 . . . . 0.0 110.809 174.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.02 -45.34 95.18 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-N 118.623 0.647 . . . . 0.0 110.545 176.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -66.23 -35.55 80.71 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 119.072 -0.49 . . . . 0.0 111.044 177.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -81.64 -39.53 24.27 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.812 0.733 . . . . 0.0 111.748 -172.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -117.3 4.96 12.58 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.582 0.753 . . . . 0.0 112.855 -170.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 55.4 t30 65.54 1.32 1.66 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 127.141 2.177 . . . . 0.0 114.186 -178.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.7 pp -63.3 147.1 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 124.095 0.958 . . . . 0.0 111.079 -174.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -78.64 133.93 37.21 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.5 m -120.15 155.51 23.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 125.064 1.346 . . . . 0.0 108.396 173.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.94 92.57 2.68 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -169.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -92.43 93.98 8.87 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -175.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 5.9 m-90 -66.33 -46.31 77.29 Favored 'General case' 0 C--O 1.232 0.153 0 O-C-N 122.341 -0.224 . . . . 0.0 110.724 173.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.49 -50.14 3.14 Favored Glycine 0 CA--C 1.531 1.084 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -169.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.0 t70 . . . . . 0 C--O 1.249 1.037 0 C-N-CA 126.818 2.047 . . . . 0.0 108.259 169.52 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.9 t . . . . . 0 C--O 1.235 0.307 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 30.7 ptt-85 -160.58 -178.14 6.68 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.896 1.278 . . . . 0.0 108.704 -176.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.8 m -116.15 154.71 29.53 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 171.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 11.0 pt -120.99 174.98 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.985 1.314 . . . . 0.0 109.038 -171.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.9 68.31 0.88 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 175.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.8 m -122.33 166.04 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 177.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -169.25 -26.24 0.02 OUTLIER Glycine 0 CA--C 1.527 0.839 0 CA-C-N 115.623 -0.717 . . . . 0.0 113.879 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -157.95 38.61 0.53 Allowed Glycine 0 CA--C 1.527 0.798 0 C-N-CA 124.022 0.82 . . . . 0.0 111.274 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.5 p -68.33 159.72 79.31 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 123.806 0.842 . . . . 0.0 109.967 177.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -54.08 -41.73 73.05 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.783 2.322 . . . . 0.0 112.719 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -161.11 2.91 0.06 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.248 1.019 . . . . 0.0 112.692 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -68.95 -28.09 66.32 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 120.2 1.364 . . . . 0.0 110.501 -175.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.3 mt -51.18 -39.62 56.83 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 125.168 1.387 . . . . 0.0 109.755 169.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -71.43 -45.35 62.9 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-N 118.655 0.661 . . . . 0.0 109.46 -177.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.0 mmtt -64.0 -46.22 85.53 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -177.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 92.6 mt -73.08 -38.28 66.47 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 118.795 -0.621 . . . . 0.0 110.112 -176.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.9 tptt -59.84 -40.15 87.56 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.402 1.001 . . . . 0.0 110.848 170.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -63.7 -43.58 96.2 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 119.084 0.856 . . . . 0.0 110.077 176.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -60.7 -35.09 75.42 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 120.143 1.338 . . . . 0.0 111.686 177.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.78 -23.78 65.28 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.04 0.836 . . . . 0.0 112.099 173.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -104.84 -20.72 13.5 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.068 1.347 . . . . 0.0 111.776 -177.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -110.69 -20.34 12.55 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 119.324 0.965 . . . . 0.0 112.358 -173.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -129.97 0.06 4.75 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.231 1.412 . . . . 0.0 111.539 178.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 63.77 6.94 2.92 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 127.05 2.14 . . . . 0.0 114.316 177.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.3 pp -65.03 157.0 5.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 O-C-N 121.63 -0.668 . . . . 0.0 111.878 -171.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 96.9 mtt-85 -67.35 142.11 56.89 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 22.6 m -137.61 151.96 26.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 173.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.8 m -146.18 130.91 17.97 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -125.16 112.48 16.5 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -169.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 8.2 m-90 -78.29 158.31 28.93 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.889 0.876 . . . . 0.0 110.533 178.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -82.53 48.06 3.89 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 109.866 -1.293 . . . . 0.0 109.866 169.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.2 t70 . . . . . 0 C--O 1.247 0.935 0 C-N-CA 124.914 1.286 . . . . 0.0 111.363 -174.228 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.467 ' HA ' HG22 ' A' ' 29' ' ' ILE . 4.1 t . . . . . 0 C--O 1.235 0.299 0 CA-C-O 121.782 0.801 . . . . 0.0 110.111 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -151.41 174.94 12.76 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 126.196 1.798 . . . . 0.0 108.69 -174.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.8 m -136.69 147.74 46.96 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 169.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.7 pt -126.68 163.5 28.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 123.638 0.775 . . . . 0.0 108.936 -169.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.28 40.77 0.87 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.669 0.788 . . . . 0.0 109.254 176.455 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 27.5 m -67.07 133.18 31.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 O-C-N 121.243 -0.91 . . . . 0.0 108.584 177.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.46 -52.58 42.13 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 171.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 160.12 41.91 0.02 OUTLIER Glycine 0 CA--C 1.526 0.763 0 CA-C-O 119.086 -0.841 . . . . 0.0 112.923 176.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.7 m -67.05 123.17 85.58 Favored Pre-proline 0 N--CA 1.454 -0.227 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 176.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -50.91 -34.77 47.0 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.274 1.983 . . . . 0.0 113.218 -178.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -74.48 -36.29 63.28 Favored 'General case' 0 N--CA 1.456 -0.148 0 O-C-N 122.121 -0.362 . . . . 0.0 110.161 -175.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -80.6 -35.88 33.52 Favored 'General case' 0 CA--C 1.521 -0.142 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -177.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 88.0 mt -56.62 -41.87 77.84 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 169.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -66.77 -56.45 10.44 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 118.544 0.611 . . . . 0.0 109.907 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -61.94 -45.35 94.05 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 118.495 0.589 . . . . 0.0 111.083 -175.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.4 mt -74.62 -35.08 62.92 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 118.517 -0.754 . . . . 0.0 110.382 -174.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.4 tptt -61.76 -39.87 93.16 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 119.935 1.243 . . . . 0.0 110.092 169.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -63.06 -39.14 93.84 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.95 0.795 . . . . 0.0 110.407 178.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -63.9 -40.43 96.49 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 119.866 1.212 . . . . 0.0 111.336 172.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.7 -23.99 66.89 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.048 0.84 . . . . 0.0 112.343 177.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 41.4 mtpt -84.35 -38.09 20.77 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.643 0.777 . . . . 0.0 110.11 172.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -70.47 -42.21 71.74 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.883 0.873 . . . . 0.0 110.426 -174.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -135.84 165.71 25.0 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.064 1.346 . . . . 0.0 109.738 -173.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -71.03 7.04 1.31 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.064 1.346 . . . . 0.0 113.535 -175.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.467 HG22 ' HA ' ' A' ' 5' ' ' VAL . 2.0 pp -64.42 154.66 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 124.294 1.038 . . . . 0.0 111.347 -171.028 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -89.95 152.15 21.35 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.014 0.435 . . . . 0.0 110.307 178.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.0 m -142.89 157.07 17.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 125.9 1.68 . . . . 0.0 107.568 174.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 32.2 m -149.41 133.53 17.23 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 173.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -121.76 110.45 15.94 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 -169.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -70.68 -32.7 70.05 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -170.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 64.49 39.9 97.23 Favored Glycine 0 CA--C 1.532 1.113 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -172.01 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.5 t70 . . . . . 0 C--O 1.248 0.989 0 C-N-CA 125.037 1.335 . . . . 0.0 111.298 -176.682 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.419 ' HA ' HG22 ' A' ' 29' ' ' ILE . 21.2 t . . . . . 0 C--O 1.236 0.353 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 33.0 ptt85 -144.28 167.36 22.63 Favored 'General case' 0 C--O 1.231 0.1 0 C-N-CA 125.495 1.518 . . . . 0.0 107.691 175.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.3 m -126.99 153.57 45.73 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.409 HG12 ' H ' ' A' ' 32' ' ' THR . 10.5 pt -126.78 170.56 16.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 124.658 1.183 . . . . 0.0 108.163 -173.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.13 75.68 1.45 Allowed 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 -178.581 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.7 m -125.08 153.53 32.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 C-N-CA 123.434 0.694 . . . . 0.0 109.713 -173.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -81.68 33.34 2.58 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 124.477 1.037 . . . . 0.0 112.574 -177.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 54.81 39.01 66.04 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-N 118.084 0.942 . . . . 0.0 111.428 -172.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -60.59 126.69 85.51 Favored Pre-proline 0 N--CA 1.451 -0.414 0 C-N-CA 125.038 1.335 . . . . 0.0 109.459 -169.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -53.59 -23.24 24.84 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.187 2.591 . . . . 0.0 113.91 173.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -92.37 -4.18 54.22 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.246 1.018 . . . . 0.0 111.878 -177.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -117.45 -36.69 3.66 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 123.763 0.825 . . . . 0.0 109.424 -178.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 28.4 mt -47.05 -34.65 6.01 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.523 1.129 . . . . 0.0 111.481 169.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.4 mttp -56.62 -25.66 53.76 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -118.53 -38.56 3.12 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 118.97 0.804 . . . . 0.0 110.303 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -68.39 -41.07 81.04 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-N 118.468 0.576 . . . . 0.0 111.277 -175.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 48.9 tptt -68.92 -34.74 75.88 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 118.499 0.591 . . . . 0.0 110.092 176.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -63.62 -45.39 90.52 Favored 'General case' 0 C--O 1.222 -0.367 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 175.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -60.1 -41.6 92.86 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 119.287 0.949 . . . . 0.0 110.516 178.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.13 -2.59 4.34 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.485 1.114 . . . . 0.0 113.829 176.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -121.72 -27.4 4.7 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.226 1.41 . . . . 0.0 110.308 175.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -70.41 -39.94 74.14 Favored 'General case' 0 C--N 1.338 0.107 0 C-N-CA 124.109 0.963 . . . . 0.0 109.343 175.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -122.84 166.58 14.76 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.729 1.211 . . . . 0.0 109.195 178.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -73.23 -1.31 17.25 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.632 1.173 . . . . 0.0 113.014 -178.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.419 HG22 ' HA ' ' A' ' 5' ' ' VAL . 2.2 pp -61.39 162.61 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 124.669 1.188 . . . . 0.0 110.83 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.48 147.66 52.57 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.0 m -127.07 167.54 21.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 124.853 1.261 . . . . 0.0 110.173 -169.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.409 ' H ' HG12 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -129.69 125.19 35.4 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.277 1.431 . . . . 0.0 108.657 -169.727 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -128.56 94.83 3.97 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 -175.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -71.75 -24.7 61.82 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -171.086 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.16 25.75 68.54 Favored Glycine 0 CA--C 1.537 1.465 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 -169.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.5 t70 . . . . . 0 C--O 1.249 1.038 0 C-N-CA 125.394 1.478 . . . . 0.0 111.48 -177.439 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.9 t . . . . . 0 CA--C 1.532 0.259 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 36.9 mtp180 -144.64 160.6 40.92 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 129.171 2.989 . . . . 0.0 104.146 170.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.5 m -139.84 151.84 46.01 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 169.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.469 HG12 ' H ' ' A' ' 32' ' ' THR . 2.5 pt -127.2 165.89 25.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.216 1.006 . . . . 0.0 109.007 -169.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -142.91 40.85 1.53 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.804 0.842 . . . . 0.0 109.593 -178.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 34.6 m -69.25 144.1 14.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 O-C-N 121.425 -0.797 . . . . 0.0 109.365 178.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -166.48 30.93 0.2 Allowed Glycine 0 CA--C 1.528 0.878 0 C-N-CA 123.573 0.606 . . . . 0.0 112.591 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -176.32 27.02 0.07 OUTLIER Glycine 0 CA--C 1.529 0.911 0 CA-C-N 117.705 0.753 . . . . 0.0 112.644 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.0 p -143.83 59.68 7.45 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 125.304 1.442 . . . . 0.0 108.226 -169.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -62.42 -26.05 76.44 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.6 2.2 . . . . 0.0 113.11 -169.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -71.27 -30.82 66.75 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.454 0.57 . . . . 0.0 110.96 177.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -75.64 -19.4 59.22 Favored 'General case' 0 N--CA 1.462 0.144 0 O-C-N 121.262 -0.899 . . . . 0.0 111.358 -176.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.0 mt -52.54 -31.21 34.55 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.116 0.966 . . . . 0.0 110.613 169.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 42.0 mtmt -62.66 -32.23 73.26 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 118.837 0.744 . . . . 0.0 111.444 177.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -85.39 -48.89 8.58 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 177.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -64.66 -40.84 96.13 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.309 0.644 . . . . 0.0 111.478 -170.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -64.7 -31.46 72.69 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 119.012 -0.518 . . . . 0.0 111.14 175.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -68.82 -46.58 68.21 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 118.921 0.782 . . . . 0.0 109.1 174.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -59.07 -37.75 77.82 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 119.451 1.023 . . . . 0.0 111.062 177.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.25 -13.89 21.96 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.253 1.021 . . . . 0.0 113.572 176.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -117.38 -30.49 5.55 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 125.052 1.341 . . . . 0.0 110.291 -179.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -77.66 -24.32 49.44 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 123.967 0.907 . . . . 0.0 111.109 177.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -138.83 168.72 19.19 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.69 1.196 . . . . 0.0 110.303 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -71.78 -10.35 59.64 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.423 1.489 . . . . 0.0 113.359 -177.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.8 pp -58.15 151.32 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 124.458 1.103 . . . . 0.0 113.547 -169.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 43.7 ttm105 -83.67 150.16 26.04 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 174.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.6 m -135.85 149.06 27.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 107.273 -1.381 . . . . 0.0 107.273 169.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.469 ' H ' HG12 ' A' ' 8' ' ' ILE . 2.6 m -144.66 139.75 28.2 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 178.446 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -131.12 118.26 20.26 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 -169.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 12.9 m-90 -95.82 151.24 19.57 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 122.907 0.483 . . . . 0.0 109.955 173.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -72.96 -41.77 47.34 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 108.928 -1.669 . . . . 0.0 108.928 169.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.3 t70 . . . . . 0 C--O 1.246 0.907 0 C-N-CA 126.996 2.119 . . . . 0.0 107.719 169.889 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.4 p . . . . . 0 CA--C 1.53 0.2 0 N-CA-C 106.314 -1.736 . . . . 0.0 106.314 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.75 170.31 18.56 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.595 1.558 . . . . 0.0 108.336 177.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.3 m -97.85 161.53 13.7 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 169.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.7 pt -120.2 174.37 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 125.127 1.371 . . . . 0.0 108.041 -179.037 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.51 88.15 1.69 Allowed 'General case' 0 C--O 1.232 0.173 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 169.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.7 p -134.02 155.76 40.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -171.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -175.91 -65.68 0.06 OUTLIER Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.782 -0.527 . . . . 0.0 111.782 170.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -83.0 39.15 2.73 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 124.341 0.972 . . . . 0.0 112.398 -174.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.1 p -148.36 71.44 10.89 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 126.617 1.967 . . . . 0.0 106.07 -169.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -52.61 -34.78 64.84 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 123.045 2.497 . . . . 0.0 114.128 -169.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -66.49 -36.9 83.88 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.938 0.399 . . . . 0.0 110.211 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -76.2 -25.27 54.99 Favored 'General case' 0 N--CA 1.454 -0.236 0 O-C-N 121.719 -0.613 . . . . 0.0 110.52 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 91.2 mt -61.27 -37.81 84.48 Favored 'General case' 0 C--O 1.227 -0.127 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 169.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -70.96 -49.85 40.92 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 119.083 0.856 . . . . 0.0 109.47 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -59.43 -48.19 82.61 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 117.834 0.288 . . . . 0.0 110.6 -178.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.0 mt -74.58 -33.75 62.73 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 118.356 -0.83 . . . . 0.0 110.296 -175.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -61.13 -37.95 84.64 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 120.102 1.319 . . . . 0.0 110.464 169.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -62.7 -45.73 91.43 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 119.788 1.176 . . . . 0.0 109.406 175.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -59.12 -28.68 66.76 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 118.818 -0.61 . . . . 0.0 112.304 175.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.33 -21.57 64.11 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.363 0.983 . . . . 0.0 112.771 175.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.41 -33.06 10.15 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 118.548 0.613 . . . . 0.0 110.454 169.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -67.46 -29.37 68.81 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 118.842 0.746 . . . . 0.0 111.08 -175.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -140.62 179.82 6.47 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.823 1.649 . . . . 0.0 109.775 -174.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -91.85 11.39 25.01 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.911 1.284 . . . . 0.0 112.105 -173.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.8 pt -61.97 156.02 4.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 124.423 1.089 . . . . 0.0 112.131 -171.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.1 ptm180 -107.12 74.77 0.99 Allowed 'General case' 0 C--O 1.235 0.319 0 C-N-CA 123.901 0.881 . . . . 0.0 109.263 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 29.8 m -54.5 139.57 13.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.056 178.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.9 m -142.87 119.91 11.38 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 104.562 -2.385 . . . . 0.0 104.562 -175.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -114.58 111.04 20.73 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -169.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 9.7 m-90 -80.07 154.52 28.07 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.144 0.578 . . . . 0.0 110.037 175.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -86.81 40.09 3.08 Favored Glycine 0 CA--C 1.532 1.121 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 169.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.3 t70 . . . . . 0 C--O 1.248 0.999 0 C-N-CA 125.129 1.372 . . . . 0.0 111.192 -173.89 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.9 p . . . . . 0 CA--C 1.535 0.373 0 CA-C-O 121.683 0.754 . . . . 0.0 110.648 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -148.1 171.4 15.93 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 125.348 1.459 . . . . 0.0 109.263 -175.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.3 m -134.51 153.85 51.73 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 171.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.409 HG12 ' H ' ' A' ' 32' ' ' THR . 7.7 pt -129.3 167.51 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 125.713 1.605 . . . . 0.0 107.755 -175.149 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.31 39.56 0.91 Allowed 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.533 0.683 . . . . 0.0 110.603 175.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 28.3 m -69.03 144.87 13.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 O-C-N 121.289 -0.882 . . . . 0.0 109.866 176.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -172.1 147.6 10.15 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 106.632 -2.587 . . . . 0.0 106.632 172.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 55.06 24.58 35.77 Favored Glycine 0 CA--C 1.537 1.451 0 CA-C-N 117.797 0.799 . . . . 0.0 113.422 -170.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -140.63 61.12 14.98 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 125.289 1.436 . . . . 0.0 109.711 -171.139 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -62.27 -23.81 75.56 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.517 2.145 . . . . 0.0 112.711 -175.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -67.36 -19.22 65.4 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.033 0.933 . . . . 0.0 112.271 176.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -90.19 -26.14 20.27 Favored 'General case' 0 N--CA 1.465 0.275 0 O-C-N 121.392 -0.817 . . . . 0.0 110.174 -178.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 59.0 mt -55.05 -30.06 58.8 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 169.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -64.68 -23.71 67.34 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 119.051 -0.499 . . . . 0.0 112.041 -177.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -99.76 -45.6 5.69 Favored 'General case' 0 C--N 1.34 0.156 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 176.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 83.5 mt -72.4 -29.89 64.15 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 118.648 -0.691 . . . . 0.0 111.702 -169.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 27.0 mmtp -62.98 -38.35 90.79 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 119.578 1.081 . . . . 0.0 110.43 169.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -63.93 -45.99 86.77 Favored 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -59.82 -42.47 93.6 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.432 1.015 . . . . 0.0 111.036 177.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.91 -6.15 11.5 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.387 1.075 . . . . 0.0 113.889 177.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -121.57 -25.05 5.2 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.068 1.347 . . . . 0.0 110.052 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -70.15 -40.46 74.75 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 125.054 1.342 . . . . 0.0 108.837 172.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -134.97 166.23 23.51 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.714 1.206 . . . . 0.0 109.236 175.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -76.2 10.36 2.02 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.796 1.239 . . . . 0.0 112.954 -176.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.4 pp -62.17 153.4 6.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-O 122.093 0.949 . . . . 0.0 112.667 -169.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.93 144.26 47.38 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 124.14 0.976 . . . . 0.0 109.329 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.5 m -143.56 152.59 16.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 125.955 1.702 . . . . 0.0 106.497 169.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.409 ' H ' HG12 ' A' ' 8' ' ' ILE . 27.5 m -143.84 133.42 23.56 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 173.298 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -120.67 102.19 8.24 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -169.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 24.3 m-90 -75.87 155.19 35.52 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 171.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -66.88 -49.66 52.96 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 108.285 -1.926 . . . . 0.0 108.285 169.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.3 t70 . . . . . 0 C--O 1.246 0.881 0 C-N-CA 126.871 2.069 . . . . 0.0 107.797 169.919 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 32.6 m . . . . . 0 CA--C 1.536 0.428 0 N-CA-C 111.652 0.241 . . . . 0.0 111.652 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 69.9 mtm-85 -124.75 -31.69 3.16 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 118.487 -0.768 . . . . 0.0 112.951 176.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.4 m 64.61 151.84 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.032 1.333 . . . . 0.0 110.056 -169.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.0 pt -135.2 172.53 15.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 125.029 1.332 . . . . 0.0 108.615 -169.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.2 37.17 0.54 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.233 0.613 . . . . 0.0 110.962 177.086 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.406 HG11 HD12 ' A' ' 20' ' ' LEU . 18.1 m -67.33 153.44 8.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 O-C-N 121.069 -1.019 . . . . 0.0 112.47 -174.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 174.64 139.54 3.03 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 108.512 -1.835 . . . . 0.0 108.512 176.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 64.11 29.36 74.71 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-N 117.181 0.491 . . . . 0.0 111.92 -172.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.4 p -141.25 65.23 21.47 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 125.462 1.505 . . . . 0.0 108.286 -172.007 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.15 -23.89 31.15 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 124.078 3.185 . . . . 0.0 115.841 -169.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -102.41 -11.59 18.5 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.783 0.833 . . . . 0.0 111.429 -173.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -88.77 -40.39 13.24 Favored 'General case' 0 CA--C 1.519 -0.225 0 O-C-N 121.103 -0.998 . . . . 0.0 108.583 -176.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.4 pp -57.28 -25.69 59.64 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-O 118.535 -0.745 . . . . 0.0 110.989 169.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -73.09 -45.89 54.54 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.337 0.971 . . . . 0.0 110.023 177.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -63.21 -43.71 97.36 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 177.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.406 HD12 HG11 ' A' ' 10' ' ' VAL . 96.1 mt -68.64 -38.78 80.75 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 118.78 -0.628 . . . . 0.0 110.296 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -58.86 -41.5 87.15 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.579 1.081 . . . . 0.0 110.726 171.236 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -61.3 -41.98 97.89 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.9 0.773 . . . . 0.0 110.041 176.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -62.72 -38.53 90.83 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 119.419 1.009 . . . . 0.0 111.802 174.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.86 -30.83 71.88 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.972 0.806 . . . . 0.0 111.561 177.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -80.21 -35.85 35.65 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.222 0.609 . . . . 0.0 110.216 174.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -76.84 -40.63 47.1 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 118.574 0.625 . . . . 0.0 111.174 -173.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -132.08 175.14 9.49 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.835 1.254 . . . . 0.0 111.13 -169.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -65.35 -17.7 64.73 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.819 1.248 . . . . 0.0 113.541 -177.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.0 pp -55.79 144.89 6.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 123.9 0.88 . . . . 0.0 112.759 -169.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 8.4 ptm85 -83.9 161.58 20.8 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 121.181 0.515 . . . . 0.0 109.845 171.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.8 m -140.3 156.07 23.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 125.24 1.416 . . . . 0.0 108.158 171.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.2 m -144.59 124.06 13.15 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 -177.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -119.19 83.89 2.11 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.223 0.609 . . . . 0.0 109.751 -169.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 13.5 m-90 -64.28 -42.68 96.3 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.46 173.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 65.3 29.35 75.06 Favored Glycine 0 CA--C 1.535 1.333 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 -169.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.9 t70 . . . . . 0 C--O 1.248 1.008 0 C-N-CA 125.075 1.35 . . . . 0.0 111.581 -175.388 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.0 t . . . . . 0 CA--C 1.535 0.397 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -149.27 174.35 12.5 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 124.909 1.284 . . . . 0.0 109.816 -174.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.9 m -108.15 160.3 15.92 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.563 1.545 . . . . 0.0 108.426 172.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.411 HG12 ' H ' ' A' ' 32' ' ' THR . 4.8 pt -131.95 163.66 36.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 169.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.78 73.18 1.33 Allowed 'General case' 0 C--O 1.233 0.21 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 175.219 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.3 m -125.52 162.13 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 121.876 0.846 . . . . 0.0 111.624 -173.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -176.71 165.58 35.88 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 126.12 1.819 . . . . 0.0 108.953 171.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 57.75 19.87 37.59 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 124.324 0.964 . . . . 0.0 114.7 173.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.2 m -140.74 73.01 29.03 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 118.325 1.062 . . . . 0.0 108.997 -171.194 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -44.02 -34.91 6.89 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.706 2.937 . . . . 0.0 113.644 173.264 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 51.3 mp0 -66.52 -9.68 37.13 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.43 1.892 . . . . 0.0 112.589 -176.01 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -130.15 -44.73 1.14 Allowed 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 125.219 1.408 . . . . 0.0 108.786 -178.216 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.1 pp -68.2 -27.23 66.21 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 119.888 1.222 . . . . 0.0 111.439 -175.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -68.0 -39.15 83.26 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 120.122 1.328 . . . . 0.0 110.417 171.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -68.63 -42.33 78.19 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 118.616 0.644 . . . . 0.0 109.736 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 79.3 mt -69.46 -34.82 74.94 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.458 0.572 . . . . 0.0 110.509 177.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -61.08 -42.8 99.18 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 119.285 0.948 . . . . 0.0 110.563 169.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -62.32 -38.19 88.46 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.76 0.709 . . . . 0.0 110.101 176.239 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -62.23 -41.71 98.65 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.174 0.99 . . . . 0.0 110.586 176.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.13 -45.76 91.91 Favored 'General case' 0 C--N 1.338 0.089 0 C-N-CA 122.869 0.467 . . . . 0.0 110.481 174.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -66.06 -32.77 74.44 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 119.038 -0.506 . . . . 0.0 111.161 177.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.2 ttpt -81.16 -49.19 11.12 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 118.955 0.798 . . . . 0.0 110.823 -173.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.99 7.33 21.55 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.137 0.975 . . . . 0.0 112.999 -169.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 54.5 t30 65.58 1.66 1.79 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.913 2.085 . . . . 0.0 114.094 -178.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.6 pp -63.23 147.49 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 121.626 0.727 . . . . 0.0 111.368 -172.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 43.1 ptt85 -67.59 149.41 50.12 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.572 175.029 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.6 m -144.08 152.8 15.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 125.323 1.449 . . . . 0.0 107.769 176.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.411 ' H ' HG12 ' A' ' 8' ' ' ILE . 10.9 m -140.85 127.29 19.95 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -178.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -121.05 102.09 8.1 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -170.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 1.9 m-90 -70.87 -34.45 71.63 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 123.558 0.743 . . . . 0.0 112.441 -175.286 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.16 27.26 72.81 Favored Glycine 0 CA--C 1.535 1.324 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 -169.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 22.8 t70 . . . . . 0 C--O 1.25 1.096 0 C-N-CA 125.083 1.353 . . . . 0.0 111.25 -177.759 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.9 p . . . . . 0 CA--C 1.537 0.474 0 CA-C-O 121.433 0.635 . . . . 0.0 111.372 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 40.4 ptt85 -147.81 174.8 11.48 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 125.19 1.396 . . . . 0.0 108.438 171.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 92.5 m -123.7 155.17 38.31 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 174.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.8 pt -128.41 172.75 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.865 1.666 . . . . 0.0 108.266 -169.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.63 35.67 0.71 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 118.505 0.593 . . . . 0.0 111.639 174.166 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.0 m -67.63 146.09 13.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 O-C-N 121.165 -0.959 . . . . 0.0 109.244 177.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -88.41 39.12 3.13 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.164 0.888 . . . . 0.0 110.913 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 54.81 33.12 55.71 Favored Glycine 0 CA--C 1.533 1.188 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 -169.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.14 125.37 85.27 Favored Pre-proline 0 N--CA 1.448 -0.53 0 C-N-CA 125.66 1.584 . . . . 0.0 110.078 -169.441 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -56.14 -15.41 14.14 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.621 2.881 . . . . 0.0 114.986 174.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -94.14 -15.72 24.41 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.574 1.15 . . . . 0.0 111.561 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -116.48 -35.42 4.27 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 121.44 -0.787 . . . . 0.0 111.043 -169.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 76.1 mt -51.51 -30.89 21.83 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.654 0.661 . . . . 0.0 110.97 170.01 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -58.0 -23.28 53.38 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 125.035 1.334 . . . . 0.0 112.835 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -113.2 -41.48 3.69 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 123.761 0.824 . . . . 0.0 109.537 176.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -64.32 -40.4 95.84 Favored 'General case' 0 N--CA 1.457 -0.088 0 C-N-CA 122.924 0.49 . . . . 0.0 112.023 -174.248 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -66.48 -37.64 85.55 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 118.86 0.754 . . . . 0.0 110.12 178.05 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -63.66 -47.63 80.49 Favored 'General case' 0 C--O 1.225 -0.217 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 175.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -59.6 -40.25 86.88 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.109 0.964 . . . . 0.0 111.051 -179.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.99 -43.61 70.13 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 124.172 0.989 . . . . 0.0 110.955 177.278 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -82.12 -34.24 29.31 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 119.302 -0.38 . . . . 0.0 111.151 177.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -71.29 -39.97 71.16 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 118.614 0.643 . . . . 0.0 110.717 -170.083 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -119.05 6.98 11.3 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.763 0.825 . . . . 0.0 112.082 -172.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 55.7 t30 62.39 1.01 0.67 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 127.07 2.148 . . . . 0.0 114.602 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.7 pp -62.56 152.95 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.517 1.127 . . . . 0.0 111.497 -174.311 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.07 152.1 44.34 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 172.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.8 m -141.22 149.17 20.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 169.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.5 m -143.18 132.82 23.74 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -122.78 105.19 9.82 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -169.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 13.6 m-90 -79.81 153.37 29.18 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 122.45 0.3 . . . . 0.0 110.396 -177.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -84.62 43.87 3.28 Favored Glycine 0 CA--C 1.532 1.107 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 169.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.0 t70 . . . . . 0 C--O 1.248 0.982 0 C-N-CA 125.066 1.346 . . . . 0.0 111.251 -173.478 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 C--O 1.234 0.287 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 29.4 ptt-85 -161.29 158.49 27.21 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 123.981 0.912 . . . . 0.0 109.005 -175.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.8 m -82.31 158.85 23.28 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 169.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.4 pt -125.99 168.42 18.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 125.141 1.376 . . . . 0.0 108.432 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.13 49.1 1.27 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.939 0.876 . . . . 0.0 110.118 176.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.1 t -60.38 134.08 25.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 169.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -147.92 -26.94 0.07 OUTLIER Glycine 0 CA--C 1.524 0.6 0 CA-C-O 119.482 -0.621 . . . . 0.0 114.175 -172.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -166.21 44.55 0.27 Allowed Glycine 0 CA--C 1.523 0.566 0 N-CA-C 108.249 -1.94 . . . . 0.0 108.249 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -138.58 78.03 32.68 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 125.663 1.585 . . . . 0.0 108.15 -168.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -63.16 -21.66 72.54 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 121.906 1.738 . . . . 0.0 112.093 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -66.53 -20.18 65.96 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.572 -0.705 . . . . 0.0 111.641 173.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -90.05 -38.15 13.78 Favored 'General case' 0 C--N 1.338 0.099 0 O-C-N 121.629 -0.669 . . . . 0.0 109.599 174.108 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.3 mt -55.59 -32.52 63.15 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.23 0.923 . . . . 0.0 110.433 169.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -64.48 -21.8 66.77 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.205 1.002 . . . . 0.0 112.499 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -126.91 -45.35 1.59 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 119.247 0.93 . . . . 0.0 111.969 -169.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 32.4 mt -70.85 -30.52 66.95 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 121.504 -0.747 . . . . 0.0 110.749 -174.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -62.31 -37.61 86.24 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.059 0.845 . . . . 0.0 111.003 170.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -68.23 -41.45 81.21 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 175.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -60.37 -37.42 80.69 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 121.387 -0.821 . . . . 0.0 111.317 178.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.99 -11.81 9.37 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.692 1.197 . . . . 0.0 113.707 174.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -118.18 -26.64 6.28 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.476 1.51 . . . . 0.0 109.75 -179.022 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -71.3 -37.8 71.81 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 123.623 0.769 . . . . 0.0 109.731 173.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -134.93 169.24 17.7 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 125.416 1.486 . . . . 0.0 109.249 -178.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -75.94 -1.46 25.67 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.37 1.068 . . . . 0.0 113.043 -176.454 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.3 pp -58.67 147.29 7.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 123.946 0.898 . . . . 0.0 111.638 -171.108 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 31.8 ptt-85 -75.06 153.61 38.32 Favored 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 123.142 0.577 . . . . 0.0 109.684 174.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.6 m -141.19 155.03 20.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 124.971 1.309 . . . . 0.0 107.647 171.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.0 m -149.38 141.17 23.64 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 173.238 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -130.32 110.45 11.53 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -169.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 18.4 m-90 -85.51 170.36 12.72 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.946 0.898 . . . . 0.0 109.778 172.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -130.57 65.45 0.59 Allowed Glycine 0 CA--C 1.524 0.602 0 N-CA-C 105.883 -2.887 . . . . 0.0 105.883 171.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.4 t70 . . . . . 0 C--O 1.247 0.962 0 C-N-CA 125.256 1.423 . . . . 0.0 111.582 -169.855 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.2 p . . . . . 0 CA--C 1.539 0.545 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -160.22 179.22 8.88 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 126.581 1.952 . . . . 0.0 108.566 177.17 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.9 m -123.63 156.88 35.0 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 126.33 1.852 . . . . 0.0 107.196 175.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.438 HG12 ' H ' ' A' ' 32' ' ' THR . 4.3 pt -118.5 167.42 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.671 1.189 . . . . 0.0 108.835 -174.553 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -147.0 69.85 1.18 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 174.101 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.5 m -118.31 158.09 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 122.999 0.52 . . . . 0.0 110.158 -177.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 173.97 150.14 7.44 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 108.291 -1.924 . . . . 0.0 108.291 178.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 61.78 31.02 76.66 Favored Glycine 0 CA--C 1.534 1.279 0 N-CA-C 111.77 -0.532 . . . . 0.0 111.77 -171.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.0 p -138.0 58.39 15.52 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 125.703 1.601 . . . . 0.0 108.995 -169.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -62.66 -20.42 70.87 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.027 2.485 . . . . 0.0 113.316 -169.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -87.91 -4.3 58.85 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.501 0.72 . . . . 0.0 112.155 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -127.69 -34.44 2.2 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.572 0.749 . . . . 0.0 110.692 -173.569 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.6 pp -62.31 -25.26 67.77 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-O 118.129 -0.938 . . . . 0.0 110.62 169.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.0 ptpp? -68.42 -37.67 80.51 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 119.987 1.267 . . . . 0.0 111.299 171.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -69.86 -43.45 71.86 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 72.3 mt -69.55 -34.08 73.69 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 118.986 -0.531 . . . . 0.0 110.546 177.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -62.32 -39.43 93.01 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.583 1.083 . . . . 0.0 111.297 171.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -59.9 -46.85 88.02 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.696 1.135 . . . . 0.0 109.141 172.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -57.25 -33.32 67.47 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.565 1.146 . . . . 0.0 111.517 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.77 -23.45 66.2 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.129 0.972 . . . . 0.0 112.771 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.36 -31.62 11.24 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 123.018 0.527 . . . . 0.0 110.28 171.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.2 ttmt -66.5 -36.43 82.7 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 118.602 0.637 . . . . 0.0 111.342 -176.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -134.82 176.22 8.84 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.743 1.217 . . . . 0.0 111.06 -169.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -80.32 1.76 27.44 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.68 1.192 . . . . 0.0 112.216 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.1 pp -59.98 158.86 1.94 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 124.0 0.92 . . . . 0.0 110.352 177.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -116.98 154.44 30.89 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 172.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 29.0 m -128.94 147.99 33.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 123.316 0.647 . . . . 0.0 110.14 -175.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.438 ' H ' HG12 ' A' ' 8' ' ' ILE . 16.0 m -144.76 131.23 19.8 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 176.628 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -123.51 110.23 14.8 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -169.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 11.3 m-90 -74.09 158.54 34.07 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.862 0.865 . . . . 0.0 109.652 172.072 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -65.57 -44.59 92.53 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 108.802 -1.719 . . . . 0.0 108.802 169.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.5 t70 . . . . . 0 C--O 1.246 0.887 0 C-N-CA 127.111 2.164 . . . . 0.0 107.676 169.806 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.5 t . . . . . 0 C--O 1.236 0.377 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 33.5 ptt-85 -155.74 157.07 35.96 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 124.386 1.074 . . . . 0.0 108.508 171.152 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.8 m -81.37 160.1 24.19 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 169.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.407 HG12 ' H ' ' A' ' 32' ' ' THR . 7.9 pt -122.66 167.45 16.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 125.0 1.32 . . . . 0.0 108.993 177.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.19 45.5 1.15 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 122.213 1.006 . . . . 0.0 108.503 170.394 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.2 p -70.72 144.02 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 O-C-N 121.444 -0.785 . . . . 0.0 110.737 -170.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -175.98 159.15 26.42 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 172.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 58.02 18.89 35.58 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.355 0.979 . . . . 0.0 113.915 -176.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.5 p -144.66 71.9 15.45 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 125.282 1.433 . . . . 0.0 108.178 -169.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -60.45 -24.02 76.7 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.296 1.997 . . . . 0.0 112.848 -176.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.5 mp0 -62.36 -39.52 93.44 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.602 0.761 . . . . 0.0 109.678 173.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -79.04 -24.14 43.8 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 121.476 -0.765 . . . . 0.0 110.775 -178.07 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.6 mt -60.92 -38.49 85.96 Favored 'General case' 0 CA--C 1.526 0.052 0 CA-C-N 119.65 1.114 . . . . 0.0 108.027 169.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -72.54 -49.46 32.53 Favored 'General case' 0 C--N 1.341 0.223 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -60.92 -45.94 92.67 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 118.596 0.635 . . . . 0.0 111.04 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 94.4 mt -72.93 -33.99 66.29 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 118.5 -0.762 . . . . 0.0 110.103 -177.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -60.99 -40.33 93.11 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.937 1.244 . . . . 0.0 110.315 169.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -62.11 -41.39 98.18 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.668 0.667 . . . . 0.0 109.941 177.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -63.45 -40.26 96.67 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 119.35 0.977 . . . . 0.0 111.628 175.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.8 -42.89 98.49 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 118.784 0.72 . . . . 0.0 110.404 176.285 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 42.2 mtpt -67.08 -37.28 83.72 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.979 -0.45 . . . . 0.0 110.941 175.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 66.3 tttm -80.44 -40.51 26.19 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 118.674 0.67 . . . . 0.0 111.851 -169.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -130.5 10.26 5.2 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.947 0.899 . . . . 0.0 113.076 -169.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 64.04 7.8 3.6 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.133 1.773 . . . . 0.0 114.05 177.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.5 pp -64.2 155.83 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 121.96 0.886 . . . . 0.0 112.551 -169.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 28.1 ttp-105 -62.44 134.25 56.17 Favored 'General case' 0 CA--C 1.527 0.073 0 C-N-CA 124.361 1.064 . . . . 0.0 109.28 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.6 m -139.56 144.29 29.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 172.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.407 ' H ' HG12 ' A' ' 8' ' ' ILE . 18.2 m -140.2 110.24 6.51 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 178.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -99.56 84.86 3.02 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.48 0.712 . . . . 0.0 109.993 -169.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 14.0 m-90 -64.65 -47.86 76.93 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.32 169.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.91 -12.51 42.2 Favored Glycine 0 CA--C 1.536 1.364 0 CA-C-O 118.923 -0.931 . . . . 0.0 113.003 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.2 t0 . . . . . 0 C--O 1.248 0.996 0 C-N-CA 127.508 2.323 . . . . 0.0 112.123 -171.463 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.0 p . . . . . 0 C--O 1.234 0.277 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 71.6 mtt180 -140.67 177.19 8.2 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 125.309 1.444 . . . . 0.0 108.169 -177.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.0 m -144.08 149.13 36.11 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 169.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.3 pt -135.15 171.79 17.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 124.932 1.293 . . . . 0.0 108.406 -175.019 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.58 43.01 1.18 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.867 0.841 . . . . 0.0 109.826 176.5 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.9 p -73.37 148.47 8.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 O-C-N 121.437 -0.789 . . . . 0.0 109.804 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -173.39 166.89 39.43 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 108.378 -1.889 . . . . 0.0 108.378 169.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 54.5 21.26 20.11 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.069 1.319 . . . . 0.0 114.974 176.382 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.7 m -145.94 75.32 13.05 Favored Pre-proline 0 CA--C 1.538 0.497 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 -169.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -50.01 -34.52 38.2 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.434 2.756 . . . . 0.0 113.639 -177.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -68.25 -41.64 80.85 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.906 0.384 . . . . 0.0 110.15 -176.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -74.72 -36.18 62.68 Favored 'General case' 0 N--CA 1.436 -1.131 0 O-C-N 121.215 -0.928 . . . . 0.0 109.429 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.3 mt -57.26 -38.43 73.84 Favored 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 123.806 0.843 . . . . 0.0 109.721 172.564 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 43.1 mtpt -68.13 -49.13 63.08 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 118.741 0.7 . . . . 0.0 109.855 176.482 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -60.8 -43.82 97.66 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 118.797 0.726 . . . . 0.0 110.954 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 69.0 mt -74.64 -31.68 62.03 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 118.552 -0.737 . . . . 0.0 110.599 -178.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -62.07 -41.58 98.31 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.815 1.189 . . . . 0.0 110.254 169.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -63.38 -42.92 98.86 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.638 0.654 . . . . 0.0 109.617 176.366 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.0 tp10 -60.23 -39.26 86.04 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.055 -1.028 . . . . 0.0 111.037 176.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.14 -3.1 6.67 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.827 1.251 . . . . 0.0 113.798 174.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -118.2 -25.54 6.59 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.23 1.412 . . . . 0.0 110.036 174.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.4 ttpt -68.45 -41.6 80.02 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 123.791 0.836 . . . . 0.0 108.905 172.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -132.49 161.25 34.21 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.193 1.397 . . . . 0.0 109.205 175.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -74.31 -7.08 51.59 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.016 0.926 . . . . 0.0 113.341 -173.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.8 pp -51.76 145.6 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 125.251 1.421 . . . . 0.0 113.944 -169.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.9 ttp180 -59.37 143.98 48.03 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 124.776 1.23 . . . . 0.0 109.476 172.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.4 m -140.18 153.55 22.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 C-N-CA 125.607 1.563 . . . . 0.0 106.789 169.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.9 m -141.46 128.24 20.43 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 -176.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -121.4 119.24 31.54 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -169.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 19.8 m-90 -94.73 157.43 15.95 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 169.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.61 -48.3 82.65 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 108.661 -1.776 . . . . 0.0 108.661 169.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.7 t70 . . . . . 0 C--O 1.247 0.961 0 C-N-CA 126.947 2.099 . . . . 0.0 107.73 169.721 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.403 ' HA ' HG22 ' A' ' 29' ' ' ILE . 53.3 t . . . . . 0 C--O 1.234 0.275 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 30.1 ptt-85 -155.43 -179.71 8.35 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 126.804 2.041 . . . . 0.0 106.599 -178.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.9 m -129.6 152.63 48.91 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 175.292 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.455 HG12 ' H ' ' A' ' 32' ' ' THR . 1.9 pt -117.07 167.13 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.765 1.226 . . . . 0.0 108.446 -171.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -144.52 36.08 1.19 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.775 0.83 . . . . 0.0 109.522 177.762 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.4 m -69.17 150.58 10.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 O-C-N 121.346 -0.846 . . . . 0.0 109.493 -178.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -81.97 42.27 2.83 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.548 1.071 . . . . 0.0 111.774 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 57.45 35.01 70.17 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 124.117 0.865 . . . . 0.0 111.691 -177.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.74 125.17 87.09 Favored Pre-proline 0 N--CA 1.45 -0.466 0 C-N-CA 124.615 1.166 . . . . 0.0 108.642 -174.693 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -65.39 -18.08 59.33 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 121.699 1.6 . . . . 0.0 111.475 175.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -77.75 -11.36 59.87 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.096 0.958 . . . . 0.0 111.085 178.173 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -125.58 -47.43 1.7 Allowed 'General case' 0 CA--C 1.519 -0.25 0 C-N-CA 123.281 0.632 . . . . 0.0 109.725 -169.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.4 pp -57.0 -27.9 61.98 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 118.77 0.714 . . . . 0.0 111.663 177.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -68.6 -13.88 62.64 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 118.703 -0.665 . . . . 0.0 112.736 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -111.43 -42.59 3.85 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.22 0.918 . . . . 0.0 109.074 173.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -62.96 -41.61 99.57 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.339 0.656 . . . . 0.0 111.518 -177.34 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.9 tptp -67.97 -31.77 71.73 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.186 0.903 . . . . 0.0 111.014 178.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -66.31 -46.17 77.83 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 172.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -60.77 -38.3 84.79 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.462 -0.774 . . . . 0.0 111.18 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.4 -15.78 40.04 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.483 1.113 . . . . 0.0 113.347 176.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -109.04 -27.17 9.79 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.886 1.274 . . . . 0.0 109.976 176.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -75.08 -35.94 61.77 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.932 0.893 . . . . 0.0 110.414 -179.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -140.03 169.91 16.84 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.329 1.452 . . . . 0.0 109.634 -177.516 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -76.75 15.47 0.64 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.901 1.28 . . . . 0.0 112.627 -174.572 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.403 HG22 ' HA ' ' A' ' 5' ' ' VAL . 1.4 pp -70.28 158.48 6.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 O-C-N 120.666 -1.271 . . . . 0.0 110.286 -174.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 41.8 ttm105 -98.93 147.29 25.13 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.086 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 29.9 m -136.67 154.58 32.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 170.135 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.455 ' H ' HG12 ' A' ' 8' ' ' ILE . 24.7 m -153.15 144.48 23.2 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 169.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -130.71 112.01 12.7 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -169.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 13.2 m-90 -93.84 150.7 20.16 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 122.887 0.475 . . . . 0.0 110.151 179.428 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -82.71 43.77 3.13 Favored Glycine 0 CA--C 1.532 1.154 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 169.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.1 t70 . . . . . 0 C--O 1.247 0.944 0 C-N-CA 125.075 1.35 . . . . 0.0 111.246 -173.924 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.234 0.263 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -160.33 158.93 30.56 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 125.998 1.719 . . . . 0.0 107.552 172.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.4 m -99.23 152.47 19.87 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 169.366 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.475 HG12 ' H ' ' A' ' 32' ' ' THR . 8.0 pt -113.38 173.81 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 124.365 1.066 . . . . 0.0 109.066 -176.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.92 72.31 1.17 Allowed 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 172.682 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.409 HG22 HD12 ' A' ' 8' ' ' ILE . 13.5 m -124.06 157.8 30.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 177.808 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -167.87 136.3 4.04 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 108.979 -1.649 . . . . 0.0 108.979 171.074 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 56.22 23.08 39.16 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 124.247 0.927 . . . . 0.0 114.19 179.554 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.0 p -68.58 150.23 97.73 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 119.072 1.436 . . . . 0.0 108.886 176.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.4 -25.99 29.74 Favored 'Trans proline' 0 CA--C 1.533 0.463 0 C-N-CA 121.965 1.777 . . . . 0.0 112.041 -172.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -159.52 -12.91 0.06 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.279 1.032 . . . . 0.0 112.019 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -66.21 -36.74 83.84 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 120.591 -1.318 . . . . 0.0 110.557 -173.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.6 pp -65.38 -21.67 66.71 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-O 118.424 -0.798 . . . . 0.0 112.16 172.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -77.85 -45.65 23.7 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 119.861 1.209 . . . . 0.0 108.935 175.142 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -58.44 -46.73 85.95 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.251 0.478 . . . . 0.0 110.316 173.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.0 mt -70.34 -34.48 72.71 Favored 'General case' 0 C--O 1.226 -0.154 0 CA-C-O 118.41 -0.805 . . . . 0.0 110.616 -178.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -60.19 -42.36 94.91 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 120.335 1.425 . . . . 0.0 110.799 169.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -61.52 -40.13 93.53 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 119.316 0.962 . . . . 0.0 110.174 175.032 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -62.23 -31.9 72.5 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.498 -0.751 . . . . 0.0 111.288 173.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.42 -28.72 67.33 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 120.162 1.346 . . . . 0.0 112.138 173.071 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -78.86 -33.1 46.11 Favored 'General case' 0 N--CA 1.463 0.19 0 O-C-N 121.82 -0.55 . . . . 0.0 109.998 172.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -90.5 -23.71 20.86 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -169.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -142.09 172.67 12.37 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.827 1.651 . . . . 0.0 109.931 -176.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -81.97 2.04 32.63 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.838 1.255 . . . . 0.0 112.982 -173.243 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.5 pt -53.18 151.05 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 125.635 1.574 . . . . 0.0 113.881 -169.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 34.2 ttp180 -94.34 75.39 3.92 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.426 1.49 . . . . 0.0 108.989 -177.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.5 m -62.93 139.66 20.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 171.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.475 ' H ' HG12 ' A' ' 8' ' ' ILE . 21.0 m -144.76 125.01 13.73 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 104.257 -2.497 . . . . 0.0 104.257 177.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -117.7 109.69 16.93 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -169.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 11.8 m-90 -72.24 165.2 24.9 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.993 0.917 . . . . 0.0 109.997 171.194 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -68.84 -45.4 64.57 Favored Glycine 0 CA--C 1.531 1.054 0 N-CA-C 108.328 -1.909 . . . . 0.0 108.328 169.281 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.3 t70 . . . . . 0 C--O 1.246 0.876 0 C-N-CA 127.111 2.165 . . . . 0.0 107.756 169.81 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 C--O 1.234 0.289 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 23.5 ptt-85 -152.25 165.66 34.18 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 126.978 2.111 . . . . 0.0 105.959 168.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.1 m -136.17 153.95 51.11 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -173.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.408 HG12 ' H ' ' A' ' 32' ' ' THR . 1.9 pt -127.33 169.15 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 125.002 1.321 . . . . 0.0 108.887 -169.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.07 37.14 0.94 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.514 0.726 . . . . 0.0 110.332 176.625 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.0 m -72.68 152.58 7.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 O-C-N 121.116 -0.99 . . . . 0.0 109.528 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -81.93 40.56 2.66 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.624 1.107 . . . . 0.0 111.727 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 53.76 34.4 50.7 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.32 0.962 . . . . 0.0 111.839 -171.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.3 m -61.89 124.42 81.62 Favored Pre-proline 0 N--CA 1.445 -0.715 0 C-N-CA 125.269 1.428 . . . . 0.0 108.68 -169.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -52.82 -27.49 34.8 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.801 2.334 . . . . 0.0 112.91 172.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -70.39 -26.44 63.7 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.63 0.772 . . . . 0.0 111.073 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -102.41 -37.06 8.19 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 124.363 1.065 . . . . 0.0 109.232 -171.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 65.5 mt -53.38 -19.2 3.19 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.257 1.023 . . . . 0.0 112.277 169.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -58.96 -28.54 66.4 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 118.945 0.793 . . . . 0.0 112.589 172.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -131.77 -37.08 1.19 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.008 0.822 . . . . 0.0 111.639 -173.585 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -61.57 -40.42 94.67 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 119.021 0.828 . . . . 0.0 111.374 -176.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.6 tptt -66.88 -32.58 73.94 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 119.303 -0.38 . . . . 0.0 111.005 177.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -69.0 -46.38 68.17 Favored 'General case' 0 C--O 1.224 -0.262 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 175.278 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -58.2 -40.17 80.87 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 119.168 0.895 . . . . 0.0 111.005 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.93 -15.66 33.61 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.138 0.975 . . . . 0.0 113.444 177.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -113.76 -29.83 6.97 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.993 1.317 . . . . 0.0 110.062 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -73.19 -34.55 66.04 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 123.873 0.869 . . . . 0.0 110.411 178.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -133.86 168.41 18.81 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.351 1.06 . . . . 0.0 110.654 -173.296 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -69.09 -9.52 53.07 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.023 1.729 . . . . 0.0 113.533 -177.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.6 pp -60.49 157.0 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.81 1.244 . . . . 0.0 111.952 -173.016 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 12.0 ptp85 -97.51 159.85 14.68 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.652 0.739 . . . . 0.0 109.648 174.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.3 m -139.22 155.01 25.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 171.021 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.408 ' H ' HG12 ' A' ' 8' ' ' ILE . 38.9 m -149.43 144.21 26.21 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 170.674 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -129.96 107.23 9.2 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -169.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 13.3 m-90 -84.21 151.29 24.92 Favored 'General case' 0 N--CA 1.461 0.118 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 -179.354 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -83.03 45.57 3.47 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 169.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.9 t70 . . . . . 0 C--O 1.249 1.066 0 C-N-CA 125.089 1.356 . . . . 0.0 111.306 -174.177 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.2 t . . . . . 0 C--O 1.233 0.224 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -151.9 145.55 24.98 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 104.539 -2.393 . . . . 0.0 104.539 173.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.7 m -102.92 145.41 29.87 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 175.262 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.489 HG12 ' H ' ' A' ' 32' ' ' THR . 8.4 pt -101.87 174.83 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.226 1.01 . . . . 0.0 109.254 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.83 46.86 1.26 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.629 0.771 . . . . 0.0 109.004 170.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.2 p -80.64 145.98 8.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 O-C-N 121.277 -0.889 . . . . 0.0 109.073 -175.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -86.27 35.67 3.28 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.692 1.139 . . . . 0.0 112.395 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 56.07 41.96 86.41 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.275 0.941 . . . . 0.0 113.15 173.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.5 m -61.55 137.45 94.82 Favored Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 177.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -51.42 -27.23 23.67 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.37 2.713 . . . . 0.0 115.466 -177.158 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -93.89 -29.68 15.17 Favored 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 123.264 0.626 . . . . 0.0 110.858 -178.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -71.88 -33.45 68.38 Favored 'General case' 0 N--CA 1.462 0.169 0 O-C-N 121.256 -0.902 . . . . 0.0 108.829 175.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 76.6 mt -62.44 -5.09 2.23 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.713 1.205 . . . . 0.0 112.445 169.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.4 mttp -109.24 -56.08 2.33 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 119.287 0.949 . . . . 0.0 108.937 170.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -62.08 -49.87 74.21 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.162 0.585 . . . . 0.0 111.098 -174.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 25.8 mt -76.16 -29.31 57.69 Favored 'General case' 0 C--O 1.224 -0.244 0 O-C-N 122.008 -0.432 . . . . 0.0 109.969 -177.257 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.3 tptt -63.3 -39.47 94.65 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 119.125 0.875 . . . . 0.0 110.503 171.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -64.68 -44.1 91.4 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 173.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -56.7 -36.9 70.18 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.666 0.786 . . . . 0.0 111.115 175.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.28 -14.03 61.35 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.562 1.145 . . . . 0.0 113.385 177.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.1 mptp? -104.72 -33.7 8.37 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.219 1.008 . . . . 0.0 109.867 172.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 32.6 tttm -66.97 -37.57 84.5 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 123.396 0.679 . . . . 0.0 110.519 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -136.05 163.46 30.25 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 126.468 1.907 . . . . 0.0 108.646 -175.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -82.14 6.43 16.49 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.006 0.923 . . . . 0.0 112.771 -174.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.0 pp -59.73 156.04 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 124.528 1.131 . . . . 0.0 112.754 -172.071 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 33.1 ttp180 -98.89 81.28 2.6 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.806 1.243 . . . . 0.0 109.975 -169.569 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.4 m -63.21 139.55 21.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.324 169.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.489 ' H ' HG12 ' A' ' 8' ' ' ILE . 19.1 m -146.04 122.06 10.73 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 104.116 -2.55 . . . . 0.0 104.116 173.733 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -112.53 111.95 23.14 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -169.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 10.3 m-90 -83.07 147.03 28.37 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 174.286 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.98 -41.23 61.69 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 169.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.6 t70 . . . . . 0 C--O 1.246 0.889 0 C-N-CA 126.885 2.074 . . . . 0.0 107.867 170.004 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.303 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.6 m -60.58 154.82 20.15 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.221 1.008 . . . . 0.0 111.448 177.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -179.88 -179.03 48.78 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -63.79 -55.63 21.59 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 176.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.4 t -63.93 136.98 25.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-O 121.746 0.784 . . . . 0.0 109.371 -175.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -159.63 176.67 11.74 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 127.46 2.304 . . . . 0.0 106.826 -173.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.4 m -139.91 155.63 47.08 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 -176.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.468 HG12 ' H ' ' A' ' 32' ' ' THR . 2.9 pt -121.02 167.37 14.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 125.022 1.329 . . . . 0.0 108.792 -172.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.26 43.37 1.12 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.71 0.804 . . . . 0.0 109.35 173.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.2 m -75.27 150.39 6.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 O-C-N 121.189 -0.945 . . . . 0.0 110.319 -177.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -88.07 33.69 3.97 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 124.867 1.222 . . . . 0.0 112.271 178.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 61.37 38.52 95.86 Favored Glycine 0 CA--C 1.531 1.037 0 CA-C-N 117.576 0.688 . . . . 0.0 112.976 174.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.3 m -62.79 136.12 96.21 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 172.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -51.32 -32.88 43.44 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 122.766 2.311 . . . . 0.0 113.801 177.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -73.51 -39.19 65.0 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.702 0.401 . . . . 0.0 110.14 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -77.07 -36.15 56.1 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -177.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 34.2 mt -59.41 -26.61 65.3 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.419 1.088 . . . . 0.0 111.451 169.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -83.81 -63.94 1.26 Allowed 'General case' 0 C--N 1.339 0.147 0 CA-C-N 119.237 0.926 . . . . 0.0 109.046 174.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -61.81 -49.21 77.22 Favored 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 122.75 0.42 . . . . 0.0 111.466 -169.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 52.4 mt -75.8 -30.29 59.0 Favored 'General case' 0 C--O 1.226 -0.134 0 CA-C-O 119.124 -0.465 . . . . 0.0 110.255 -171.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -62.95 -38.76 92.36 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.225 0.921 . . . . 0.0 110.059 169.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -61.88 -42.87 99.58 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 118.762 0.71 . . . . 0.0 109.938 174.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -62.35 -39.31 92.72 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.361 0.982 . . . . 0.0 111.23 175.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.34 -46.34 90.27 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 118.771 0.714 . . . . 0.0 110.319 175.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 43.1 mtpt -66.75 -37.24 84.23 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 122.982 0.513 . . . . 0.0 110.904 177.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -83.7 -33.12 25.22 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 118.755 -0.641 . . . . 0.0 112.035 -170.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -128.52 5.65 5.66 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.858 0.863 . . . . 0.0 113.081 -169.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 64.84 3.64 2.12 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.555 1.942 . . . . 0.0 114.309 178.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.0 pp -65.11 156.4 5.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 123.777 0.831 . . . . 0.0 111.577 -173.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 51.5 mtt85 -71.1 143.59 50.58 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -176.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.9 m -141.13 141.76 30.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 169.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.468 ' H ' HG12 ' A' ' 8' ' ' ILE . 19.7 m -145.06 130.16 18.46 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 175.311 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -120.93 110.99 16.95 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 -169.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 11.9 m-90 -86.75 148.2 25.52 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -85.81 44.68 3.38 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 169.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.6 t70 . . . . . 0 C--O 1.25 1.086 0 C-N-CA 125.022 1.329 . . . . 0.0 111.397 -173.397 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.227 0 N-CA-C 111.181 -0.767 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.1 m -60.47 155.02 19.26 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.241 1.016 . . . . 0.0 111.36 177.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 179.8 -178.95 48.82 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -66.21 -38.45 87.99 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.114 0.566 . . . . 0.0 110.682 177.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.7 t -64.76 140.5 19.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 124.439 1.096 . . . . 0.0 108.867 179.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -149.13 178.84 8.37 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 124.443 1.097 . . . . 0.0 110.089 -174.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 38.3 m -132.28 153.4 50.71 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 169.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.41 HG12 ' H ' ' A' ' 32' ' ' THR . 5.3 pt -126.2 170.34 16.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 125.443 1.497 . . . . 0.0 108.109 -174.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.3 34.9 0.88 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.302 0.572 . . . . 0.0 111.092 174.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.3 m -74.33 158.37 5.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 O-C-N 121.205 -0.935 . . . . 0.0 109.769 176.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -169.72 154.97 24.55 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 108.521 -1.832 . . . . 0.0 108.521 169.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 51.54 28.76 22.52 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 124.385 0.993 . . . . 0.0 114.29 178.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 26.4 m -138.63 74.91 38.63 Favored Pre-proline 0 CA--C 1.537 0.446 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 -170.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -59.55 -27.51 85.15 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.327 2.018 . . . . 0.0 111.778 -177.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -63.6 -17.32 62.75 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.392 1.077 . . . . 0.0 112.168 -178.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -126.92 -34.56 2.35 Favored 'General case' 0 C--N 1.34 0.172 0 C-N-CA 123.453 0.701 . . . . 0.0 111.262 -177.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.16 -25.43 68.34 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 119.47 1.032 . . . . 0.0 110.155 173.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -68.47 -42.88 78.09 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.803 1.183 . . . . 0.0 110.79 173.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -75.29 -29.69 60.17 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.325 0.966 . . . . 0.0 111.536 178.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.0 mt -72.71 -34.87 67.41 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.445 1.021 . . . . 0.0 109.916 172.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.7 mmtt -60.02 -45.41 92.87 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 119.51 1.05 . . . . 0.0 109.829 169.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -57.82 -46.04 85.29 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.575 0.75 . . . . 0.0 109.717 177.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -60.73 -41.64 95.72 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.227 0.921 . . . . 0.0 110.704 176.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.95 -2.96 11.07 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 177.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -117.19 -26.12 6.88 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.978 1.311 . . . . 0.0 109.806 175.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.0 tttm -72.43 -39.95 67.46 Favored 'General case' 0 C--O 1.23 0.073 0 C-N-CA 124.844 1.258 . . . . 0.0 109.521 173.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -133.64 167.88 19.7 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.873 1.669 . . . . 0.0 108.954 178.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -78.82 4.04 15.08 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.722 1.209 . . . . 0.0 113.114 -174.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.1 pp -59.75 151.58 5.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 121.997 0.904 . . . . 0.0 112.978 -169.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.13 144.38 42.86 Favored 'General case' 0 C--O 1.23 0.076 0 C-N-CA 124.003 0.921 . . . . 0.0 109.05 178.031 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.1 m -143.46 153.76 16.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 125.79 1.636 . . . . 0.0 107.156 169.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.41 ' H ' HG12 ' A' ' 8' ' ' ILE . 25.6 m -146.75 141.65 26.95 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 173.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -128.39 111.83 13.75 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -169.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 18.6 m-90 -86.67 156.11 20.12 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 122.838 0.455 . . . . 0.0 110.679 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -83.46 48.49 4.05 Favored Glycine 0 CA--C 1.529 0.969 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 170.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.7 t70 . . . . . 0 C--O 1.247 0.942 0 C-N-CA 124.918 1.287 . . . . 0.0 111.513 -173.869 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.366 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.0 m -63.85 -24.77 67.88 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.322 1.049 . . . . 0.0 113.105 -176.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -178.72 -178.4 48.0 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 124.96 1.267 . . . . 0.0 109.935 178.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -70.33 -18.73 63.09 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.584 0.753 . . . . 0.0 111.857 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.7 t -59.76 142.97 14.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 O-C-N 121.419 -0.801 . . . . 0.0 109.818 -178.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.32 179.43 6.4 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.408 1.883 . . . . 0.0 106.945 170.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.8 m -140.05 152.27 46.07 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 126.456 1.902 . . . . 0.0 106.426 178.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 13.6 pt -128.33 170.82 17.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 125.052 1.341 . . . . 0.0 108.6 -170.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -150.89 37.88 0.65 Allowed 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 121.727 0.775 . . . . 0.0 110.335 176.116 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 27.2 m -68.75 152.36 9.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 O-C-N 121.325 -0.86 . . . . 0.0 111.42 -177.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -158.28 41.14 0.51 Allowed Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.071 1.32 . . . . 0.0 110.719 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 162.1 -170.49 37.77 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 108.979 -1.649 . . . . 0.0 108.979 -175.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.5 m 58.38 73.83 0.68 Allowed Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 124.954 1.301 . . . . 0.0 110.061 176.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -58.64 -23.37 65.23 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.396 2.064 . . . . 0.0 112.924 -177.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -62.7 -43.39 98.92 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.346 0.521 . . . . 0.0 110.191 172.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -74.92 -32.11 61.71 Favored 'General case' 0 N--CA 1.438 -1.069 0 C-N-CA 124.085 0.954 . . . . 0.0 109.721 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 78.3 mt -60.36 -43.67 96.32 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-N 120.086 1.312 . . . . 0.0 108.718 172.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -64.42 -47.23 79.92 Favored 'General case' 0 C--N 1.339 0.114 0 CA-C-O 119.212 -0.423 . . . . 0.0 110.323 176.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -63.18 -45.7 90.58 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.995 0.816 . . . . 0.0 111.091 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 73.2 mt -66.69 -37.23 84.31 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 118.815 0.734 . . . . 0.0 110.108 178.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -60.52 -41.06 93.64 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 119.194 0.906 . . . . 0.0 110.606 171.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -63.06 -40.89 99.02 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 118.707 0.685 . . . . 0.0 110.444 177.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -62.29 -41.57 98.61 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 119.472 1.033 . . . . 0.0 110.809 174.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.02 -45.34 95.18 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-N 118.623 0.647 . . . . 0.0 110.545 176.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -66.23 -35.55 80.71 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 119.072 -0.49 . . . . 0.0 111.044 177.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -81.64 -39.53 24.27 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.812 0.733 . . . . 0.0 111.748 -172.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -117.3 4.96 12.58 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.582 0.753 . . . . 0.0 112.855 -170.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 55.4 t30 65.54 1.32 1.66 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 127.141 2.177 . . . . 0.0 114.186 -178.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.7 pp -63.3 147.1 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 124.095 0.958 . . . . 0.0 111.079 -174.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -78.64 133.93 37.21 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.5 m -120.15 155.51 23.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 125.064 1.346 . . . . 0.0 108.396 173.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.94 92.57 2.68 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -169.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -92.43 93.98 8.87 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -175.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 5.9 m-90 -66.33 -46.31 77.29 Favored 'General case' 0 C--O 1.232 0.153 0 O-C-N 122.341 -0.224 . . . . 0.0 110.724 173.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.49 -50.14 3.14 Favored Glycine 0 CA--C 1.531 1.084 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -169.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.0 t70 . . . . . 0 C--O 1.249 1.037 0 C-N-CA 126.818 2.047 . . . . 0.0 108.259 169.52 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.252 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.8 m -143.91 164.8 29.53 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.124 1.37 . . . . 0.0 109.144 -177.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -177.71 177.95 48.37 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 30.1 tp60 -68.79 -27.97 66.36 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.265 0.626 . . . . 0.0 111.41 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.9 t -61.77 124.65 16.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 30.7 ptt-85 -160.58 -178.14 6.68 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.896 1.278 . . . . 0.0 108.704 -176.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.8 m -116.15 154.71 29.53 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 171.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 11.0 pt -120.99 174.98 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.985 1.314 . . . . 0.0 109.038 -171.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.9 68.31 0.88 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 175.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.8 m -122.33 166.04 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 177.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -169.25 -26.24 0.02 OUTLIER Glycine 0 CA--C 1.527 0.839 0 CA-C-N 115.623 -0.717 . . . . 0.0 113.879 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -157.95 38.61 0.53 Allowed Glycine 0 CA--C 1.527 0.798 0 C-N-CA 124.022 0.82 . . . . 0.0 111.274 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.5 p -68.33 159.72 79.31 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 123.806 0.842 . . . . 0.0 109.967 177.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -54.08 -41.73 73.05 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.783 2.322 . . . . 0.0 112.719 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -161.11 2.91 0.06 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.248 1.019 . . . . 0.0 112.692 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -68.95 -28.09 66.32 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 120.2 1.364 . . . . 0.0 110.501 -175.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.3 mt -51.18 -39.62 56.83 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 125.168 1.387 . . . . 0.0 109.755 169.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -71.43 -45.35 62.9 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-N 118.655 0.661 . . . . 0.0 109.46 -177.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.0 mmtt -64.0 -46.22 85.53 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -177.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 92.6 mt -73.08 -38.28 66.47 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 118.795 -0.621 . . . . 0.0 110.112 -176.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.9 tptt -59.84 -40.15 87.56 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.402 1.001 . . . . 0.0 110.848 170.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -63.7 -43.58 96.2 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 119.084 0.856 . . . . 0.0 110.077 176.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -60.7 -35.09 75.42 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 120.143 1.338 . . . . 0.0 111.686 177.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.78 -23.78 65.28 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.04 0.836 . . . . 0.0 112.099 173.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -104.84 -20.72 13.5 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.068 1.347 . . . . 0.0 111.776 -177.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -110.69 -20.34 12.55 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 119.324 0.965 . . . . 0.0 112.358 -173.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -129.97 0.06 4.75 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.231 1.412 . . . . 0.0 111.539 178.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 63.77 6.94 2.92 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 127.05 2.14 . . . . 0.0 114.316 177.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.3 pp -65.03 157.0 5.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 O-C-N 121.63 -0.668 . . . . 0.0 111.878 -171.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 96.9 mtt-85 -67.35 142.11 56.89 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 22.6 m -137.61 151.96 26.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 173.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.8 m -146.18 130.91 17.97 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -125.16 112.48 16.5 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -169.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 8.2 m-90 -78.29 158.31 28.93 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.889 0.876 . . . . 0.0 110.533 178.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -82.53 48.06 3.89 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 109.866 -1.293 . . . . 0.0 109.866 169.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.2 t70 . . . . . 0 C--O 1.247 0.935 0 C-N-CA 124.914 1.286 . . . . 0.0 111.363 -174.228 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.337 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.8 p -66.14 -29.5 69.81 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.353 1.061 . . . . 0.0 112.351 178.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 171.35 -168.46 41.59 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -71.02 25.06 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.481 1.513 . . . . 0.0 113.677 178.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.467 ' HA ' HG22 ' A' ' 29' ' ' ILE . 4.1 t -61.27 147.25 10.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 125.708 1.603 . . . . 0.0 110.111 -174.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -151.41 174.94 12.76 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 126.196 1.798 . . . . 0.0 108.69 -174.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.8 m -136.69 147.74 46.96 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 169.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.7 pt -126.68 163.5 28.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 123.638 0.775 . . . . 0.0 108.936 -169.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.28 40.77 0.87 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.669 0.788 . . . . 0.0 109.254 176.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 27.5 m -67.07 133.18 31.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 O-C-N 121.243 -0.91 . . . . 0.0 108.584 177.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.46 -52.58 42.13 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 171.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 160.12 41.91 0.02 OUTLIER Glycine 0 CA--C 1.526 0.763 0 CA-C-O 119.086 -0.841 . . . . 0.0 112.923 176.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.7 m -67.05 123.17 85.58 Favored Pre-proline 0 N--CA 1.454 -0.227 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 176.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -50.91 -34.77 47.0 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.274 1.983 . . . . 0.0 113.218 -178.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -74.48 -36.29 63.28 Favored 'General case' 0 N--CA 1.456 -0.148 0 O-C-N 122.121 -0.362 . . . . 0.0 110.161 -175.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -80.6 -35.88 33.52 Favored 'General case' 0 CA--C 1.521 -0.142 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -177.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 88.0 mt -56.62 -41.87 77.84 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 169.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -66.77 -56.45 10.44 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 118.544 0.611 . . . . 0.0 109.907 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -61.94 -45.35 94.05 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 118.495 0.589 . . . . 0.0 111.083 -175.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.4 mt -74.62 -35.08 62.92 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 118.517 -0.754 . . . . 0.0 110.382 -174.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.4 tptt -61.76 -39.87 93.16 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 119.935 1.243 . . . . 0.0 110.092 169.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -63.06 -39.14 93.84 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.95 0.795 . . . . 0.0 110.407 178.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -63.9 -40.43 96.49 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 119.866 1.212 . . . . 0.0 111.336 172.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.7 -23.99 66.89 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.048 0.84 . . . . 0.0 112.343 177.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 41.4 mtpt -84.35 -38.09 20.77 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.643 0.777 . . . . 0.0 110.11 172.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -70.47 -42.21 71.74 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.883 0.873 . . . . 0.0 110.426 -174.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -135.84 165.71 25.0 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.064 1.346 . . . . 0.0 109.738 -173.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -71.03 7.04 1.31 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.064 1.346 . . . . 0.0 113.535 -175.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.467 HG22 ' HA ' ' A' ' 5' ' ' VAL . 2.0 pp -64.42 154.66 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 124.294 1.038 . . . . 0.0 111.347 -171.028 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -89.95 152.15 21.35 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.014 0.435 . . . . 0.0 110.307 178.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.0 m -142.89 157.07 17.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 125.9 1.68 . . . . 0.0 107.568 174.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 32.2 m -149.41 133.53 17.23 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 173.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -121.76 110.45 15.94 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 -169.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -70.68 -32.7 70.05 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -170.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 64.49 39.9 97.23 Favored Glycine 0 CA--C 1.532 1.113 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -172.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.5 t70 . . . . . 0 C--O 1.248 0.989 0 C-N-CA 125.037 1.335 . . . . 0.0 111.298 -176.682 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.3 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.1 m -64.13 -24.67 67.78 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.219 1.008 . . . . 0.0 113.078 -176.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -178.68 -178.51 48.05 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 109.914 -1.275 . . . . 0.0 109.914 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -139.88 18.1 2.48 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.388 1.075 . . . . 0.0 111.699 -177.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.419 ' HA ' HG22 ' A' ' 29' ' ' ILE . 21.2 t -59.54 139.9 18.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 123.617 0.767 . . . . 0.0 109.583 -176.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 33.0 ptt85 -144.28 167.36 22.63 Favored 'General case' 0 C--O 1.231 0.1 0 C-N-CA 125.495 1.518 . . . . 0.0 107.691 175.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.3 m -126.99 153.57 45.73 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.409 HG12 ' H ' ' A' ' 32' ' ' THR . 10.5 pt -126.78 170.56 16.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 124.658 1.183 . . . . 0.0 108.163 -173.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.13 75.68 1.45 Allowed 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 -178.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.7 m -125.08 153.53 32.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 C-N-CA 123.434 0.694 . . . . 0.0 109.713 -173.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -81.68 33.34 2.58 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 124.477 1.037 . . . . 0.0 112.574 -177.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 54.81 39.01 66.04 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-N 118.084 0.942 . . . . 0.0 111.428 -172.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -60.59 126.69 85.51 Favored Pre-proline 0 N--CA 1.451 -0.414 0 C-N-CA 125.038 1.335 . . . . 0.0 109.459 -169.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -53.59 -23.24 24.84 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.187 2.591 . . . . 0.0 113.91 173.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -92.37 -4.18 54.22 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.246 1.018 . . . . 0.0 111.878 -177.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -117.45 -36.69 3.66 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 123.763 0.825 . . . . 0.0 109.424 -178.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 28.4 mt -47.05 -34.65 6.01 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.523 1.129 . . . . 0.0 111.481 169.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.4 mttp -56.62 -25.66 53.76 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -118.53 -38.56 3.12 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 118.97 0.804 . . . . 0.0 110.303 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -68.39 -41.07 81.04 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-N 118.468 0.576 . . . . 0.0 111.277 -175.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 48.9 tptt -68.92 -34.74 75.88 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 118.499 0.591 . . . . 0.0 110.092 176.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -63.62 -45.39 90.52 Favored 'General case' 0 C--O 1.222 -0.367 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 175.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -60.1 -41.6 92.86 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 119.287 0.949 . . . . 0.0 110.516 178.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.13 -2.59 4.34 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.485 1.114 . . . . 0.0 113.829 176.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -121.72 -27.4 4.7 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.226 1.41 . . . . 0.0 110.308 175.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -70.41 -39.94 74.14 Favored 'General case' 0 C--N 1.338 0.107 0 C-N-CA 124.109 0.963 . . . . 0.0 109.343 175.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -122.84 166.58 14.76 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.729 1.211 . . . . 0.0 109.195 178.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -73.23 -1.31 17.25 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.632 1.173 . . . . 0.0 113.014 -178.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.419 HG22 ' HA ' ' A' ' 5' ' ' VAL . 2.2 pp -61.39 162.61 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 124.669 1.188 . . . . 0.0 110.83 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.48 147.66 52.57 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.0 m -127.07 167.54 21.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 124.853 1.261 . . . . 0.0 110.173 -169.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.409 ' H ' HG12 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -129.69 125.19 35.4 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.277 1.431 . . . . 0.0 108.657 -169.727 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -128.56 94.83 3.97 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 -175.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -71.75 -24.7 61.82 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -171.086 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.16 25.75 68.54 Favored Glycine 0 CA--C 1.537 1.465 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 -169.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.5 t70 . . . . . 0 C--O 1.249 1.038 0 C-N-CA 125.394 1.478 . . . . 0.0 111.48 -177.439 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.293 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.2 m -143.48 161.01 39.54 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.173 1.389 . . . . 0.0 109.048 -177.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -151.34 23.99 0.97 Allowed Glycine 0 CA--C 1.529 0.924 0 C-N-CA 123.636 0.636 . . . . 0.0 112.71 -175.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -61.77 149.4 40.02 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 117.946 0.873 . . . . 0.0 108.77 171.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.9 t -138.51 135.64 43.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 172.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 36.9 mtp180 -144.64 160.6 40.92 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 129.171 2.989 . . . . 0.0 104.146 170.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.5 m -139.84 151.84 46.01 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 169.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.469 HG12 ' H ' ' A' ' 32' ' ' THR . 2.5 pt -127.2 165.89 25.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.216 1.006 . . . . 0.0 109.007 -169.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -142.91 40.85 1.53 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.804 0.842 . . . . 0.0 109.593 -178.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 34.6 m -69.25 144.1 14.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 O-C-N 121.425 -0.797 . . . . 0.0 109.365 178.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -166.48 30.93 0.2 Allowed Glycine 0 CA--C 1.528 0.878 0 C-N-CA 123.573 0.606 . . . . 0.0 112.591 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -176.32 27.02 0.07 OUTLIER Glycine 0 CA--C 1.529 0.911 0 CA-C-N 117.705 0.753 . . . . 0.0 112.644 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.0 p -143.83 59.68 7.45 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 125.304 1.442 . . . . 0.0 108.226 -169.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -62.42 -26.05 76.44 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.6 2.2 . . . . 0.0 113.11 -169.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -71.27 -30.82 66.75 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.454 0.57 . . . . 0.0 110.96 177.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -75.64 -19.4 59.22 Favored 'General case' 0 N--CA 1.462 0.144 0 O-C-N 121.262 -0.899 . . . . 0.0 111.358 -176.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.0 mt -52.54 -31.21 34.55 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.116 0.966 . . . . 0.0 110.613 169.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 42.0 mtmt -62.66 -32.23 73.26 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 118.837 0.744 . . . . 0.0 111.444 177.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -85.39 -48.89 8.58 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 177.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -64.66 -40.84 96.13 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.309 0.644 . . . . 0.0 111.478 -170.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -64.7 -31.46 72.69 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 119.012 -0.518 . . . . 0.0 111.14 175.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -68.82 -46.58 68.21 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 118.921 0.782 . . . . 0.0 109.1 174.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -59.07 -37.75 77.82 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 119.451 1.023 . . . . 0.0 111.062 177.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.25 -13.89 21.96 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.253 1.021 . . . . 0.0 113.572 176.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -117.38 -30.49 5.55 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 125.052 1.341 . . . . 0.0 110.291 -179.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -77.66 -24.32 49.44 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 123.967 0.907 . . . . 0.0 111.109 177.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -138.83 168.72 19.19 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.69 1.196 . . . . 0.0 110.303 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -71.78 -10.35 59.64 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.423 1.489 . . . . 0.0 113.359 -177.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.8 pp -58.15 151.32 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 124.458 1.103 . . . . 0.0 113.547 -169.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 43.7 ttm105 -83.67 150.16 26.04 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 174.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.6 m -135.85 149.06 27.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 107.273 -1.381 . . . . 0.0 107.273 169.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.469 ' H ' HG12 ' A' ' 8' ' ' ILE . 2.6 m -144.66 139.75 28.2 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 178.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -131.12 118.26 20.26 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 -169.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 12.9 m-90 -95.82 151.24 19.57 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 122.907 0.483 . . . . 0.0 109.955 173.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -72.96 -41.77 47.34 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 108.928 -1.669 . . . . 0.0 108.928 169.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.3 t70 . . . . . 0 C--O 1.246 0.907 0 C-N-CA 126.996 2.119 . . . . 0.0 107.719 169.889 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.387 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.9 m -64.18 -23.96 67.51 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.229 1.011 . . . . 0.0 113.157 -176.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -177.27 179.9 47.86 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 109.859 -1.297 . . . . 0.0 109.859 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -155.07 164.17 39.25 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.983 1.313 . . . . 0.0 109.047 177.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.4 p -143.74 127.53 13.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 106.314 -1.736 . . . . 0.0 106.314 169.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.75 170.31 18.56 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.595 1.558 . . . . 0.0 108.336 177.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.3 m -97.85 161.53 13.7 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 169.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.7 pt -120.2 174.37 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 125.127 1.371 . . . . 0.0 108.041 -179.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.51 88.15 1.69 Allowed 'General case' 0 C--O 1.232 0.173 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 169.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.7 p -134.02 155.76 40.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -171.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -175.91 -65.68 0.06 OUTLIER Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.782 -0.527 . . . . 0.0 111.782 170.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -83.0 39.15 2.73 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 124.341 0.972 . . . . 0.0 112.398 -174.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.1 p -148.36 71.44 10.89 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 126.617 1.967 . . . . 0.0 106.07 -169.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -52.61 -34.78 64.84 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 123.045 2.497 . . . . 0.0 114.128 -169.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -66.49 -36.9 83.88 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.938 0.399 . . . . 0.0 110.211 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -76.2 -25.27 54.99 Favored 'General case' 0 N--CA 1.454 -0.236 0 O-C-N 121.719 -0.613 . . . . 0.0 110.52 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 91.2 mt -61.27 -37.81 84.48 Favored 'General case' 0 C--O 1.227 -0.127 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 169.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -70.96 -49.85 40.92 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 119.083 0.856 . . . . 0.0 109.47 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -59.43 -48.19 82.61 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 117.834 0.288 . . . . 0.0 110.6 -178.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.0 mt -74.58 -33.75 62.73 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 118.356 -0.83 . . . . 0.0 110.296 -175.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -61.13 -37.95 84.64 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 120.102 1.319 . . . . 0.0 110.464 169.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -62.7 -45.73 91.43 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 119.788 1.176 . . . . 0.0 109.406 175.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -59.12 -28.68 66.76 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 118.818 -0.61 . . . . 0.0 112.304 175.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.33 -21.57 64.11 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.363 0.983 . . . . 0.0 112.771 175.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.41 -33.06 10.15 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 118.548 0.613 . . . . 0.0 110.454 169.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -67.46 -29.37 68.81 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 118.842 0.746 . . . . 0.0 111.08 -175.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -140.62 179.82 6.47 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.823 1.649 . . . . 0.0 109.775 -174.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -91.85 11.39 25.01 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.911 1.284 . . . . 0.0 112.105 -173.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.8 pt -61.97 156.02 4.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 124.423 1.089 . . . . 0.0 112.131 -171.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.1 ptm180 -107.12 74.77 0.99 Allowed 'General case' 0 C--O 1.235 0.319 0 C-N-CA 123.901 0.881 . . . . 0.0 109.263 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 29.8 m -54.5 139.57 13.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.056 178.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.9 m -142.87 119.91 11.38 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 104.562 -2.385 . . . . 0.0 104.562 -175.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -114.58 111.04 20.73 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -169.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 9.7 m-90 -80.07 154.52 28.07 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.144 0.578 . . . . 0.0 110.037 175.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -86.81 40.09 3.08 Favored Glycine 0 CA--C 1.532 1.121 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 169.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.3 t70 . . . . . 0 C--O 1.248 0.999 0 C-N-CA 125.129 1.372 . . . . 0.0 111.192 -173.89 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.358 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.9 m -143.79 164.39 30.64 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.078 1.351 . . . . 0.0 109.26 -177.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -178.97 179.82 48.82 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 178.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -66.54 -35.66 80.78 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.093 0.557 . . . . 0.0 110.951 178.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.9 p -61.63 147.35 11.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 123.743 0.817 . . . . 0.0 110.648 -177.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -148.1 171.4 15.93 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 125.348 1.459 . . . . 0.0 109.263 -175.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.3 m -134.51 153.85 51.73 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 171.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.409 HG12 ' H ' ' A' ' 32' ' ' THR . 7.7 pt -129.3 167.51 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 125.713 1.605 . . . . 0.0 107.755 -175.149 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.31 39.56 0.91 Allowed 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.533 0.683 . . . . 0.0 110.603 175.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 28.3 m -69.03 144.87 13.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 O-C-N 121.289 -0.882 . . . . 0.0 109.866 176.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -172.1 147.6 10.15 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 106.632 -2.587 . . . . 0.0 106.632 172.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 55.06 24.58 35.77 Favored Glycine 0 CA--C 1.537 1.451 0 CA-C-N 117.797 0.799 . . . . 0.0 113.422 -170.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -140.63 61.12 14.98 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 125.289 1.436 . . . . 0.0 109.711 -171.139 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -62.27 -23.81 75.56 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.517 2.145 . . . . 0.0 112.711 -175.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -67.36 -19.22 65.4 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.033 0.933 . . . . 0.0 112.271 176.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -90.19 -26.14 20.27 Favored 'General case' 0 N--CA 1.465 0.275 0 O-C-N 121.392 -0.817 . . . . 0.0 110.174 -178.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 59.0 mt -55.05 -30.06 58.8 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 169.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -64.68 -23.71 67.34 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 119.051 -0.499 . . . . 0.0 112.041 -177.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -99.76 -45.6 5.69 Favored 'General case' 0 C--N 1.34 0.156 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 176.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 83.5 mt -72.4 -29.89 64.15 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 118.648 -0.691 . . . . 0.0 111.702 -169.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 27.0 mmtp -62.98 -38.35 90.79 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 119.578 1.081 . . . . 0.0 110.43 169.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -63.93 -45.99 86.77 Favored 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -59.82 -42.47 93.6 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.432 1.015 . . . . 0.0 111.036 177.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.91 -6.15 11.5 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.387 1.075 . . . . 0.0 113.889 177.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -121.57 -25.05 5.2 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.068 1.347 . . . . 0.0 110.052 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -70.15 -40.46 74.75 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 125.054 1.342 . . . . 0.0 108.837 172.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -134.97 166.23 23.51 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.714 1.206 . . . . 0.0 109.236 175.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -76.2 10.36 2.02 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.796 1.239 . . . . 0.0 112.954 -176.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.4 pp -62.17 153.4 6.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-O 122.093 0.949 . . . . 0.0 112.667 -169.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.93 144.26 47.38 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 124.14 0.976 . . . . 0.0 109.329 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.5 m -143.56 152.59 16.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 125.955 1.702 . . . . 0.0 106.497 169.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.409 ' H ' HG12 ' A' ' 8' ' ' ILE . 27.5 m -143.84 133.42 23.56 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 173.298 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -120.67 102.19 8.24 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -169.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 24.3 m-90 -75.87 155.19 35.52 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 171.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -66.88 -49.66 52.96 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 108.285 -1.926 . . . . 0.0 108.285 169.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.3 t70 . . . . . 0 C--O 1.246 0.881 0 C-N-CA 126.871 2.069 . . . . 0.0 107.797 169.919 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.253 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.4 m -59.04 149.87 26.38 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.275 1.03 . . . . 0.0 111.309 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 177.09 -172.41 45.32 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.0 tp60 64.51 -9.74 0.17 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 127.329 2.252 . . . . 0.0 115.268 174.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 32.6 m -52.12 141.85 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 120.112 1.324 . . . . 0.0 111.652 -175.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 69.9 mtm-85 -124.75 -31.69 3.16 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 118.487 -0.768 . . . . 0.0 112.951 176.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.4 m 64.61 151.84 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.032 1.333 . . . . 0.0 110.056 -169.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.0 pt -135.2 172.53 15.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 125.029 1.332 . . . . 0.0 108.615 -169.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.2 37.17 0.54 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.233 0.613 . . . . 0.0 110.962 177.086 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.406 HG11 HD12 ' A' ' 20' ' ' LEU . 18.1 m -67.33 153.44 8.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 O-C-N 121.069 -1.019 . . . . 0.0 112.47 -174.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 174.64 139.54 3.03 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 108.512 -1.835 . . . . 0.0 108.512 176.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 64.11 29.36 74.71 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-N 117.181 0.491 . . . . 0.0 111.92 -172.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.4 p -141.25 65.23 21.47 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 125.462 1.505 . . . . 0.0 108.286 -172.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.15 -23.89 31.15 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 124.078 3.185 . . . . 0.0 115.841 -169.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -102.41 -11.59 18.5 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.783 0.833 . . . . 0.0 111.429 -173.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -88.77 -40.39 13.24 Favored 'General case' 0 CA--C 1.519 -0.225 0 O-C-N 121.103 -0.998 . . . . 0.0 108.583 -176.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.4 pp -57.28 -25.69 59.64 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-O 118.535 -0.745 . . . . 0.0 110.989 169.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -73.09 -45.89 54.54 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.337 0.971 . . . . 0.0 110.023 177.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -63.21 -43.71 97.36 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 177.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.406 HD12 HG11 ' A' ' 10' ' ' VAL . 96.1 mt -68.64 -38.78 80.75 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 118.78 -0.628 . . . . 0.0 110.296 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -58.86 -41.5 87.15 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.579 1.081 . . . . 0.0 110.726 171.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -61.3 -41.98 97.89 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.9 0.773 . . . . 0.0 110.041 176.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -62.72 -38.53 90.83 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 119.419 1.009 . . . . 0.0 111.802 174.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.86 -30.83 71.88 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.972 0.806 . . . . 0.0 111.561 177.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -80.21 -35.85 35.65 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.222 0.609 . . . . 0.0 110.216 174.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -76.84 -40.63 47.1 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 118.574 0.625 . . . . 0.0 111.174 -173.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -132.08 175.14 9.49 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.835 1.254 . . . . 0.0 111.13 -169.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -65.35 -17.7 64.73 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.819 1.248 . . . . 0.0 113.541 -177.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.0 pp -55.79 144.89 6.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 123.9 0.88 . . . . 0.0 112.759 -169.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 8.4 ptm85 -83.9 161.58 20.8 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 121.181 0.515 . . . . 0.0 109.845 171.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.8 m -140.3 156.07 23.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 125.24 1.416 . . . . 0.0 108.158 171.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.2 m -144.59 124.06 13.15 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 -177.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -119.19 83.89 2.11 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.223 0.609 . . . . 0.0 109.751 -169.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 13.5 m-90 -64.28 -42.68 96.3 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.46 173.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 65.3 29.35 75.06 Favored Glycine 0 CA--C 1.535 1.333 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 -169.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.9 t70 . . . . . 0 C--O 1.248 1.008 0 C-N-CA 125.075 1.35 . . . . 0.0 111.581 -175.388 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.351 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.8 m -57.18 -26.06 59.99 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.779 1.231 . . . . 0.0 113.62 -173.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -59.53 -19.64 48.75 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 123.879 0.752 . . . . 0.0 113.562 176.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 18.9 tp60 -66.19 -27.42 67.98 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.691 1.246 . . . . 0.0 111.784 175.064 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.0 t -63.57 138.99 22.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -149.27 174.35 12.5 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 124.909 1.284 . . . . 0.0 109.816 -174.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.9 m -108.15 160.3 15.92 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.563 1.545 . . . . 0.0 108.426 172.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.411 HG12 ' H ' ' A' ' 32' ' ' THR . 4.8 pt -131.95 163.66 36.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 169.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.78 73.18 1.33 Allowed 'General case' 0 C--O 1.233 0.21 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 175.219 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.3 m -125.52 162.13 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 121.876 0.846 . . . . 0.0 111.624 -173.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -176.71 165.58 35.88 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 126.12 1.819 . . . . 0.0 108.953 171.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 57.75 19.87 37.59 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 124.324 0.964 . . . . 0.0 114.7 173.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.2 m -140.74 73.01 29.03 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 118.325 1.062 . . . . 0.0 108.997 -171.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -44.02 -34.91 6.89 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.706 2.937 . . . . 0.0 113.644 173.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 51.3 mp0 -66.52 -9.68 37.13 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.43 1.892 . . . . 0.0 112.589 -176.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -130.15 -44.73 1.14 Allowed 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 125.219 1.408 . . . . 0.0 108.786 -178.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.1 pp -68.2 -27.23 66.21 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 119.888 1.222 . . . . 0.0 111.439 -175.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -68.0 -39.15 83.26 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 120.122 1.328 . . . . 0.0 110.417 171.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -68.63 -42.33 78.19 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 118.616 0.644 . . . . 0.0 109.736 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 79.3 mt -69.46 -34.82 74.94 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.458 0.572 . . . . 0.0 110.509 177.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -61.08 -42.8 99.18 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 119.285 0.948 . . . . 0.0 110.563 169.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -62.32 -38.19 88.46 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.76 0.709 . . . . 0.0 110.101 176.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -62.23 -41.71 98.65 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.174 0.99 . . . . 0.0 110.586 176.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.13 -45.76 91.91 Favored 'General case' 0 C--N 1.338 0.089 0 C-N-CA 122.869 0.467 . . . . 0.0 110.481 174.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -66.06 -32.77 74.44 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 119.038 -0.506 . . . . 0.0 111.161 177.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.2 ttpt -81.16 -49.19 11.12 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 118.955 0.798 . . . . 0.0 110.823 -173.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.99 7.33 21.55 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.137 0.975 . . . . 0.0 112.999 -169.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 54.5 t30 65.58 1.66 1.79 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.913 2.085 . . . . 0.0 114.094 -178.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.6 pp -63.23 147.49 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 121.626 0.727 . . . . 0.0 111.368 -172.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 43.1 ptt85 -67.59 149.41 50.12 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.572 175.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.6 m -144.08 152.8 15.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 125.323 1.449 . . . . 0.0 107.769 176.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.411 ' H ' HG12 ' A' ' 8' ' ' ILE . 10.9 m -140.85 127.29 19.95 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -178.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -121.05 102.09 8.1 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -170.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 1.9 m-90 -70.87 -34.45 71.63 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 123.558 0.743 . . . . 0.0 112.441 -175.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.16 27.26 72.81 Favored Glycine 0 CA--C 1.535 1.324 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 -169.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 22.8 t70 . . . . . 0 C--O 1.25 1.096 0 C-N-CA 125.083 1.353 . . . . 0.0 111.25 -177.759 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.288 0 N-CA-C 111.707 -0.557 . . . . 0.0 111.707 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.9 p -66.74 -30.48 70.71 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.406 1.082 . . . . 0.0 112.287 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 70.04 -160.03 53.34 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 -177.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.6 pm0 -68.55 1.4 3.15 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.644 1.578 . . . . 0.0 114.676 -173.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.9 p -55.51 145.62 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 124.134 0.974 . . . . 0.0 111.372 -177.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 40.4 ptt85 -147.81 174.8 11.48 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 125.19 1.396 . . . . 0.0 108.438 171.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 92.5 m -123.7 155.17 38.31 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 174.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.8 pt -128.41 172.75 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.865 1.666 . . . . 0.0 108.266 -169.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.63 35.67 0.71 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 118.505 0.593 . . . . 0.0 111.639 174.166 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.0 m -67.63 146.09 13.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 O-C-N 121.165 -0.959 . . . . 0.0 109.244 177.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -88.41 39.12 3.13 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.164 0.888 . . . . 0.0 110.913 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 54.81 33.12 55.71 Favored Glycine 0 CA--C 1.533 1.188 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 -169.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.14 125.37 85.27 Favored Pre-proline 0 N--CA 1.448 -0.53 0 C-N-CA 125.66 1.584 . . . . 0.0 110.078 -169.441 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -56.14 -15.41 14.14 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.621 2.881 . . . . 0.0 114.986 174.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -94.14 -15.72 24.41 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.574 1.15 . . . . 0.0 111.561 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -116.48 -35.42 4.27 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 121.44 -0.787 . . . . 0.0 111.043 -169.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 76.1 mt -51.51 -30.89 21.83 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.654 0.661 . . . . 0.0 110.97 170.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -58.0 -23.28 53.38 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 125.035 1.334 . . . . 0.0 112.835 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -113.2 -41.48 3.69 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 123.761 0.824 . . . . 0.0 109.537 176.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -64.32 -40.4 95.84 Favored 'General case' 0 N--CA 1.457 -0.088 0 C-N-CA 122.924 0.49 . . . . 0.0 112.023 -174.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -66.48 -37.64 85.55 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 118.86 0.754 . . . . 0.0 110.12 178.05 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -63.66 -47.63 80.49 Favored 'General case' 0 C--O 1.225 -0.217 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 175.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -59.6 -40.25 86.88 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.109 0.964 . . . . 0.0 111.051 -179.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.99 -43.61 70.13 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 124.172 0.989 . . . . 0.0 110.955 177.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -82.12 -34.24 29.31 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 119.302 -0.38 . . . . 0.0 111.151 177.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -71.29 -39.97 71.16 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 118.614 0.643 . . . . 0.0 110.717 -170.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -119.05 6.98 11.3 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.763 0.825 . . . . 0.0 112.082 -172.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 55.7 t30 62.39 1.01 0.67 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 127.07 2.148 . . . . 0.0 114.602 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.7 pp -62.56 152.95 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.517 1.127 . . . . 0.0 111.497 -174.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.07 152.1 44.34 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 172.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.8 m -141.22 149.17 20.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 169.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.5 m -143.18 132.82 23.74 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -122.78 105.19 9.82 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -169.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 13.6 m-90 -79.81 153.37 29.18 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 122.45 0.3 . . . . 0.0 110.396 -177.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -84.62 43.87 3.28 Favored Glycine 0 CA--C 1.532 1.107 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 169.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.0 t70 . . . . . 0 C--O 1.248 0.982 0 C-N-CA 125.066 1.346 . . . . 0.0 111.251 -173.478 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.341 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.6 m -60.39 154.76 19.63 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.262 1.025 . . . . 0.0 111.401 178.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 178.22 -178.21 48.52 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 179.021 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 41.3 tp60 -65.65 -33.51 76.07 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 122.961 0.504 . . . . 0.0 110.83 177.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -61.63 123.5 14.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 C-N-CA 123.62 0.768 . . . . 0.0 109.422 176.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 29.4 ptt-85 -161.29 158.49 27.21 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 123.981 0.912 . . . . 0.0 109.005 -175.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.8 m -82.31 158.85 23.28 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 169.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.4 pt -125.99 168.42 18.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 125.141 1.376 . . . . 0.0 108.432 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.13 49.1 1.27 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.939 0.876 . . . . 0.0 110.118 176.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.1 t -60.38 134.08 25.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 169.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -147.92 -26.94 0.07 OUTLIER Glycine 0 CA--C 1.524 0.6 0 CA-C-O 119.482 -0.621 . . . . 0.0 114.175 -172.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -166.21 44.55 0.27 Allowed Glycine 0 CA--C 1.523 0.566 0 N-CA-C 108.249 -1.94 . . . . 0.0 108.249 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -138.58 78.03 32.68 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 125.663 1.585 . . . . 0.0 108.15 -168.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -63.16 -21.66 72.54 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 121.906 1.738 . . . . 0.0 112.093 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -66.53 -20.18 65.96 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.572 -0.705 . . . . 0.0 111.641 173.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -90.05 -38.15 13.78 Favored 'General case' 0 C--N 1.338 0.099 0 O-C-N 121.629 -0.669 . . . . 0.0 109.599 174.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.3 mt -55.59 -32.52 63.15 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.23 0.923 . . . . 0.0 110.433 169.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -64.48 -21.8 66.77 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.205 1.002 . . . . 0.0 112.499 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -126.91 -45.35 1.59 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 119.247 0.93 . . . . 0.0 111.969 -169.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 32.4 mt -70.85 -30.52 66.95 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 121.504 -0.747 . . . . 0.0 110.749 -174.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -62.31 -37.61 86.24 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.059 0.845 . . . . 0.0 111.003 170.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -68.23 -41.45 81.21 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 175.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -60.37 -37.42 80.69 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 121.387 -0.821 . . . . 0.0 111.317 178.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.99 -11.81 9.37 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.692 1.197 . . . . 0.0 113.707 174.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -118.18 -26.64 6.28 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.476 1.51 . . . . 0.0 109.75 -179.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -71.3 -37.8 71.81 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 123.623 0.769 . . . . 0.0 109.731 173.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -134.93 169.24 17.7 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 125.416 1.486 . . . . 0.0 109.249 -178.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -75.94 -1.46 25.67 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.37 1.068 . . . . 0.0 113.043 -176.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.3 pp -58.67 147.29 7.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 123.946 0.898 . . . . 0.0 111.638 -171.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 31.8 ptt-85 -75.06 153.61 38.32 Favored 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 123.142 0.577 . . . . 0.0 109.684 174.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.6 m -141.19 155.03 20.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 124.971 1.309 . . . . 0.0 107.647 171.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.0 m -149.38 141.17 23.64 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 173.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -130.32 110.45 11.53 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -169.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 18.4 m-90 -85.51 170.36 12.72 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.946 0.898 . . . . 0.0 109.778 172.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -130.57 65.45 0.59 Allowed Glycine 0 CA--C 1.524 0.602 0 N-CA-C 105.883 -2.887 . . . . 0.0 105.883 171.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.4 t70 . . . . . 0 C--O 1.247 0.962 0 C-N-CA 125.256 1.423 . . . . 0.0 111.582 -169.855 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.306 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.4 p -66.88 -28.75 68.58 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.099 0.96 . . . . 0.0 112.337 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 56.71 41.93 90.69 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 123.886 0.755 . . . . 0.0 111.832 -178.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 51.21 20.93 0.98 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 127.827 2.451 . . . . 0.0 115.291 -177.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.2 p -45.93 134.74 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 125.412 1.485 . . . . 0.0 113.464 -171.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -160.22 179.22 8.88 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 126.581 1.952 . . . . 0.0 108.566 177.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.9 m -123.63 156.88 35.0 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 126.33 1.852 . . . . 0.0 107.196 175.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.438 HG12 ' H ' ' A' ' 32' ' ' THR . 4.3 pt -118.5 167.42 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.671 1.189 . . . . 0.0 108.835 -174.553 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -147.0 69.85 1.18 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 174.101 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.5 m -118.31 158.09 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 122.999 0.52 . . . . 0.0 110.158 -177.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 173.97 150.14 7.44 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 108.291 -1.924 . . . . 0.0 108.291 178.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 61.78 31.02 76.66 Favored Glycine 0 CA--C 1.534 1.279 0 N-CA-C 111.77 -0.532 . . . . 0.0 111.77 -171.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.0 p -138.0 58.39 15.52 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 125.703 1.601 . . . . 0.0 108.995 -169.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -62.66 -20.42 70.87 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.027 2.485 . . . . 0.0 113.316 -169.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -87.91 -4.3 58.85 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.501 0.72 . . . . 0.0 112.155 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -127.69 -34.44 2.2 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.572 0.749 . . . . 0.0 110.692 -173.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.6 pp -62.31 -25.26 67.77 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-O 118.129 -0.938 . . . . 0.0 110.62 169.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.0 ptpp? -68.42 -37.67 80.51 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 119.987 1.267 . . . . 0.0 111.299 171.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -69.86 -43.45 71.86 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 72.3 mt -69.55 -34.08 73.69 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 118.986 -0.531 . . . . 0.0 110.546 177.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -62.32 -39.43 93.01 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.583 1.083 . . . . 0.0 111.297 171.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -59.9 -46.85 88.02 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.696 1.135 . . . . 0.0 109.141 172.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -57.25 -33.32 67.47 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.565 1.146 . . . . 0.0 111.517 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.77 -23.45 66.2 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.129 0.972 . . . . 0.0 112.771 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.36 -31.62 11.24 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 123.018 0.527 . . . . 0.0 110.28 171.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.2 ttmt -66.5 -36.43 82.7 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 118.602 0.637 . . . . 0.0 111.342 -176.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -134.82 176.22 8.84 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.743 1.217 . . . . 0.0 111.06 -169.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -80.32 1.76 27.44 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.68 1.192 . . . . 0.0 112.216 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.1 pp -59.98 158.86 1.94 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 124.0 0.92 . . . . 0.0 110.352 177.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -116.98 154.44 30.89 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 172.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 29.0 m -128.94 147.99 33.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 123.316 0.647 . . . . 0.0 110.14 -175.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.438 ' H ' HG12 ' A' ' 8' ' ' ILE . 16.0 m -144.76 131.23 19.8 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 176.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -123.51 110.23 14.8 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -169.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 11.3 m-90 -74.09 158.54 34.07 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.862 0.865 . . . . 0.0 109.652 172.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -65.57 -44.59 92.53 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 108.802 -1.719 . . . . 0.0 108.802 169.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.5 t70 . . . . . 0 C--O 1.246 0.887 0 C-N-CA 127.111 2.164 . . . . 0.0 107.676 169.806 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.299 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.2 m -143.57 162.94 34.57 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.1 1.36 . . . . 0.0 109.198 -177.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 177.91 -178.31 48.45 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.07 24.3 2.35 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.176 0.99 . . . . 0.0 111.566 -178.256 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.5 t -64.92 132.16 30.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 33.5 ptt-85 -155.74 157.07 35.96 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 124.386 1.074 . . . . 0.0 108.508 171.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.8 m -81.37 160.1 24.19 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 169.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.407 HG12 ' H ' ' A' ' 32' ' ' THR . 7.9 pt -122.66 167.45 16.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 125.0 1.32 . . . . 0.0 108.993 177.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.19 45.5 1.15 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 122.213 1.006 . . . . 0.0 108.503 170.394 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.2 p -70.72 144.02 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 O-C-N 121.444 -0.785 . . . . 0.0 110.737 -170.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -175.98 159.15 26.42 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 172.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 58.02 18.89 35.58 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.355 0.979 . . . . 0.0 113.915 -176.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.5 p -144.66 71.9 15.45 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 125.282 1.433 . . . . 0.0 108.178 -169.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -60.45 -24.02 76.7 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.296 1.997 . . . . 0.0 112.848 -176.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.5 mp0 -62.36 -39.52 93.44 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.602 0.761 . . . . 0.0 109.678 173.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -79.04 -24.14 43.8 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 121.476 -0.765 . . . . 0.0 110.775 -178.07 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.6 mt -60.92 -38.49 85.96 Favored 'General case' 0 CA--C 1.526 0.052 0 CA-C-N 119.65 1.114 . . . . 0.0 108.027 169.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -72.54 -49.46 32.53 Favored 'General case' 0 C--N 1.341 0.223 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -60.92 -45.94 92.67 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 118.596 0.635 . . . . 0.0 111.04 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 94.4 mt -72.93 -33.99 66.29 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 118.5 -0.762 . . . . 0.0 110.103 -177.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -60.99 -40.33 93.11 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.937 1.244 . . . . 0.0 110.315 169.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -62.11 -41.39 98.18 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.668 0.667 . . . . 0.0 109.941 177.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -63.45 -40.26 96.67 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 119.35 0.977 . . . . 0.0 111.628 175.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.8 -42.89 98.49 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 118.784 0.72 . . . . 0.0 110.404 176.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 42.2 mtpt -67.08 -37.28 83.72 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.979 -0.45 . . . . 0.0 110.941 175.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 66.3 tttm -80.44 -40.51 26.19 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 118.674 0.67 . . . . 0.0 111.851 -169.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -130.5 10.26 5.2 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.947 0.899 . . . . 0.0 113.076 -169.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 64.04 7.8 3.6 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.133 1.773 . . . . 0.0 114.05 177.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.5 pp -64.2 155.83 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 121.96 0.886 . . . . 0.0 112.551 -169.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 28.1 ttp-105 -62.44 134.25 56.17 Favored 'General case' 0 CA--C 1.527 0.073 0 C-N-CA 124.361 1.064 . . . . 0.0 109.28 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.6 m -139.56 144.29 29.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 172.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.407 ' H ' HG12 ' A' ' 8' ' ' ILE . 18.2 m -140.2 110.24 6.51 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 178.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -99.56 84.86 3.02 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.48 0.712 . . . . 0.0 109.993 -169.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 14.0 m-90 -64.65 -47.86 76.93 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.32 169.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.91 -12.51 42.2 Favored Glycine 0 CA--C 1.536 1.364 0 CA-C-O 118.923 -0.931 . . . . 0.0 113.003 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.2 t0 . . . . . 0 C--O 1.248 0.996 0 C-N-CA 127.508 2.323 . . . . 0.0 112.123 -171.463 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.319 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.6 m -62.6 -30.44 71.34 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.302 1.041 . . . . 0.0 112.914 -175.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 151.45 -29.75 0.95 Allowed Glycine 0 CA--C 1.529 0.926 0 C-N-CA 124.568 1.08 . . . . 0.0 111.583 178.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -150.77 154.35 37.17 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 126.06 1.744 . . . . 0.0 107.028 176.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.0 p -151.27 152.6 11.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 169.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 71.6 mtt180 -140.67 177.19 8.2 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 125.309 1.444 . . . . 0.0 108.169 -177.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.0 m -144.08 149.13 36.11 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 169.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.3 pt -135.15 171.79 17.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 124.932 1.293 . . . . 0.0 108.406 -175.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.58 43.01 1.18 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.867 0.841 . . . . 0.0 109.826 176.5 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.9 p -73.37 148.47 8.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 O-C-N 121.437 -0.789 . . . . 0.0 109.804 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -173.39 166.89 39.43 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 108.378 -1.889 . . . . 0.0 108.378 169.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 54.5 21.26 20.11 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.069 1.319 . . . . 0.0 114.974 176.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.7 m -145.94 75.32 13.05 Favored Pre-proline 0 CA--C 1.538 0.497 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 -169.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -50.01 -34.52 38.2 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.434 2.756 . . . . 0.0 113.639 -177.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -68.25 -41.64 80.85 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.906 0.384 . . . . 0.0 110.15 -176.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -74.72 -36.18 62.68 Favored 'General case' 0 N--CA 1.436 -1.131 0 O-C-N 121.215 -0.928 . . . . 0.0 109.429 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.3 mt -57.26 -38.43 73.84 Favored 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 123.806 0.843 . . . . 0.0 109.721 172.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 43.1 mtpt -68.13 -49.13 63.08 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 118.741 0.7 . . . . 0.0 109.855 176.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -60.8 -43.82 97.66 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 118.797 0.726 . . . . 0.0 110.954 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 69.0 mt -74.64 -31.68 62.03 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 118.552 -0.737 . . . . 0.0 110.599 -178.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -62.07 -41.58 98.31 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.815 1.189 . . . . 0.0 110.254 169.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -63.38 -42.92 98.86 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.638 0.654 . . . . 0.0 109.617 176.366 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.0 tp10 -60.23 -39.26 86.04 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.055 -1.028 . . . . 0.0 111.037 176.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.14 -3.1 6.67 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.827 1.251 . . . . 0.0 113.798 174.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -118.2 -25.54 6.59 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.23 1.412 . . . . 0.0 110.036 174.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.4 ttpt -68.45 -41.6 80.02 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 123.791 0.836 . . . . 0.0 108.905 172.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -132.49 161.25 34.21 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.193 1.397 . . . . 0.0 109.205 175.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -74.31 -7.08 51.59 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.016 0.926 . . . . 0.0 113.341 -173.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.8 pp -51.76 145.6 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 125.251 1.421 . . . . 0.0 113.944 -169.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.9 ttp180 -59.37 143.98 48.03 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 124.776 1.23 . . . . 0.0 109.476 172.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.4 m -140.18 153.55 22.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 C-N-CA 125.607 1.563 . . . . 0.0 106.789 169.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.9 m -141.46 128.24 20.43 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 -176.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -121.4 119.24 31.54 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -169.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 19.8 m-90 -94.73 157.43 15.95 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 169.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.61 -48.3 82.65 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 108.661 -1.776 . . . . 0.0 108.661 169.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.7 t70 . . . . . 0 C--O 1.247 0.961 0 C-N-CA 126.947 2.099 . . . . 0.0 107.73 169.721 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.343 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.5 m -60.24 155.19 18.13 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.264 1.026 . . . . 0.0 111.426 178.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 179.14 -179.24 48.92 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 179.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -141.31 31.06 1.73 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.524 1.129 . . . . 0.0 110.937 -178.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.403 ' HA ' HG22 ' A' ' 29' ' ' ILE . 53.3 t -58.83 124.38 12.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 172.013 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 30.1 ptt-85 -155.43 -179.71 8.35 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 126.804 2.041 . . . . 0.0 106.599 -178.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.9 m -129.6 152.63 48.91 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 175.292 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.455 HG12 ' H ' ' A' ' 32' ' ' THR . 1.9 pt -117.07 167.13 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.765 1.226 . . . . 0.0 108.446 -171.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -144.52 36.08 1.19 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.775 0.83 . . . . 0.0 109.522 177.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.4 m -69.17 150.58 10.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 O-C-N 121.346 -0.846 . . . . 0.0 109.493 -178.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -81.97 42.27 2.83 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.548 1.071 . . . . 0.0 111.774 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 57.45 35.01 70.17 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 124.117 0.865 . . . . 0.0 111.691 -177.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.74 125.17 87.09 Favored Pre-proline 0 N--CA 1.45 -0.466 0 C-N-CA 124.615 1.166 . . . . 0.0 108.642 -174.693 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -65.39 -18.08 59.33 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 121.699 1.6 . . . . 0.0 111.475 175.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -77.75 -11.36 59.87 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.096 0.958 . . . . 0.0 111.085 178.173 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -125.58 -47.43 1.7 Allowed 'General case' 0 CA--C 1.519 -0.25 0 C-N-CA 123.281 0.632 . . . . 0.0 109.725 -169.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.4 pp -57.0 -27.9 61.98 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 118.77 0.714 . . . . 0.0 111.663 177.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -68.6 -13.88 62.64 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 118.703 -0.665 . . . . 0.0 112.736 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -111.43 -42.59 3.85 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.22 0.918 . . . . 0.0 109.074 173.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -62.96 -41.61 99.57 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.339 0.656 . . . . 0.0 111.518 -177.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.9 tptp -67.97 -31.77 71.73 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.186 0.903 . . . . 0.0 111.014 178.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -66.31 -46.17 77.83 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 172.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -60.77 -38.3 84.79 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.462 -0.774 . . . . 0.0 111.18 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.4 -15.78 40.04 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.483 1.113 . . . . 0.0 113.347 176.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -109.04 -27.17 9.79 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.886 1.274 . . . . 0.0 109.976 176.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -75.08 -35.94 61.77 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.932 0.893 . . . . 0.0 110.414 -179.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -140.03 169.91 16.84 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.329 1.452 . . . . 0.0 109.634 -177.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -76.75 15.47 0.64 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.901 1.28 . . . . 0.0 112.627 -174.572 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.403 HG22 ' HA ' ' A' ' 5' ' ' VAL . 1.4 pp -70.28 158.48 6.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 O-C-N 120.666 -1.271 . . . . 0.0 110.286 -174.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 41.8 ttm105 -98.93 147.29 25.13 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.086 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 29.9 m -136.67 154.58 32.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 170.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.455 ' H ' HG12 ' A' ' 8' ' ' ILE . 24.7 m -153.15 144.48 23.2 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 169.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -130.71 112.01 12.7 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -169.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 13.2 m-90 -93.84 150.7 20.16 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 122.887 0.475 . . . . 0.0 110.151 179.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -82.71 43.77 3.13 Favored Glycine 0 CA--C 1.532 1.154 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 169.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.1 t70 . . . . . 0 C--O 1.247 0.944 0 C-N-CA 125.075 1.35 . . . . 0.0 111.246 -173.924 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.303 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.3 m -60.27 153.56 22.14 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.295 1.038 . . . . 0.0 111.275 178.008 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 177.1 -178.33 48.22 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -151.67 164.46 36.87 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.041 1.337 . . . . 0.0 108.947 176.112 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -138.64 131.37 38.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 176.067 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -160.33 158.93 30.56 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 125.998 1.719 . . . . 0.0 107.552 172.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.4 m -99.23 152.47 19.87 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 169.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.475 HG12 ' H ' ' A' ' 32' ' ' THR . 8.0 pt -113.38 173.81 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 124.365 1.066 . . . . 0.0 109.066 -176.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.92 72.31 1.17 Allowed 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 172.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.409 HG22 HD12 ' A' ' 8' ' ' ILE . 13.5 m -124.06 157.8 30.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 177.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -167.87 136.3 4.04 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 108.979 -1.649 . . . . 0.0 108.979 171.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 56.22 23.08 39.16 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 124.247 0.927 . . . . 0.0 114.19 179.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.0 p -68.58 150.23 97.73 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 119.072 1.436 . . . . 0.0 108.886 176.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.4 -25.99 29.74 Favored 'Trans proline' 0 CA--C 1.533 0.463 0 C-N-CA 121.965 1.777 . . . . 0.0 112.041 -172.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -159.52 -12.91 0.06 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.279 1.032 . . . . 0.0 112.019 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -66.21 -36.74 83.84 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 120.591 -1.318 . . . . 0.0 110.557 -173.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.6 pp -65.38 -21.67 66.71 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-O 118.424 -0.798 . . . . 0.0 112.16 172.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -77.85 -45.65 23.7 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 119.861 1.209 . . . . 0.0 108.935 175.142 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -58.44 -46.73 85.95 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.251 0.478 . . . . 0.0 110.316 173.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.0 mt -70.34 -34.48 72.71 Favored 'General case' 0 C--O 1.226 -0.154 0 CA-C-O 118.41 -0.805 . . . . 0.0 110.616 -178.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -60.19 -42.36 94.91 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 120.335 1.425 . . . . 0.0 110.799 169.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -61.52 -40.13 93.53 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 119.316 0.962 . . . . 0.0 110.174 175.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -62.23 -31.9 72.5 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.498 -0.751 . . . . 0.0 111.288 173.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.42 -28.72 67.33 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 120.162 1.346 . . . . 0.0 112.138 173.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -78.86 -33.1 46.11 Favored 'General case' 0 N--CA 1.463 0.19 0 O-C-N 121.82 -0.55 . . . . 0.0 109.998 172.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -90.5 -23.71 20.86 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -169.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -142.09 172.67 12.37 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.827 1.651 . . . . 0.0 109.931 -176.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -81.97 2.04 32.63 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.838 1.255 . . . . 0.0 112.982 -173.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.5 pt -53.18 151.05 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 125.635 1.574 . . . . 0.0 113.881 -169.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 34.2 ttp180 -94.34 75.39 3.92 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.426 1.49 . . . . 0.0 108.989 -177.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.5 m -62.93 139.66 20.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 171.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.475 ' H ' HG12 ' A' ' 8' ' ' ILE . 21.0 m -144.76 125.01 13.73 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 104.257 -2.497 . . . . 0.0 104.257 177.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -117.7 109.69 16.93 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -169.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 11.8 m-90 -72.24 165.2 24.9 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.993 0.917 . . . . 0.0 109.997 171.194 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -68.84 -45.4 64.57 Favored Glycine 0 CA--C 1.531 1.054 0 N-CA-C 108.328 -1.909 . . . . 0.0 108.328 169.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.3 t70 . . . . . 0 C--O 1.246 0.876 0 C-N-CA 127.111 2.165 . . . . 0.0 107.756 169.81 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.287 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.1 m -65.15 -21.93 66.85 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.285 1.034 . . . . 0.0 113.275 -176.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -178.73 -173.19 43.85 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 125.021 1.296 . . . . 0.0 109.995 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -145.21 153.03 40.9 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.072 1.349 . . . . 0.0 108.475 176.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.3 t -146.01 140.78 21.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 174.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 23.5 ptt-85 -152.25 165.66 34.18 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 126.978 2.111 . . . . 0.0 105.959 168.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.1 m -136.17 153.95 51.11 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -173.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.408 HG12 ' H ' ' A' ' 32' ' ' THR . 1.9 pt -127.33 169.15 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 125.002 1.321 . . . . 0.0 108.887 -169.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.07 37.14 0.94 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.514 0.726 . . . . 0.0 110.332 176.625 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.0 m -72.68 152.58 7.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 O-C-N 121.116 -0.99 . . . . 0.0 109.528 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -81.93 40.56 2.66 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.624 1.107 . . . . 0.0 111.727 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 53.76 34.4 50.7 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.32 0.962 . . . . 0.0 111.839 -171.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.3 m -61.89 124.42 81.62 Favored Pre-proline 0 N--CA 1.445 -0.715 0 C-N-CA 125.269 1.428 . . . . 0.0 108.68 -169.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -52.82 -27.49 34.8 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.801 2.334 . . . . 0.0 112.91 172.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -70.39 -26.44 63.7 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.63 0.772 . . . . 0.0 111.073 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -102.41 -37.06 8.19 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 124.363 1.065 . . . . 0.0 109.232 -171.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 65.5 mt -53.38 -19.2 3.19 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.257 1.023 . . . . 0.0 112.277 169.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -58.96 -28.54 66.4 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 118.945 0.793 . . . . 0.0 112.589 172.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -131.77 -37.08 1.19 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.008 0.822 . . . . 0.0 111.639 -173.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -61.57 -40.42 94.67 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 119.021 0.828 . . . . 0.0 111.374 -176.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.6 tptt -66.88 -32.58 73.94 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 119.303 -0.38 . . . . 0.0 111.005 177.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -69.0 -46.38 68.17 Favored 'General case' 0 C--O 1.224 -0.262 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 175.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -58.2 -40.17 80.87 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 119.168 0.895 . . . . 0.0 111.005 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.93 -15.66 33.61 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.138 0.975 . . . . 0.0 113.444 177.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -113.76 -29.83 6.97 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.993 1.317 . . . . 0.0 110.062 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -73.19 -34.55 66.04 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 123.873 0.869 . . . . 0.0 110.411 178.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -133.86 168.41 18.81 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.351 1.06 . . . . 0.0 110.654 -173.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -69.09 -9.52 53.07 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.023 1.729 . . . . 0.0 113.533 -177.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.6 pp -60.49 157.0 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.81 1.244 . . . . 0.0 111.952 -173.016 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 12.0 ptp85 -97.51 159.85 14.68 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.652 0.739 . . . . 0.0 109.648 174.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.3 m -139.22 155.01 25.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 171.021 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.408 ' H ' HG12 ' A' ' 8' ' ' ILE . 38.9 m -149.43 144.21 26.21 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 170.674 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -129.96 107.23 9.2 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -169.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 13.3 m-90 -84.21 151.29 24.92 Favored 'General case' 0 N--CA 1.461 0.118 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 -179.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -83.03 45.57 3.47 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 169.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.9 t70 . . . . . 0 C--O 1.249 1.066 0 C-N-CA 125.089 1.356 . . . . 0.0 111.306 -174.177 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.397 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.2 p -63.89 -23.56 67.4 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.297 1.039 . . . . 0.0 111.939 173.252 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -152.51 -175.29 23.91 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 126.473 1.987 . . . . 0.0 108.499 169.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.91 140.65 23.6 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 125.475 1.51 . . . . 0.0 107.332 -177.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.2 t -136.04 136.11 49.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -176.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -151.9 145.55 24.98 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 104.539 -2.393 . . . . 0.0 104.539 173.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.7 m -102.92 145.41 29.87 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 175.262 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.489 HG12 ' H ' ' A' ' 32' ' ' THR . 8.4 pt -101.87 174.83 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.226 1.01 . . . . 0.0 109.254 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.83 46.86 1.26 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.629 0.771 . . . . 0.0 109.004 170.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.2 p -80.64 145.98 8.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 O-C-N 121.277 -0.889 . . . . 0.0 109.073 -175.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -86.27 35.67 3.28 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.692 1.139 . . . . 0.0 112.395 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 56.07 41.96 86.41 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.275 0.941 . . . . 0.0 113.15 173.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.5 m -61.55 137.45 94.82 Favored Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 177.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -51.42 -27.23 23.67 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.37 2.713 . . . . 0.0 115.466 -177.158 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -93.89 -29.68 15.17 Favored 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 123.264 0.626 . . . . 0.0 110.858 -178.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -71.88 -33.45 68.38 Favored 'General case' 0 N--CA 1.462 0.169 0 O-C-N 121.256 -0.902 . . . . 0.0 108.829 175.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 76.6 mt -62.44 -5.09 2.23 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.713 1.205 . . . . 0.0 112.445 169.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.4 mttp -109.24 -56.08 2.33 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 119.287 0.949 . . . . 0.0 108.937 170.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -62.08 -49.87 74.21 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.162 0.585 . . . . 0.0 111.098 -174.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 25.8 mt -76.16 -29.31 57.69 Favored 'General case' 0 C--O 1.224 -0.244 0 O-C-N 122.008 -0.432 . . . . 0.0 109.969 -177.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.3 tptt -63.3 -39.47 94.65 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 119.125 0.875 . . . . 0.0 110.503 171.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -64.68 -44.1 91.4 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 173.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -56.7 -36.9 70.18 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.666 0.786 . . . . 0.0 111.115 175.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.28 -14.03 61.35 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.562 1.145 . . . . 0.0 113.385 177.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.1 mptp? -104.72 -33.7 8.37 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.219 1.008 . . . . 0.0 109.867 172.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 32.6 tttm -66.97 -37.57 84.5 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 123.396 0.679 . . . . 0.0 110.519 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -136.05 163.46 30.25 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 126.468 1.907 . . . . 0.0 108.646 -175.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -82.14 6.43 16.49 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.006 0.923 . . . . 0.0 112.771 -174.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.0 pp -59.73 156.04 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 124.528 1.131 . . . . 0.0 112.754 -172.071 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 33.1 ttp180 -98.89 81.28 2.6 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.806 1.243 . . . . 0.0 109.975 -169.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.4 m -63.21 139.55 21.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.324 169.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.489 ' H ' HG12 ' A' ' 8' ' ' ILE . 19.1 m -146.04 122.06 10.73 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 104.116 -2.55 . . . . 0.0 104.116 173.733 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -112.53 111.95 23.14 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -169.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 10.3 m-90 -83.07 147.03 28.37 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 174.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.98 -41.23 61.69 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 169.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.6 t70 . . . . . 0 C--O 1.246 0.889 0 C-N-CA 126.885 2.074 . . . . 0.0 107.867 170.004 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.4 t . . . . . 0 C--O 1.235 0.301 0 CA-C-O 121.746 0.784 . . . . 0.0 109.371 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -159.63 176.67 11.74 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 127.46 2.304 . . . . 0.0 106.826 -173.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.4 m -139.91 155.63 47.08 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 -176.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.468 HG12 ' H ' ' A' ' 32' ' ' THR . 2.9 pt -121.02 167.37 14.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 125.022 1.329 . . . . 0.0 108.792 -172.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.26 43.37 1.12 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.71 0.804 . . . . 0.0 109.35 173.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.2 m -75.27 150.39 6.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 O-C-N 121.189 -0.945 . . . . 0.0 110.319 -177.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -88.07 33.69 3.97 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 124.867 1.222 . . . . 0.0 112.271 178.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 61.37 38.52 95.86 Favored Glycine 0 CA--C 1.531 1.037 0 CA-C-N 117.576 0.688 . . . . 0.0 112.976 174.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.3 m -62.79 136.12 96.21 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 172.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -51.32 -32.88 43.44 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 122.766 2.311 . . . . 0.0 113.801 177.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -73.51 -39.19 65.0 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.702 0.401 . . . . 0.0 110.14 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -77.07 -36.15 56.1 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -177.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 34.2 mt -59.41 -26.61 65.3 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.419 1.088 . . . . 0.0 111.451 169.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -83.81 -63.94 1.26 Allowed 'General case' 0 C--N 1.339 0.147 0 CA-C-N 119.237 0.926 . . . . 0.0 109.046 174.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -61.81 -49.21 77.22 Favored 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 122.75 0.42 . . . . 0.0 111.466 -169.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 52.4 mt -75.8 -30.29 59.0 Favored 'General case' 0 C--O 1.226 -0.134 0 CA-C-O 119.124 -0.465 . . . . 0.0 110.255 -171.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -62.95 -38.76 92.36 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.225 0.921 . . . . 0.0 110.059 169.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -61.88 -42.87 99.58 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 118.762 0.71 . . . . 0.0 109.938 174.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -62.35 -39.31 92.72 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.361 0.982 . . . . 0.0 111.23 175.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.34 -46.34 90.27 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 118.771 0.714 . . . . 0.0 110.319 175.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 43.1 mtpt -66.75 -37.24 84.23 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 122.982 0.513 . . . . 0.0 110.904 177.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -83.7 -33.12 25.22 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 118.755 -0.641 . . . . 0.0 112.035 -170.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -128.52 5.65 5.66 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.858 0.863 . . . . 0.0 113.081 -169.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 64.84 3.64 2.12 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.555 1.942 . . . . 0.0 114.309 178.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.0 pp -65.11 156.4 5.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 123.777 0.831 . . . . 0.0 111.577 -173.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 51.5 mtt85 -71.1 143.59 50.58 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -176.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.9 m -141.13 141.76 30.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 169.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.468 ' H ' HG12 ' A' ' 8' ' ' ILE . 19.7 m -145.06 130.16 18.46 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 175.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -120.93 110.99 16.95 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 -169.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 11.9 m-90 -86.75 148.2 25.52 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -85.81 44.68 3.38 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 169.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.6 t70 . . . . . 0 C--O 1.25 1.086 0 C-N-CA 125.022 1.329 . . . . 0.0 111.397 -173.397 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.7 t . . . . . 0 C--O 1.235 0.31 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -149.13 178.84 8.37 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 124.443 1.097 . . . . 0.0 110.089 -174.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 38.3 m -132.28 153.4 50.71 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 169.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.41 HG12 ' H ' ' A' ' 32' ' ' THR . 5.3 pt -126.2 170.34 16.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 125.443 1.497 . . . . 0.0 108.109 -174.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.3 34.9 0.88 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.302 0.572 . . . . 0.0 111.092 174.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.3 m -74.33 158.37 5.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 O-C-N 121.205 -0.935 . . . . 0.0 109.769 176.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -169.72 154.97 24.55 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 108.521 -1.832 . . . . 0.0 108.521 169.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 51.54 28.76 22.52 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 124.385 0.993 . . . . 0.0 114.29 178.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 26.4 m -138.63 74.91 38.63 Favored Pre-proline 0 CA--C 1.537 0.446 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 -170.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -59.55 -27.51 85.15 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.327 2.018 . . . . 0.0 111.778 -177.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -63.6 -17.32 62.75 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.392 1.077 . . . . 0.0 112.168 -178.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -126.92 -34.56 2.35 Favored 'General case' 0 C--N 1.34 0.172 0 C-N-CA 123.453 0.701 . . . . 0.0 111.262 -177.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.16 -25.43 68.34 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 119.47 1.032 . . . . 0.0 110.155 173.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -68.47 -42.88 78.09 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.803 1.183 . . . . 0.0 110.79 173.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -75.29 -29.69 60.17 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.325 0.966 . . . . 0.0 111.536 178.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.0 mt -72.71 -34.87 67.41 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.445 1.021 . . . . 0.0 109.916 172.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.7 mmtt -60.02 -45.41 92.87 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 119.51 1.05 . . . . 0.0 109.829 169.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -57.82 -46.04 85.29 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.575 0.75 . . . . 0.0 109.717 177.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -60.73 -41.64 95.72 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.227 0.921 . . . . 0.0 110.704 176.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.95 -2.96 11.07 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 177.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -117.19 -26.12 6.88 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.978 1.311 . . . . 0.0 109.806 175.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.0 tttm -72.43 -39.95 67.46 Favored 'General case' 0 C--O 1.23 0.073 0 C-N-CA 124.844 1.258 . . . . 0.0 109.521 173.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -133.64 167.88 19.7 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.873 1.669 . . . . 0.0 108.954 178.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -78.82 4.04 15.08 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.722 1.209 . . . . 0.0 113.114 -174.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.1 pp -59.75 151.58 5.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 121.997 0.904 . . . . 0.0 112.978 -169.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.13 144.38 42.86 Favored 'General case' 0 C--O 1.23 0.076 0 C-N-CA 124.003 0.921 . . . . 0.0 109.05 178.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.1 m -143.46 153.76 16.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 125.79 1.636 . . . . 0.0 107.156 169.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.41 ' H ' HG12 ' A' ' 8' ' ' ILE . 25.6 m -146.75 141.65 26.95 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 173.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -128.39 111.83 13.75 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -169.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 18.6 m-90 -86.67 156.11 20.12 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 122.838 0.455 . . . . 0.0 110.679 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -83.46 48.49 4.05 Favored Glycine 0 CA--C 1.529 0.969 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 170.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.7 t70 . . . . . 0 C--O 1.247 0.942 0 C-N-CA 124.918 1.287 . . . . 0.0 111.513 -173.869 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.7 t . . . . . 0 CA--C 1.538 0.519 0 CA-C-O 121.574 0.702 . . . . 0.0 109.818 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.32 179.43 6.4 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.408 1.883 . . . . 0.0 106.945 170.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.8 m -140.05 152.27 46.07 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 126.456 1.902 . . . . 0.0 106.426 178.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 13.6 pt -128.33 170.82 17.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 125.052 1.341 . . . . 0.0 108.6 -170.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -150.89 37.88 0.65 Allowed 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 121.727 0.775 . . . . 0.0 110.335 176.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 27.2 m -68.75 152.36 9.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 O-C-N 121.325 -0.86 . . . . 0.0 111.42 -177.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -158.28 41.14 0.51 Allowed Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.071 1.32 . . . . 0.0 110.719 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 162.1 -170.49 37.77 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 108.979 -1.649 . . . . 0.0 108.979 -175.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.5 m 58.38 73.83 0.68 Allowed Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 124.954 1.301 . . . . 0.0 110.061 176.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -58.64 -23.37 65.23 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.396 2.064 . . . . 0.0 112.924 -177.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -62.7 -43.39 98.92 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.346 0.521 . . . . 0.0 110.191 172.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -74.92 -32.11 61.71 Favored 'General case' 0 N--CA 1.438 -1.069 0 C-N-CA 124.085 0.954 . . . . 0.0 109.721 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 78.3 mt -60.36 -43.67 96.32 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-N 120.086 1.312 . . . . 0.0 108.718 172.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -64.42 -47.23 79.92 Favored 'General case' 0 C--N 1.339 0.114 0 CA-C-O 119.212 -0.423 . . . . 0.0 110.323 176.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -63.18 -45.7 90.58 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.995 0.816 . . . . 0.0 111.091 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 73.2 mt -66.69 -37.23 84.31 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 118.815 0.734 . . . . 0.0 110.108 178.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -60.52 -41.06 93.64 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 119.194 0.906 . . . . 0.0 110.606 171.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -63.06 -40.89 99.02 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 118.707 0.685 . . . . 0.0 110.444 177.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -62.29 -41.57 98.61 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 119.472 1.033 . . . . 0.0 110.809 174.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.02 -45.34 95.18 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-N 118.623 0.647 . . . . 0.0 110.545 176.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -66.23 -35.55 80.71 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 119.072 -0.49 . . . . 0.0 111.044 177.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -81.64 -39.53 24.27 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.812 0.733 . . . . 0.0 111.748 -172.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -117.3 4.96 12.58 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.582 0.753 . . . . 0.0 112.855 -170.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 55.4 t30 65.54 1.32 1.66 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 127.141 2.177 . . . . 0.0 114.186 -178.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.7 pp -63.3 147.1 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 124.095 0.958 . . . . 0.0 111.079 -174.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -78.64 133.93 37.21 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.5 m -120.15 155.51 23.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 125.064 1.346 . . . . 0.0 108.396 173.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.94 92.57 2.68 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -169.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -92.43 93.98 8.87 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -175.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 5.9 m-90 -66.33 -46.31 77.29 Favored 'General case' 0 C--O 1.232 0.153 0 O-C-N 122.341 -0.224 . . . . 0.0 110.724 173.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.49 -50.14 3.14 Favored Glycine 0 CA--C 1.531 1.084 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -169.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.0 t70 . . . . . 0 C--O 1.249 1.037 0 C-N-CA 126.818 2.047 . . . . 0.0 108.259 169.52 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.9 t . . . . . 0 C--O 1.235 0.307 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 30.7 ptt-85 -160.58 -178.14 6.68 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.896 1.278 . . . . 0.0 108.704 -176.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.8 m -116.15 154.71 29.53 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 171.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 11.0 pt -120.99 174.98 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.985 1.314 . . . . 0.0 109.038 -171.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.9 68.31 0.88 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 175.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.8 m -122.33 166.04 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 177.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -169.25 -26.24 0.02 OUTLIER Glycine 0 CA--C 1.527 0.839 0 CA-C-N 115.623 -0.717 . . . . 0.0 113.879 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -157.95 38.61 0.53 Allowed Glycine 0 CA--C 1.527 0.798 0 C-N-CA 124.022 0.82 . . . . 0.0 111.274 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.5 p -68.33 159.72 79.31 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 123.806 0.842 . . . . 0.0 109.967 177.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -54.08 -41.73 73.05 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.783 2.322 . . . . 0.0 112.719 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -161.11 2.91 0.06 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.248 1.019 . . . . 0.0 112.692 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -68.95 -28.09 66.32 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 120.2 1.364 . . . . 0.0 110.501 -175.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.3 mt -51.18 -39.62 56.83 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 125.168 1.387 . . . . 0.0 109.755 169.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -71.43 -45.35 62.9 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-N 118.655 0.661 . . . . 0.0 109.46 -177.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.0 mmtt -64.0 -46.22 85.53 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -177.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 92.6 mt -73.08 -38.28 66.47 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 118.795 -0.621 . . . . 0.0 110.112 -176.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.9 tptt -59.84 -40.15 87.56 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.402 1.001 . . . . 0.0 110.848 170.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -63.7 -43.58 96.2 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 119.084 0.856 . . . . 0.0 110.077 176.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -60.7 -35.09 75.42 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 120.143 1.338 . . . . 0.0 111.686 177.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.78 -23.78 65.28 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.04 0.836 . . . . 0.0 112.099 173.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -104.84 -20.72 13.5 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.068 1.347 . . . . 0.0 111.776 -177.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -110.69 -20.34 12.55 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 119.324 0.965 . . . . 0.0 112.358 -173.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -129.97 0.06 4.75 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.231 1.412 . . . . 0.0 111.539 178.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 63.77 6.94 2.92 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 127.05 2.14 . . . . 0.0 114.316 177.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.3 pp -65.03 157.0 5.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 O-C-N 121.63 -0.668 . . . . 0.0 111.878 -171.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 96.9 mtt-85 -67.35 142.11 56.89 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 22.6 m -137.61 151.96 26.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 173.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.8 m -146.18 130.91 17.97 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -125.16 112.48 16.5 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -169.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 8.2 m-90 -78.29 158.31 28.93 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.889 0.876 . . . . 0.0 110.533 178.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -82.53 48.06 3.89 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 109.866 -1.293 . . . . 0.0 109.866 169.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.2 t70 . . . . . 0 C--O 1.247 0.935 0 C-N-CA 124.914 1.286 . . . . 0.0 111.363 -174.228 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.467 ' HA ' HG22 ' A' ' 29' ' ' ILE . 4.1 t . . . . . 0 C--O 1.235 0.299 0 CA-C-O 121.782 0.801 . . . . 0.0 110.111 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -151.41 174.94 12.76 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 126.196 1.798 . . . . 0.0 108.69 -174.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.8 m -136.69 147.74 46.96 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 169.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.7 pt -126.68 163.5 28.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 123.638 0.775 . . . . 0.0 108.936 -169.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.28 40.77 0.87 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.669 0.788 . . . . 0.0 109.254 176.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 27.5 m -67.07 133.18 31.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 O-C-N 121.243 -0.91 . . . . 0.0 108.584 177.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.46 -52.58 42.13 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 171.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 160.12 41.91 0.02 OUTLIER Glycine 0 CA--C 1.526 0.763 0 CA-C-O 119.086 -0.841 . . . . 0.0 112.923 176.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.7 m -67.05 123.17 85.58 Favored Pre-proline 0 N--CA 1.454 -0.227 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 176.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -50.91 -34.77 47.0 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.274 1.983 . . . . 0.0 113.218 -178.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -74.48 -36.29 63.28 Favored 'General case' 0 N--CA 1.456 -0.148 0 O-C-N 122.121 -0.362 . . . . 0.0 110.161 -175.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -80.6 -35.88 33.52 Favored 'General case' 0 CA--C 1.521 -0.142 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -177.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 88.0 mt -56.62 -41.87 77.84 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 169.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -66.77 -56.45 10.44 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 118.544 0.611 . . . . 0.0 109.907 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -61.94 -45.35 94.05 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 118.495 0.589 . . . . 0.0 111.083 -175.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.4 mt -74.62 -35.08 62.92 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 118.517 -0.754 . . . . 0.0 110.382 -174.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.4 tptt -61.76 -39.87 93.16 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 119.935 1.243 . . . . 0.0 110.092 169.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -63.06 -39.14 93.84 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.95 0.795 . . . . 0.0 110.407 178.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -63.9 -40.43 96.49 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 119.866 1.212 . . . . 0.0 111.336 172.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.7 -23.99 66.89 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.048 0.84 . . . . 0.0 112.343 177.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 41.4 mtpt -84.35 -38.09 20.77 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.643 0.777 . . . . 0.0 110.11 172.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -70.47 -42.21 71.74 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.883 0.873 . . . . 0.0 110.426 -174.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -135.84 165.71 25.0 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.064 1.346 . . . . 0.0 109.738 -173.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -71.03 7.04 1.31 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.064 1.346 . . . . 0.0 113.535 -175.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.467 HG22 ' HA ' ' A' ' 5' ' ' VAL . 2.0 pp -64.42 154.66 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 124.294 1.038 . . . . 0.0 111.347 -171.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -89.95 152.15 21.35 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.014 0.435 . . . . 0.0 110.307 178.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.0 m -142.89 157.07 17.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 125.9 1.68 . . . . 0.0 107.568 174.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 32.2 m -149.41 133.53 17.23 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 173.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -121.76 110.45 15.94 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 -169.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -70.68 -32.7 70.05 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -170.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 64.49 39.9 97.23 Favored Glycine 0 CA--C 1.532 1.113 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -172.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.5 t70 . . . . . 0 C--O 1.248 0.989 0 C-N-CA 125.037 1.335 . . . . 0.0 111.298 -176.682 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.419 ' HA ' HG22 ' A' ' 29' ' ' ILE . 21.2 t . . . . . 0 C--O 1.236 0.353 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 33.0 ptt85 -144.28 167.36 22.63 Favored 'General case' 0 C--O 1.231 0.1 0 C-N-CA 125.495 1.518 . . . . 0.0 107.691 175.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.3 m -126.99 153.57 45.73 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.409 HG12 ' H ' ' A' ' 32' ' ' THR . 10.5 pt -126.78 170.56 16.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 124.658 1.183 . . . . 0.0 108.163 -173.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.13 75.68 1.45 Allowed 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 -178.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.7 m -125.08 153.53 32.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 C-N-CA 123.434 0.694 . . . . 0.0 109.713 -173.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -81.68 33.34 2.58 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 124.477 1.037 . . . . 0.0 112.574 -177.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 54.81 39.01 66.04 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-N 118.084 0.942 . . . . 0.0 111.428 -172.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -60.59 126.69 85.51 Favored Pre-proline 0 N--CA 1.451 -0.414 0 C-N-CA 125.038 1.335 . . . . 0.0 109.459 -169.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -53.59 -23.24 24.84 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.187 2.591 . . . . 0.0 113.91 173.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -92.37 -4.18 54.22 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.246 1.018 . . . . 0.0 111.878 -177.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -117.45 -36.69 3.66 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 123.763 0.825 . . . . 0.0 109.424 -178.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 28.4 mt -47.05 -34.65 6.01 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.523 1.129 . . . . 0.0 111.481 169.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.4 mttp -56.62 -25.66 53.76 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -118.53 -38.56 3.12 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 118.97 0.804 . . . . 0.0 110.303 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -68.39 -41.07 81.04 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-N 118.468 0.576 . . . . 0.0 111.277 -175.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 48.9 tptt -68.92 -34.74 75.88 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 118.499 0.591 . . . . 0.0 110.092 176.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -63.62 -45.39 90.52 Favored 'General case' 0 C--O 1.222 -0.367 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 175.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -60.1 -41.6 92.86 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 119.287 0.949 . . . . 0.0 110.516 178.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.13 -2.59 4.34 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.485 1.114 . . . . 0.0 113.829 176.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -121.72 -27.4 4.7 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.226 1.41 . . . . 0.0 110.308 175.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -70.41 -39.94 74.14 Favored 'General case' 0 C--N 1.338 0.107 0 C-N-CA 124.109 0.963 . . . . 0.0 109.343 175.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -122.84 166.58 14.76 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.729 1.211 . . . . 0.0 109.195 178.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -73.23 -1.31 17.25 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.632 1.173 . . . . 0.0 113.014 -178.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.419 HG22 ' HA ' ' A' ' 5' ' ' VAL . 2.2 pp -61.39 162.61 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 124.669 1.188 . . . . 0.0 110.83 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.48 147.66 52.57 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.0 m -127.07 167.54 21.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 124.853 1.261 . . . . 0.0 110.173 -169.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.409 ' H ' HG12 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -129.69 125.19 35.4 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.277 1.431 . . . . 0.0 108.657 -169.727 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -128.56 94.83 3.97 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 -175.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -71.75 -24.7 61.82 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -171.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.16 25.75 68.54 Favored Glycine 0 CA--C 1.537 1.465 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 -169.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.5 t70 . . . . . 0 C--O 1.249 1.038 0 C-N-CA 125.394 1.478 . . . . 0.0 111.48 -177.439 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.9 t . . . . . 0 CA--C 1.532 0.259 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 36.9 mtp180 -144.64 160.6 40.92 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 129.171 2.989 . . . . 0.0 104.146 170.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.5 m -139.84 151.84 46.01 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 169.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.469 HG12 ' H ' ' A' ' 32' ' ' THR . 2.5 pt -127.2 165.89 25.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.216 1.006 . . . . 0.0 109.007 -169.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -142.91 40.85 1.53 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.804 0.842 . . . . 0.0 109.593 -178.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 34.6 m -69.25 144.1 14.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 O-C-N 121.425 -0.797 . . . . 0.0 109.365 178.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -166.48 30.93 0.2 Allowed Glycine 0 CA--C 1.528 0.878 0 C-N-CA 123.573 0.606 . . . . 0.0 112.591 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -176.32 27.02 0.07 OUTLIER Glycine 0 CA--C 1.529 0.911 0 CA-C-N 117.705 0.753 . . . . 0.0 112.644 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.0 p -143.83 59.68 7.45 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 125.304 1.442 . . . . 0.0 108.226 -169.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -62.42 -26.05 76.44 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.6 2.2 . . . . 0.0 113.11 -169.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -71.27 -30.82 66.75 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.454 0.57 . . . . 0.0 110.96 177.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -75.64 -19.4 59.22 Favored 'General case' 0 N--CA 1.462 0.144 0 O-C-N 121.262 -0.899 . . . . 0.0 111.358 -176.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.0 mt -52.54 -31.21 34.55 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.116 0.966 . . . . 0.0 110.613 169.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 42.0 mtmt -62.66 -32.23 73.26 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 118.837 0.744 . . . . 0.0 111.444 177.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -85.39 -48.89 8.58 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 177.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -64.66 -40.84 96.13 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.309 0.644 . . . . 0.0 111.478 -170.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -64.7 -31.46 72.69 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 119.012 -0.518 . . . . 0.0 111.14 175.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -68.82 -46.58 68.21 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 118.921 0.782 . . . . 0.0 109.1 174.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -59.07 -37.75 77.82 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 119.451 1.023 . . . . 0.0 111.062 177.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.25 -13.89 21.96 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.253 1.021 . . . . 0.0 113.572 176.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -117.38 -30.49 5.55 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 125.052 1.341 . . . . 0.0 110.291 -179.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -77.66 -24.32 49.44 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 123.967 0.907 . . . . 0.0 111.109 177.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -138.83 168.72 19.19 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.69 1.196 . . . . 0.0 110.303 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -71.78 -10.35 59.64 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.423 1.489 . . . . 0.0 113.359 -177.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.8 pp -58.15 151.32 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 124.458 1.103 . . . . 0.0 113.547 -169.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 43.7 ttm105 -83.67 150.16 26.04 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 174.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.6 m -135.85 149.06 27.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 107.273 -1.381 . . . . 0.0 107.273 169.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.469 ' H ' HG12 ' A' ' 8' ' ' ILE . 2.6 m -144.66 139.75 28.2 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 178.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -131.12 118.26 20.26 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 -169.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 12.9 m-90 -95.82 151.24 19.57 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 122.907 0.483 . . . . 0.0 109.955 173.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -72.96 -41.77 47.34 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 108.928 -1.669 . . . . 0.0 108.928 169.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.3 t70 . . . . . 0 C--O 1.246 0.907 0 C-N-CA 126.996 2.119 . . . . 0.0 107.719 169.889 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.4 p . . . . . 0 CA--C 1.53 0.2 0 N-CA-C 106.314 -1.736 . . . . 0.0 106.314 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.75 170.31 18.56 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.595 1.558 . . . . 0.0 108.336 177.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.3 m -97.85 161.53 13.7 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 169.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.7 pt -120.2 174.37 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 125.127 1.371 . . . . 0.0 108.041 -179.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.51 88.15 1.69 Allowed 'General case' 0 C--O 1.232 0.173 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 169.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.7 p -134.02 155.76 40.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -171.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -175.91 -65.68 0.06 OUTLIER Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.782 -0.527 . . . . 0.0 111.782 170.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -83.0 39.15 2.73 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 124.341 0.972 . . . . 0.0 112.398 -174.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.1 p -148.36 71.44 10.89 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 126.617 1.967 . . . . 0.0 106.07 -169.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -52.61 -34.78 64.84 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 123.045 2.497 . . . . 0.0 114.128 -169.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -66.49 -36.9 83.88 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.938 0.399 . . . . 0.0 110.211 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -76.2 -25.27 54.99 Favored 'General case' 0 N--CA 1.454 -0.236 0 O-C-N 121.719 -0.613 . . . . 0.0 110.52 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 91.2 mt -61.27 -37.81 84.48 Favored 'General case' 0 C--O 1.227 -0.127 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 169.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -70.96 -49.85 40.92 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 119.083 0.856 . . . . 0.0 109.47 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -59.43 -48.19 82.61 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 117.834 0.288 . . . . 0.0 110.6 -178.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.0 mt -74.58 -33.75 62.73 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 118.356 -0.83 . . . . 0.0 110.296 -175.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -61.13 -37.95 84.64 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 120.102 1.319 . . . . 0.0 110.464 169.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -62.7 -45.73 91.43 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 119.788 1.176 . . . . 0.0 109.406 175.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -59.12 -28.68 66.76 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 118.818 -0.61 . . . . 0.0 112.304 175.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.33 -21.57 64.11 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.363 0.983 . . . . 0.0 112.771 175.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.41 -33.06 10.15 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 118.548 0.613 . . . . 0.0 110.454 169.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -67.46 -29.37 68.81 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 118.842 0.746 . . . . 0.0 111.08 -175.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -140.62 179.82 6.47 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.823 1.649 . . . . 0.0 109.775 -174.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -91.85 11.39 25.01 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.911 1.284 . . . . 0.0 112.105 -173.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.8 pt -61.97 156.02 4.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 124.423 1.089 . . . . 0.0 112.131 -171.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.1 ptm180 -107.12 74.77 0.99 Allowed 'General case' 0 C--O 1.235 0.319 0 C-N-CA 123.901 0.881 . . . . 0.0 109.263 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 29.8 m -54.5 139.57 13.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.056 178.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.9 m -142.87 119.91 11.38 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 104.562 -2.385 . . . . 0.0 104.562 -175.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -114.58 111.04 20.73 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -169.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 9.7 m-90 -80.07 154.52 28.07 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.144 0.578 . . . . 0.0 110.037 175.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -86.81 40.09 3.08 Favored Glycine 0 CA--C 1.532 1.121 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 169.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.3 t70 . . . . . 0 C--O 1.248 0.999 0 C-N-CA 125.129 1.372 . . . . 0.0 111.192 -173.89 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.9 p . . . . . 0 CA--C 1.535 0.373 0 CA-C-O 121.683 0.754 . . . . 0.0 110.648 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -148.1 171.4 15.93 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 125.348 1.459 . . . . 0.0 109.263 -175.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.3 m -134.51 153.85 51.73 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 171.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.409 HG12 ' H ' ' A' ' 32' ' ' THR . 7.7 pt -129.3 167.51 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 125.713 1.605 . . . . 0.0 107.755 -175.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.31 39.56 0.91 Allowed 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.533 0.683 . . . . 0.0 110.603 175.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 28.3 m -69.03 144.87 13.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 O-C-N 121.289 -0.882 . . . . 0.0 109.866 176.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -172.1 147.6 10.15 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 106.632 -2.587 . . . . 0.0 106.632 172.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 55.06 24.58 35.77 Favored Glycine 0 CA--C 1.537 1.451 0 CA-C-N 117.797 0.799 . . . . 0.0 113.422 -170.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -140.63 61.12 14.98 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 125.289 1.436 . . . . 0.0 109.711 -171.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -62.27 -23.81 75.56 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.517 2.145 . . . . 0.0 112.711 -175.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -67.36 -19.22 65.4 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.033 0.933 . . . . 0.0 112.271 176.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -90.19 -26.14 20.27 Favored 'General case' 0 N--CA 1.465 0.275 0 O-C-N 121.392 -0.817 . . . . 0.0 110.174 -178.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 59.0 mt -55.05 -30.06 58.8 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 169.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -64.68 -23.71 67.34 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 119.051 -0.499 . . . . 0.0 112.041 -177.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -99.76 -45.6 5.69 Favored 'General case' 0 C--N 1.34 0.156 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 176.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 83.5 mt -72.4 -29.89 64.15 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 118.648 -0.691 . . . . 0.0 111.702 -169.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 27.0 mmtp -62.98 -38.35 90.79 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 119.578 1.081 . . . . 0.0 110.43 169.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -63.93 -45.99 86.77 Favored 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -59.82 -42.47 93.6 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.432 1.015 . . . . 0.0 111.036 177.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.91 -6.15 11.5 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.387 1.075 . . . . 0.0 113.889 177.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -121.57 -25.05 5.2 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.068 1.347 . . . . 0.0 110.052 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -70.15 -40.46 74.75 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 125.054 1.342 . . . . 0.0 108.837 172.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -134.97 166.23 23.51 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.714 1.206 . . . . 0.0 109.236 175.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -76.2 10.36 2.02 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.796 1.239 . . . . 0.0 112.954 -176.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.4 pp -62.17 153.4 6.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-O 122.093 0.949 . . . . 0.0 112.667 -169.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.93 144.26 47.38 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 124.14 0.976 . . . . 0.0 109.329 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.5 m -143.56 152.59 16.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 125.955 1.702 . . . . 0.0 106.497 169.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.409 ' H ' HG12 ' A' ' 8' ' ' ILE . 27.5 m -143.84 133.42 23.56 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 173.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -120.67 102.19 8.24 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -169.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 24.3 m-90 -75.87 155.19 35.52 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 171.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -66.88 -49.66 52.96 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 108.285 -1.926 . . . . 0.0 108.285 169.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.3 t70 . . . . . 0 C--O 1.246 0.881 0 C-N-CA 126.871 2.069 . . . . 0.0 107.797 169.919 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 32.6 m . . . . . 0 CA--C 1.536 0.428 0 N-CA-C 111.652 0.241 . . . . 0.0 111.652 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 69.9 mtm-85 -124.75 -31.69 3.16 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 118.487 -0.768 . . . . 0.0 112.951 176.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.4 m 64.61 151.84 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.032 1.333 . . . . 0.0 110.056 -169.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.0 pt -135.2 172.53 15.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 125.029 1.332 . . . . 0.0 108.615 -169.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.2 37.17 0.54 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.233 0.613 . . . . 0.0 110.962 177.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.406 HG11 HD12 ' A' ' 20' ' ' LEU . 18.1 m -67.33 153.44 8.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 O-C-N 121.069 -1.019 . . . . 0.0 112.47 -174.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 174.64 139.54 3.03 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 108.512 -1.835 . . . . 0.0 108.512 176.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 64.11 29.36 74.71 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-N 117.181 0.491 . . . . 0.0 111.92 -172.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.4 p -141.25 65.23 21.47 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 125.462 1.505 . . . . 0.0 108.286 -172.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.15 -23.89 31.15 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 124.078 3.185 . . . . 0.0 115.841 -169.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -102.41 -11.59 18.5 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.783 0.833 . . . . 0.0 111.429 -173.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -88.77 -40.39 13.24 Favored 'General case' 0 CA--C 1.519 -0.225 0 O-C-N 121.103 -0.998 . . . . 0.0 108.583 -176.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.4 pp -57.28 -25.69 59.64 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-O 118.535 -0.745 . . . . 0.0 110.989 169.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -73.09 -45.89 54.54 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.337 0.971 . . . . 0.0 110.023 177.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -63.21 -43.71 97.36 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 177.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.406 HD12 HG11 ' A' ' 10' ' ' VAL . 96.1 mt -68.64 -38.78 80.75 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 118.78 -0.628 . . . . 0.0 110.296 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -58.86 -41.5 87.15 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.579 1.081 . . . . 0.0 110.726 171.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -61.3 -41.98 97.89 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.9 0.773 . . . . 0.0 110.041 176.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -62.72 -38.53 90.83 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 119.419 1.009 . . . . 0.0 111.802 174.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.86 -30.83 71.88 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.972 0.806 . . . . 0.0 111.561 177.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -80.21 -35.85 35.65 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.222 0.609 . . . . 0.0 110.216 174.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -76.84 -40.63 47.1 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 118.574 0.625 . . . . 0.0 111.174 -173.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -132.08 175.14 9.49 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.835 1.254 . . . . 0.0 111.13 -169.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -65.35 -17.7 64.73 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.819 1.248 . . . . 0.0 113.541 -177.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.0 pp -55.79 144.89 6.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 123.9 0.88 . . . . 0.0 112.759 -169.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 8.4 ptm85 -83.9 161.58 20.8 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 121.181 0.515 . . . . 0.0 109.845 171.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.8 m -140.3 156.07 23.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 125.24 1.416 . . . . 0.0 108.158 171.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.2 m -144.59 124.06 13.15 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 -177.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -119.19 83.89 2.11 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.223 0.609 . . . . 0.0 109.751 -169.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 13.5 m-90 -64.28 -42.68 96.3 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.46 173.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 65.3 29.35 75.06 Favored Glycine 0 CA--C 1.535 1.333 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 -169.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.9 t70 . . . . . 0 C--O 1.248 1.008 0 C-N-CA 125.075 1.35 . . . . 0.0 111.581 -175.388 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.0 t . . . . . 0 CA--C 1.535 0.397 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -149.27 174.35 12.5 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 124.909 1.284 . . . . 0.0 109.816 -174.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.9 m -108.15 160.3 15.92 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.563 1.545 . . . . 0.0 108.426 172.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.411 HG12 ' H ' ' A' ' 32' ' ' THR . 4.8 pt -131.95 163.66 36.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 169.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.78 73.18 1.33 Allowed 'General case' 0 C--O 1.233 0.21 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 175.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.3 m -125.52 162.13 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 121.876 0.846 . . . . 0.0 111.624 -173.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -176.71 165.58 35.88 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 126.12 1.819 . . . . 0.0 108.953 171.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 57.75 19.87 37.59 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 124.324 0.964 . . . . 0.0 114.7 173.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.2 m -140.74 73.01 29.03 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 118.325 1.062 . . . . 0.0 108.997 -171.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -44.02 -34.91 6.89 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.706 2.937 . . . . 0.0 113.644 173.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 51.3 mp0 -66.52 -9.68 37.13 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.43 1.892 . . . . 0.0 112.589 -176.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -130.15 -44.73 1.14 Allowed 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 125.219 1.408 . . . . 0.0 108.786 -178.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.1 pp -68.2 -27.23 66.21 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 119.888 1.222 . . . . 0.0 111.439 -175.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -68.0 -39.15 83.26 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 120.122 1.328 . . . . 0.0 110.417 171.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -68.63 -42.33 78.19 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 118.616 0.644 . . . . 0.0 109.736 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 79.3 mt -69.46 -34.82 74.94 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.458 0.572 . . . . 0.0 110.509 177.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -61.08 -42.8 99.18 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 119.285 0.948 . . . . 0.0 110.563 169.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -62.32 -38.19 88.46 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.76 0.709 . . . . 0.0 110.101 176.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -62.23 -41.71 98.65 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.174 0.99 . . . . 0.0 110.586 176.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.13 -45.76 91.91 Favored 'General case' 0 C--N 1.338 0.089 0 C-N-CA 122.869 0.467 . . . . 0.0 110.481 174.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -66.06 -32.77 74.44 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 119.038 -0.506 . . . . 0.0 111.161 177.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.2 ttpt -81.16 -49.19 11.12 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 118.955 0.798 . . . . 0.0 110.823 -173.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.99 7.33 21.55 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.137 0.975 . . . . 0.0 112.999 -169.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 54.5 t30 65.58 1.66 1.79 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.913 2.085 . . . . 0.0 114.094 -178.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.6 pp -63.23 147.49 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 121.626 0.727 . . . . 0.0 111.368 -172.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 43.1 ptt85 -67.59 149.41 50.12 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.572 175.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.6 m -144.08 152.8 15.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 125.323 1.449 . . . . 0.0 107.769 176.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.411 ' H ' HG12 ' A' ' 8' ' ' ILE . 10.9 m -140.85 127.29 19.95 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -178.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -121.05 102.09 8.1 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -170.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 1.9 m-90 -70.87 -34.45 71.63 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 123.558 0.743 . . . . 0.0 112.441 -175.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.16 27.26 72.81 Favored Glycine 0 CA--C 1.535 1.324 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 -169.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 22.8 t70 . . . . . 0 C--O 1.25 1.096 0 C-N-CA 125.083 1.353 . . . . 0.0 111.25 -177.759 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.9 p . . . . . 0 CA--C 1.537 0.474 0 CA-C-O 121.433 0.635 . . . . 0.0 111.372 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 40.4 ptt85 -147.81 174.8 11.48 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 125.19 1.396 . . . . 0.0 108.438 171.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 92.5 m -123.7 155.17 38.31 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 174.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.8 pt -128.41 172.75 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.865 1.666 . . . . 0.0 108.266 -169.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.63 35.67 0.71 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 118.505 0.593 . . . . 0.0 111.639 174.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.0 m -67.63 146.09 13.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 O-C-N 121.165 -0.959 . . . . 0.0 109.244 177.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -88.41 39.12 3.13 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.164 0.888 . . . . 0.0 110.913 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 54.81 33.12 55.71 Favored Glycine 0 CA--C 1.533 1.188 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 -169.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.14 125.37 85.27 Favored Pre-proline 0 N--CA 1.448 -0.53 0 C-N-CA 125.66 1.584 . . . . 0.0 110.078 -169.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -56.14 -15.41 14.14 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.621 2.881 . . . . 0.0 114.986 174.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -94.14 -15.72 24.41 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.574 1.15 . . . . 0.0 111.561 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -116.48 -35.42 4.27 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 121.44 -0.787 . . . . 0.0 111.043 -169.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 76.1 mt -51.51 -30.89 21.83 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.654 0.661 . . . . 0.0 110.97 170.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -58.0 -23.28 53.38 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 125.035 1.334 . . . . 0.0 112.835 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -113.2 -41.48 3.69 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 123.761 0.824 . . . . 0.0 109.537 176.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -64.32 -40.4 95.84 Favored 'General case' 0 N--CA 1.457 -0.088 0 C-N-CA 122.924 0.49 . . . . 0.0 112.023 -174.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -66.48 -37.64 85.55 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 118.86 0.754 . . . . 0.0 110.12 178.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -63.66 -47.63 80.49 Favored 'General case' 0 C--O 1.225 -0.217 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 175.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -59.6 -40.25 86.88 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.109 0.964 . . . . 0.0 111.051 -179.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.99 -43.61 70.13 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 124.172 0.989 . . . . 0.0 110.955 177.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -82.12 -34.24 29.31 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 119.302 -0.38 . . . . 0.0 111.151 177.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -71.29 -39.97 71.16 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 118.614 0.643 . . . . 0.0 110.717 -170.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -119.05 6.98 11.3 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.763 0.825 . . . . 0.0 112.082 -172.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 55.7 t30 62.39 1.01 0.67 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 127.07 2.148 . . . . 0.0 114.602 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.7 pp -62.56 152.95 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.517 1.127 . . . . 0.0 111.497 -174.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.07 152.1 44.34 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 172.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.8 m -141.22 149.17 20.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 169.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.5 m -143.18 132.82 23.74 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -122.78 105.19 9.82 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -169.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 13.6 m-90 -79.81 153.37 29.18 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 122.45 0.3 . . . . 0.0 110.396 -177.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -84.62 43.87 3.28 Favored Glycine 0 CA--C 1.532 1.107 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 169.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.0 t70 . . . . . 0 C--O 1.248 0.982 0 C-N-CA 125.066 1.346 . . . . 0.0 111.251 -173.478 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 C--O 1.234 0.287 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 29.4 ptt-85 -161.29 158.49 27.21 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 123.981 0.912 . . . . 0.0 109.005 -175.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.8 m -82.31 158.85 23.28 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 169.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.4 pt -125.99 168.42 18.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 125.141 1.376 . . . . 0.0 108.432 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.13 49.1 1.27 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.939 0.876 . . . . 0.0 110.118 176.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.1 t -60.38 134.08 25.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 169.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -147.92 -26.94 0.07 OUTLIER Glycine 0 CA--C 1.524 0.6 0 CA-C-O 119.482 -0.621 . . . . 0.0 114.175 -172.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -166.21 44.55 0.27 Allowed Glycine 0 CA--C 1.523 0.566 0 N-CA-C 108.249 -1.94 . . . . 0.0 108.249 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -138.58 78.03 32.68 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 125.663 1.585 . . . . 0.0 108.15 -168.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -63.16 -21.66 72.54 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 121.906 1.738 . . . . 0.0 112.093 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -66.53 -20.18 65.96 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.572 -0.705 . . . . 0.0 111.641 173.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -90.05 -38.15 13.78 Favored 'General case' 0 C--N 1.338 0.099 0 O-C-N 121.629 -0.669 . . . . 0.0 109.599 174.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.3 mt -55.59 -32.52 63.15 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.23 0.923 . . . . 0.0 110.433 169.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -64.48 -21.8 66.77 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.205 1.002 . . . . 0.0 112.499 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -126.91 -45.35 1.59 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 119.247 0.93 . . . . 0.0 111.969 -169.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 32.4 mt -70.85 -30.52 66.95 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 121.504 -0.747 . . . . 0.0 110.749 -174.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -62.31 -37.61 86.24 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.059 0.845 . . . . 0.0 111.003 170.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -68.23 -41.45 81.21 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 175.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -60.37 -37.42 80.69 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 121.387 -0.821 . . . . 0.0 111.317 178.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.99 -11.81 9.37 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.692 1.197 . . . . 0.0 113.707 174.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -118.18 -26.64 6.28 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.476 1.51 . . . . 0.0 109.75 -179.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -71.3 -37.8 71.81 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 123.623 0.769 . . . . 0.0 109.731 173.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -134.93 169.24 17.7 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 125.416 1.486 . . . . 0.0 109.249 -178.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -75.94 -1.46 25.67 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.37 1.068 . . . . 0.0 113.043 -176.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.3 pp -58.67 147.29 7.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 123.946 0.898 . . . . 0.0 111.638 -171.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 31.8 ptt-85 -75.06 153.61 38.32 Favored 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 123.142 0.577 . . . . 0.0 109.684 174.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.6 m -141.19 155.03 20.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 124.971 1.309 . . . . 0.0 107.647 171.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.0 m -149.38 141.17 23.64 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 173.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -130.32 110.45 11.53 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -169.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 18.4 m-90 -85.51 170.36 12.72 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.946 0.898 . . . . 0.0 109.778 172.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -130.57 65.45 0.59 Allowed Glycine 0 CA--C 1.524 0.602 0 N-CA-C 105.883 -2.887 . . . . 0.0 105.883 171.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.4 t70 . . . . . 0 C--O 1.247 0.962 0 C-N-CA 125.256 1.423 . . . . 0.0 111.582 -169.855 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.2 p . . . . . 0 CA--C 1.539 0.545 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -160.22 179.22 8.88 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 126.581 1.952 . . . . 0.0 108.566 177.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.9 m -123.63 156.88 35.0 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 126.33 1.852 . . . . 0.0 107.196 175.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.438 HG12 ' H ' ' A' ' 32' ' ' THR . 4.3 pt -118.5 167.42 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.671 1.189 . . . . 0.0 108.835 -174.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -147.0 69.85 1.18 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 174.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.5 m -118.31 158.09 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 122.999 0.52 . . . . 0.0 110.158 -177.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 173.97 150.14 7.44 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 108.291 -1.924 . . . . 0.0 108.291 178.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 61.78 31.02 76.66 Favored Glycine 0 CA--C 1.534 1.279 0 N-CA-C 111.77 -0.532 . . . . 0.0 111.77 -171.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.0 p -138.0 58.39 15.52 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 125.703 1.601 . . . . 0.0 108.995 -169.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -62.66 -20.42 70.87 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.027 2.485 . . . . 0.0 113.316 -169.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -87.91 -4.3 58.85 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.501 0.72 . . . . 0.0 112.155 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -127.69 -34.44 2.2 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.572 0.749 . . . . 0.0 110.692 -173.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.6 pp -62.31 -25.26 67.77 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-O 118.129 -0.938 . . . . 0.0 110.62 169.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.0 ptpp? -68.42 -37.67 80.51 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 119.987 1.267 . . . . 0.0 111.299 171.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -69.86 -43.45 71.86 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 72.3 mt -69.55 -34.08 73.69 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 118.986 -0.531 . . . . 0.0 110.546 177.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -62.32 -39.43 93.01 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.583 1.083 . . . . 0.0 111.297 171.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -59.9 -46.85 88.02 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.696 1.135 . . . . 0.0 109.141 172.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -57.25 -33.32 67.47 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.565 1.146 . . . . 0.0 111.517 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.77 -23.45 66.2 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.129 0.972 . . . . 0.0 112.771 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.36 -31.62 11.24 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 123.018 0.527 . . . . 0.0 110.28 171.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.2 ttmt -66.5 -36.43 82.7 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 118.602 0.637 . . . . 0.0 111.342 -176.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -134.82 176.22 8.84 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.743 1.217 . . . . 0.0 111.06 -169.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -80.32 1.76 27.44 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.68 1.192 . . . . 0.0 112.216 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.1 pp -59.98 158.86 1.94 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 124.0 0.92 . . . . 0.0 110.352 177.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -116.98 154.44 30.89 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 172.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 29.0 m -128.94 147.99 33.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 123.316 0.647 . . . . 0.0 110.14 -175.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.438 ' H ' HG12 ' A' ' 8' ' ' ILE . 16.0 m -144.76 131.23 19.8 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 176.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -123.51 110.23 14.8 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -169.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 11.3 m-90 -74.09 158.54 34.07 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.862 0.865 . . . . 0.0 109.652 172.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -65.57 -44.59 92.53 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 108.802 -1.719 . . . . 0.0 108.802 169.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.5 t70 . . . . . 0 C--O 1.246 0.887 0 C-N-CA 127.111 2.164 . . . . 0.0 107.676 169.806 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.5 t . . . . . 0 C--O 1.236 0.377 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 33.5 ptt-85 -155.74 157.07 35.96 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 124.386 1.074 . . . . 0.0 108.508 171.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.8 m -81.37 160.1 24.19 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 169.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.407 HG12 ' H ' ' A' ' 32' ' ' THR . 7.9 pt -122.66 167.45 16.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 125.0 1.32 . . . . 0.0 108.993 177.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.19 45.5 1.15 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 122.213 1.006 . . . . 0.0 108.503 170.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.2 p -70.72 144.02 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 O-C-N 121.444 -0.785 . . . . 0.0 110.737 -170.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -175.98 159.15 26.42 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 172.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 58.02 18.89 35.58 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.355 0.979 . . . . 0.0 113.915 -176.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.5 p -144.66 71.9 15.45 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 125.282 1.433 . . . . 0.0 108.178 -169.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -60.45 -24.02 76.7 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.296 1.997 . . . . 0.0 112.848 -176.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.5 mp0 -62.36 -39.52 93.44 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.602 0.761 . . . . 0.0 109.678 173.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -79.04 -24.14 43.8 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 121.476 -0.765 . . . . 0.0 110.775 -178.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.6 mt -60.92 -38.49 85.96 Favored 'General case' 0 CA--C 1.526 0.052 0 CA-C-N 119.65 1.114 . . . . 0.0 108.027 169.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -72.54 -49.46 32.53 Favored 'General case' 0 C--N 1.341 0.223 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -60.92 -45.94 92.67 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 118.596 0.635 . . . . 0.0 111.04 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 94.4 mt -72.93 -33.99 66.29 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 118.5 -0.762 . . . . 0.0 110.103 -177.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -60.99 -40.33 93.11 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.937 1.244 . . . . 0.0 110.315 169.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -62.11 -41.39 98.18 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.668 0.667 . . . . 0.0 109.941 177.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -63.45 -40.26 96.67 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 119.35 0.977 . . . . 0.0 111.628 175.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.8 -42.89 98.49 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 118.784 0.72 . . . . 0.0 110.404 176.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 42.2 mtpt -67.08 -37.28 83.72 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.979 -0.45 . . . . 0.0 110.941 175.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 66.3 tttm -80.44 -40.51 26.19 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 118.674 0.67 . . . . 0.0 111.851 -169.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -130.5 10.26 5.2 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.947 0.899 . . . . 0.0 113.076 -169.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 64.04 7.8 3.6 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.133 1.773 . . . . 0.0 114.05 177.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.5 pp -64.2 155.83 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 121.96 0.886 . . . . 0.0 112.551 -169.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 28.1 ttp-105 -62.44 134.25 56.17 Favored 'General case' 0 CA--C 1.527 0.073 0 C-N-CA 124.361 1.064 . . . . 0.0 109.28 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.6 m -139.56 144.29 29.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 172.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.407 ' H ' HG12 ' A' ' 8' ' ' ILE . 18.2 m -140.2 110.24 6.51 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 178.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -99.56 84.86 3.02 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.48 0.712 . . . . 0.0 109.993 -169.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 14.0 m-90 -64.65 -47.86 76.93 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.32 169.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.91 -12.51 42.2 Favored Glycine 0 CA--C 1.536 1.364 0 CA-C-O 118.923 -0.931 . . . . 0.0 113.003 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.2 t0 . . . . . 0 C--O 1.248 0.996 0 C-N-CA 127.508 2.323 . . . . 0.0 112.123 -171.463 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.0 p . . . . . 0 C--O 1.234 0.277 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 71.6 mtt180 -140.67 177.19 8.2 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 125.309 1.444 . . . . 0.0 108.169 -177.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.0 m -144.08 149.13 36.11 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 169.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.3 pt -135.15 171.79 17.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 124.932 1.293 . . . . 0.0 108.406 -175.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.58 43.01 1.18 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.867 0.841 . . . . 0.0 109.826 176.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.9 p -73.37 148.47 8.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 O-C-N 121.437 -0.789 . . . . 0.0 109.804 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -173.39 166.89 39.43 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 108.378 -1.889 . . . . 0.0 108.378 169.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 54.5 21.26 20.11 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.069 1.319 . . . . 0.0 114.974 176.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.7 m -145.94 75.32 13.05 Favored Pre-proline 0 CA--C 1.538 0.497 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 -169.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -50.01 -34.52 38.2 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.434 2.756 . . . . 0.0 113.639 -177.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -68.25 -41.64 80.85 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.906 0.384 . . . . 0.0 110.15 -176.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -74.72 -36.18 62.68 Favored 'General case' 0 N--CA 1.436 -1.131 0 O-C-N 121.215 -0.928 . . . . 0.0 109.429 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.3 mt -57.26 -38.43 73.84 Favored 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 123.806 0.843 . . . . 0.0 109.721 172.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 43.1 mtpt -68.13 -49.13 63.08 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 118.741 0.7 . . . . 0.0 109.855 176.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -60.8 -43.82 97.66 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 118.797 0.726 . . . . 0.0 110.954 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 69.0 mt -74.64 -31.68 62.03 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 118.552 -0.737 . . . . 0.0 110.599 -178.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -62.07 -41.58 98.31 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.815 1.189 . . . . 0.0 110.254 169.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -63.38 -42.92 98.86 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.638 0.654 . . . . 0.0 109.617 176.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.0 tp10 -60.23 -39.26 86.04 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.055 -1.028 . . . . 0.0 111.037 176.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.14 -3.1 6.67 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.827 1.251 . . . . 0.0 113.798 174.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -118.2 -25.54 6.59 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.23 1.412 . . . . 0.0 110.036 174.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.4 ttpt -68.45 -41.6 80.02 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 123.791 0.836 . . . . 0.0 108.905 172.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -132.49 161.25 34.21 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.193 1.397 . . . . 0.0 109.205 175.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -74.31 -7.08 51.59 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.016 0.926 . . . . 0.0 113.341 -173.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.8 pp -51.76 145.6 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 125.251 1.421 . . . . 0.0 113.944 -169.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.9 ttp180 -59.37 143.98 48.03 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 124.776 1.23 . . . . 0.0 109.476 172.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.4 m -140.18 153.55 22.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 C-N-CA 125.607 1.563 . . . . 0.0 106.789 169.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.9 m -141.46 128.24 20.43 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 -176.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -121.4 119.24 31.54 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -169.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 19.8 m-90 -94.73 157.43 15.95 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 169.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.61 -48.3 82.65 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 108.661 -1.776 . . . . 0.0 108.661 169.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.7 t70 . . . . . 0 C--O 1.247 0.961 0 C-N-CA 126.947 2.099 . . . . 0.0 107.73 169.721 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.403 ' HA ' HG22 ' A' ' 29' ' ' ILE . 53.3 t . . . . . 0 C--O 1.234 0.275 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 30.1 ptt-85 -155.43 -179.71 8.35 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 126.804 2.041 . . . . 0.0 106.599 -178.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.9 m -129.6 152.63 48.91 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 175.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.455 HG12 ' H ' ' A' ' 32' ' ' THR . 1.9 pt -117.07 167.13 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.765 1.226 . . . . 0.0 108.446 -171.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -144.52 36.08 1.19 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.775 0.83 . . . . 0.0 109.522 177.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.4 m -69.17 150.58 10.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 O-C-N 121.346 -0.846 . . . . 0.0 109.493 -178.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -81.97 42.27 2.83 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.548 1.071 . . . . 0.0 111.774 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 57.45 35.01 70.17 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 124.117 0.865 . . . . 0.0 111.691 -177.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.74 125.17 87.09 Favored Pre-proline 0 N--CA 1.45 -0.466 0 C-N-CA 124.615 1.166 . . . . 0.0 108.642 -174.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -65.39 -18.08 59.33 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 121.699 1.6 . . . . 0.0 111.475 175.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -77.75 -11.36 59.87 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.096 0.958 . . . . 0.0 111.085 178.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -125.58 -47.43 1.7 Allowed 'General case' 0 CA--C 1.519 -0.25 0 C-N-CA 123.281 0.632 . . . . 0.0 109.725 -169.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.4 pp -57.0 -27.9 61.98 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 118.77 0.714 . . . . 0.0 111.663 177.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -68.6 -13.88 62.64 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 118.703 -0.665 . . . . 0.0 112.736 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -111.43 -42.59 3.85 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.22 0.918 . . . . 0.0 109.074 173.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -62.96 -41.61 99.57 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.339 0.656 . . . . 0.0 111.518 -177.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.9 tptp -67.97 -31.77 71.73 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.186 0.903 . . . . 0.0 111.014 178.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -66.31 -46.17 77.83 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 172.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -60.77 -38.3 84.79 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.462 -0.774 . . . . 0.0 111.18 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.4 -15.78 40.04 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.483 1.113 . . . . 0.0 113.347 176.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -109.04 -27.17 9.79 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.886 1.274 . . . . 0.0 109.976 176.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -75.08 -35.94 61.77 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.932 0.893 . . . . 0.0 110.414 -179.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -140.03 169.91 16.84 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.329 1.452 . . . . 0.0 109.634 -177.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -76.75 15.47 0.64 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.901 1.28 . . . . 0.0 112.627 -174.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.403 HG22 ' HA ' ' A' ' 5' ' ' VAL . 1.4 pp -70.28 158.48 6.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 O-C-N 120.666 -1.271 . . . . 0.0 110.286 -174.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 41.8 ttm105 -98.93 147.29 25.13 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 29.9 m -136.67 154.58 32.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 170.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.455 ' H ' HG12 ' A' ' 8' ' ' ILE . 24.7 m -153.15 144.48 23.2 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 169.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -130.71 112.01 12.7 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -169.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 13.2 m-90 -93.84 150.7 20.16 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 122.887 0.475 . . . . 0.0 110.151 179.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -82.71 43.77 3.13 Favored Glycine 0 CA--C 1.532 1.154 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 169.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.1 t70 . . . . . 0 C--O 1.247 0.944 0 C-N-CA 125.075 1.35 . . . . 0.0 111.246 -173.924 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.234 0.263 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -160.33 158.93 30.56 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 125.998 1.719 . . . . 0.0 107.552 172.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.4 m -99.23 152.47 19.87 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 169.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.475 HG12 ' H ' ' A' ' 32' ' ' THR . 8.0 pt -113.38 173.81 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 124.365 1.066 . . . . 0.0 109.066 -176.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.92 72.31 1.17 Allowed 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 172.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.409 HG22 HD12 ' A' ' 8' ' ' ILE . 13.5 m -124.06 157.8 30.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 177.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -167.87 136.3 4.04 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 108.979 -1.649 . . . . 0.0 108.979 171.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 56.22 23.08 39.16 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 124.247 0.927 . . . . 0.0 114.19 179.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.0 p -68.58 150.23 97.73 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 119.072 1.436 . . . . 0.0 108.886 176.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.4 -25.99 29.74 Favored 'Trans proline' 0 CA--C 1.533 0.463 0 C-N-CA 121.965 1.777 . . . . 0.0 112.041 -172.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -159.52 -12.91 0.06 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.279 1.032 . . . . 0.0 112.019 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -66.21 -36.74 83.84 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 120.591 -1.318 . . . . 0.0 110.557 -173.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.6 pp -65.38 -21.67 66.71 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-O 118.424 -0.798 . . . . 0.0 112.16 172.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -77.85 -45.65 23.7 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 119.861 1.209 . . . . 0.0 108.935 175.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -58.44 -46.73 85.95 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.251 0.478 . . . . 0.0 110.316 173.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.0 mt -70.34 -34.48 72.71 Favored 'General case' 0 C--O 1.226 -0.154 0 CA-C-O 118.41 -0.805 . . . . 0.0 110.616 -178.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -60.19 -42.36 94.91 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 120.335 1.425 . . . . 0.0 110.799 169.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -61.52 -40.13 93.53 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 119.316 0.962 . . . . 0.0 110.174 175.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -62.23 -31.9 72.5 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.498 -0.751 . . . . 0.0 111.288 173.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.42 -28.72 67.33 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 120.162 1.346 . . . . 0.0 112.138 173.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -78.86 -33.1 46.11 Favored 'General case' 0 N--CA 1.463 0.19 0 O-C-N 121.82 -0.55 . . . . 0.0 109.998 172.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -90.5 -23.71 20.86 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -169.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -142.09 172.67 12.37 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.827 1.651 . . . . 0.0 109.931 -176.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -81.97 2.04 32.63 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.838 1.255 . . . . 0.0 112.982 -173.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.5 pt -53.18 151.05 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 125.635 1.574 . . . . 0.0 113.881 -169.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 34.2 ttp180 -94.34 75.39 3.92 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.426 1.49 . . . . 0.0 108.989 -177.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.5 m -62.93 139.66 20.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 171.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.475 ' H ' HG12 ' A' ' 8' ' ' ILE . 21.0 m -144.76 125.01 13.73 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 104.257 -2.497 . . . . 0.0 104.257 177.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -117.7 109.69 16.93 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -169.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 11.8 m-90 -72.24 165.2 24.9 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.993 0.917 . . . . 0.0 109.997 171.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -68.84 -45.4 64.57 Favored Glycine 0 CA--C 1.531 1.054 0 N-CA-C 108.328 -1.909 . . . . 0.0 108.328 169.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.3 t70 . . . . . 0 C--O 1.246 0.876 0 C-N-CA 127.111 2.165 . . . . 0.0 107.756 169.81 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 C--O 1.234 0.289 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 23.5 ptt-85 -152.25 165.66 34.18 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 126.978 2.111 . . . . 0.0 105.959 168.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.1 m -136.17 153.95 51.11 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -173.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.408 HG12 ' H ' ' A' ' 32' ' ' THR . 1.9 pt -127.33 169.15 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 125.002 1.321 . . . . 0.0 108.887 -169.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.07 37.14 0.94 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.514 0.726 . . . . 0.0 110.332 176.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.0 m -72.68 152.58 7.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 O-C-N 121.116 -0.99 . . . . 0.0 109.528 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -81.93 40.56 2.66 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.624 1.107 . . . . 0.0 111.727 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 53.76 34.4 50.7 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.32 0.962 . . . . 0.0 111.839 -171.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.3 m -61.89 124.42 81.62 Favored Pre-proline 0 N--CA 1.445 -0.715 0 C-N-CA 125.269 1.428 . . . . 0.0 108.68 -169.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -52.82 -27.49 34.8 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.801 2.334 . . . . 0.0 112.91 172.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -70.39 -26.44 63.7 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.63 0.772 . . . . 0.0 111.073 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -102.41 -37.06 8.19 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 124.363 1.065 . . . . 0.0 109.232 -171.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 65.5 mt -53.38 -19.2 3.19 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.257 1.023 . . . . 0.0 112.277 169.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -58.96 -28.54 66.4 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 118.945 0.793 . . . . 0.0 112.589 172.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -131.77 -37.08 1.19 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.008 0.822 . . . . 0.0 111.639 -173.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -61.57 -40.42 94.67 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 119.021 0.828 . . . . 0.0 111.374 -176.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.6 tptt -66.88 -32.58 73.94 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 119.303 -0.38 . . . . 0.0 111.005 177.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -69.0 -46.38 68.17 Favored 'General case' 0 C--O 1.224 -0.262 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 175.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -58.2 -40.17 80.87 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 119.168 0.895 . . . . 0.0 111.005 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.93 -15.66 33.61 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.138 0.975 . . . . 0.0 113.444 177.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -113.76 -29.83 6.97 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.993 1.317 . . . . 0.0 110.062 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -73.19 -34.55 66.04 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 123.873 0.869 . . . . 0.0 110.411 178.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -133.86 168.41 18.81 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.351 1.06 . . . . 0.0 110.654 -173.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -69.09 -9.52 53.07 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.023 1.729 . . . . 0.0 113.533 -177.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.6 pp -60.49 157.0 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.81 1.244 . . . . 0.0 111.952 -173.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 12.0 ptp85 -97.51 159.85 14.68 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.652 0.739 . . . . 0.0 109.648 174.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.3 m -139.22 155.01 25.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 171.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.408 ' H ' HG12 ' A' ' 8' ' ' ILE . 38.9 m -149.43 144.21 26.21 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 170.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -129.96 107.23 9.2 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -169.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 13.3 m-90 -84.21 151.29 24.92 Favored 'General case' 0 N--CA 1.461 0.118 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 -179.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -83.03 45.57 3.47 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 169.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.9 t70 . . . . . 0 C--O 1.249 1.066 0 C-N-CA 125.089 1.356 . . . . 0.0 111.306 -174.177 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.2 t . . . . . 0 C--O 1.233 0.224 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -151.9 145.55 24.98 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 104.539 -2.393 . . . . 0.0 104.539 173.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.7 m -102.92 145.41 29.87 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 175.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.489 HG12 ' H ' ' A' ' 32' ' ' THR . 8.4 pt -101.87 174.83 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.226 1.01 . . . . 0.0 109.254 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.83 46.86 1.26 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.629 0.771 . . . . 0.0 109.004 170.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.2 p -80.64 145.98 8.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 O-C-N 121.277 -0.889 . . . . 0.0 109.073 -175.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -86.27 35.67 3.28 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.692 1.139 . . . . 0.0 112.395 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 56.07 41.96 86.41 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.275 0.941 . . . . 0.0 113.15 173.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.5 m -61.55 137.45 94.82 Favored Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 177.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -51.42 -27.23 23.67 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.37 2.713 . . . . 0.0 115.466 -177.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -93.89 -29.68 15.17 Favored 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 123.264 0.626 . . . . 0.0 110.858 -178.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -71.88 -33.45 68.38 Favored 'General case' 0 N--CA 1.462 0.169 0 O-C-N 121.256 -0.902 . . . . 0.0 108.829 175.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 76.6 mt -62.44 -5.09 2.23 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.713 1.205 . . . . 0.0 112.445 169.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.4 mttp -109.24 -56.08 2.33 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 119.287 0.949 . . . . 0.0 108.937 170.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -62.08 -49.87 74.21 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.162 0.585 . . . . 0.0 111.098 -174.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 25.8 mt -76.16 -29.31 57.69 Favored 'General case' 0 C--O 1.224 -0.244 0 O-C-N 122.008 -0.432 . . . . 0.0 109.969 -177.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.3 tptt -63.3 -39.47 94.65 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 119.125 0.875 . . . . 0.0 110.503 171.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -64.68 -44.1 91.4 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 173.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -56.7 -36.9 70.18 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.666 0.786 . . . . 0.0 111.115 175.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.28 -14.03 61.35 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.562 1.145 . . . . 0.0 113.385 177.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.1 mptp? -104.72 -33.7 8.37 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.219 1.008 . . . . 0.0 109.867 172.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 32.6 tttm -66.97 -37.57 84.5 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 123.396 0.679 . . . . 0.0 110.519 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -136.05 163.46 30.25 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 126.468 1.907 . . . . 0.0 108.646 -175.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -82.14 6.43 16.49 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.006 0.923 . . . . 0.0 112.771 -174.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.0 pp -59.73 156.04 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 124.528 1.131 . . . . 0.0 112.754 -172.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 33.1 ttp180 -98.89 81.28 2.6 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.806 1.243 . . . . 0.0 109.975 -169.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.4 m -63.21 139.55 21.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.324 169.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.489 ' H ' HG12 ' A' ' 8' ' ' ILE . 19.1 m -146.04 122.06 10.73 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 104.116 -2.55 . . . . 0.0 104.116 173.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -112.53 111.95 23.14 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -169.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 10.3 m-90 -83.07 147.03 28.37 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 174.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.98 -41.23 61.69 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 169.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.6 t70 . . . . . 0 C--O 1.246 0.889 0 C-N-CA 126.885 2.074 . . . . 0.0 107.867 170.004 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.303 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.6 m -60.58 154.82 20.15 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.221 1.008 . . . . 0.0 111.448 177.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -179.88 -179.03 48.78 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -63.79 -55.63 21.59 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 176.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.4 t -63.93 136.98 25.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-O 121.746 0.784 . . . . 0.0 109.371 -175.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -159.63 176.67 11.74 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 127.46 2.304 . . . . 0.0 106.826 -173.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.4 m -139.91 155.63 47.08 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 -176.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.468 HG12 ' H ' ' A' ' 32' ' ' THR . 2.9 pt -121.02 167.37 14.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 125.022 1.329 . . . . 0.0 108.792 -172.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.26 43.37 1.12 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.71 0.804 . . . . 0.0 109.35 173.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.2 m -75.27 150.39 6.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 O-C-N 121.189 -0.945 . . . . 0.0 110.319 -177.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -88.07 33.69 3.97 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 124.867 1.222 . . . . 0.0 112.271 178.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 61.37 38.52 95.86 Favored Glycine 0 CA--C 1.531 1.037 0 CA-C-N 117.576 0.688 . . . . 0.0 112.976 174.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.3 m -62.79 136.12 96.21 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 172.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -51.32 -32.88 43.44 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 122.766 2.311 . . . . 0.0 113.801 177.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -73.51 -39.19 65.0 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.702 0.401 . . . . 0.0 110.14 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -77.07 -36.15 56.1 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -177.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 34.2 mt -59.41 -26.61 65.3 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.419 1.088 . . . . 0.0 111.451 169.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -83.81 -63.94 1.26 Allowed 'General case' 0 C--N 1.339 0.147 0 CA-C-N 119.237 0.926 . . . . 0.0 109.046 174.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -61.81 -49.21 77.22 Favored 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 122.75 0.42 . . . . 0.0 111.466 -169.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 52.4 mt -75.8 -30.29 59.0 Favored 'General case' 0 C--O 1.226 -0.134 0 CA-C-O 119.124 -0.465 . . . . 0.0 110.255 -171.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -62.95 -38.76 92.36 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.225 0.921 . . . . 0.0 110.059 169.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -61.88 -42.87 99.58 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 118.762 0.71 . . . . 0.0 109.938 174.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -62.35 -39.31 92.72 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.361 0.982 . . . . 0.0 111.23 175.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.34 -46.34 90.27 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 118.771 0.714 . . . . 0.0 110.319 175.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 43.1 mtpt -66.75 -37.24 84.23 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 122.982 0.513 . . . . 0.0 110.904 177.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -83.7 -33.12 25.22 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 118.755 -0.641 . . . . 0.0 112.035 -170.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -128.52 5.65 5.66 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.858 0.863 . . . . 0.0 113.081 -169.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 64.84 3.64 2.12 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.555 1.942 . . . . 0.0 114.309 178.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.0 pp -65.11 156.4 5.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 123.777 0.831 . . . . 0.0 111.577 -173.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 51.5 mtt85 -71.1 143.59 50.58 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -176.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.9 m -141.13 141.76 30.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 169.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.468 ' H ' HG12 ' A' ' 8' ' ' ILE . 19.7 m -145.06 130.16 18.46 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 175.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -120.93 110.99 16.95 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 -169.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 11.9 m-90 -86.75 148.2 25.52 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -85.81 44.68 3.38 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 169.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.6 t70 . . . . . 0 C--O 1.25 1.086 0 C-N-CA 125.022 1.329 . . . . 0.0 111.397 -173.397 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.227 0 N-CA-C 111.181 -0.767 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.1 m -60.47 155.02 19.26 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.241 1.016 . . . . 0.0 111.36 177.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 179.8 -178.95 48.82 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -66.21 -38.45 87.99 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.114 0.566 . . . . 0.0 110.682 177.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.7 t -64.76 140.5 19.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 124.439 1.096 . . . . 0.0 108.867 179.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -149.13 178.84 8.37 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 124.443 1.097 . . . . 0.0 110.089 -174.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 38.3 m -132.28 153.4 50.71 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 169.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.41 HG12 ' H ' ' A' ' 32' ' ' THR . 5.3 pt -126.2 170.34 16.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 125.443 1.497 . . . . 0.0 108.109 -174.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.3 34.9 0.88 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.302 0.572 . . . . 0.0 111.092 174.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.3 m -74.33 158.37 5.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 O-C-N 121.205 -0.935 . . . . 0.0 109.769 176.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -169.72 154.97 24.55 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 108.521 -1.832 . . . . 0.0 108.521 169.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 51.54 28.76 22.52 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 124.385 0.993 . . . . 0.0 114.29 178.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 26.4 m -138.63 74.91 38.63 Favored Pre-proline 0 CA--C 1.537 0.446 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 -170.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -59.55 -27.51 85.15 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.327 2.018 . . . . 0.0 111.778 -177.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -63.6 -17.32 62.75 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.392 1.077 . . . . 0.0 112.168 -178.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -126.92 -34.56 2.35 Favored 'General case' 0 C--N 1.34 0.172 0 C-N-CA 123.453 0.701 . . . . 0.0 111.262 -177.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.16 -25.43 68.34 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 119.47 1.032 . . . . 0.0 110.155 173.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -68.47 -42.88 78.09 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.803 1.183 . . . . 0.0 110.79 173.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -75.29 -29.69 60.17 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.325 0.966 . . . . 0.0 111.536 178.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.0 mt -72.71 -34.87 67.41 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.445 1.021 . . . . 0.0 109.916 172.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.7 mmtt -60.02 -45.41 92.87 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 119.51 1.05 . . . . 0.0 109.829 169.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -57.82 -46.04 85.29 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.575 0.75 . . . . 0.0 109.717 177.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -60.73 -41.64 95.72 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.227 0.921 . . . . 0.0 110.704 176.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.95 -2.96 11.07 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 177.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -117.19 -26.12 6.88 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.978 1.311 . . . . 0.0 109.806 175.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.0 tttm -72.43 -39.95 67.46 Favored 'General case' 0 C--O 1.23 0.073 0 C-N-CA 124.844 1.258 . . . . 0.0 109.521 173.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -133.64 167.88 19.7 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.873 1.669 . . . . 0.0 108.954 178.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -78.82 4.04 15.08 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.722 1.209 . . . . 0.0 113.114 -174.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.1 pp -59.75 151.58 5.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 121.997 0.904 . . . . 0.0 112.978 -169.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.13 144.38 42.86 Favored 'General case' 0 C--O 1.23 0.076 0 C-N-CA 124.003 0.921 . . . . 0.0 109.05 178.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.1 m -143.46 153.76 16.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 125.79 1.636 . . . . 0.0 107.156 169.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.41 ' H ' HG12 ' A' ' 8' ' ' ILE . 25.6 m -146.75 141.65 26.95 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 173.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -128.39 111.83 13.75 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -169.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 18.6 m-90 -86.67 156.11 20.12 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 122.838 0.455 . . . . 0.0 110.679 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -83.46 48.49 4.05 Favored Glycine 0 CA--C 1.529 0.969 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 170.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.7 t70 . . . . . 0 C--O 1.247 0.942 0 C-N-CA 124.918 1.287 . . . . 0.0 111.513 -173.869 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.366 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.0 m -63.85 -24.77 67.88 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.322 1.049 . . . . 0.0 113.105 -176.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -178.72 -178.4 48.0 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 124.96 1.267 . . . . 0.0 109.935 178.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -70.33 -18.73 63.09 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.584 0.753 . . . . 0.0 111.857 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.7 t -59.76 142.97 14.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 O-C-N 121.419 -0.801 . . . . 0.0 109.818 -178.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.32 179.43 6.4 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.408 1.883 . . . . 0.0 106.945 170.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.8 m -140.05 152.27 46.07 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 126.456 1.902 . . . . 0.0 106.426 178.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 13.6 pt -128.33 170.82 17.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 125.052 1.341 . . . . 0.0 108.6 -170.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -150.89 37.88 0.65 Allowed 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 121.727 0.775 . . . . 0.0 110.335 176.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 27.2 m -68.75 152.36 9.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 O-C-N 121.325 -0.86 . . . . 0.0 111.42 -177.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -158.28 41.14 0.51 Allowed Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.071 1.32 . . . . 0.0 110.719 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 162.1 -170.49 37.77 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 108.979 -1.649 . . . . 0.0 108.979 -175.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.5 m 58.38 73.83 0.68 Allowed Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 124.954 1.301 . . . . 0.0 110.061 176.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -58.64 -23.37 65.23 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.396 2.064 . . . . 0.0 112.924 -177.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -62.7 -43.39 98.92 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.346 0.521 . . . . 0.0 110.191 172.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -74.92 -32.11 61.71 Favored 'General case' 0 N--CA 1.438 -1.069 0 C-N-CA 124.085 0.954 . . . . 0.0 109.721 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 78.3 mt -60.36 -43.67 96.32 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-N 120.086 1.312 . . . . 0.0 108.718 172.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -64.42 -47.23 79.92 Favored 'General case' 0 C--N 1.339 0.114 0 CA-C-O 119.212 -0.423 . . . . 0.0 110.323 176.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -63.18 -45.7 90.58 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.995 0.816 . . . . 0.0 111.091 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 73.2 mt -66.69 -37.23 84.31 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 118.815 0.734 . . . . 0.0 110.108 178.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -60.52 -41.06 93.64 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 119.194 0.906 . . . . 0.0 110.606 171.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -63.06 -40.89 99.02 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 118.707 0.685 . . . . 0.0 110.444 177.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -62.29 -41.57 98.61 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 119.472 1.033 . . . . 0.0 110.809 174.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.02 -45.34 95.18 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-N 118.623 0.647 . . . . 0.0 110.545 176.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -66.23 -35.55 80.71 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 119.072 -0.49 . . . . 0.0 111.044 177.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -81.64 -39.53 24.27 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.812 0.733 . . . . 0.0 111.748 -172.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -117.3 4.96 12.58 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.582 0.753 . . . . 0.0 112.855 -170.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 55.4 t30 65.54 1.32 1.66 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 127.141 2.177 . . . . 0.0 114.186 -178.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.7 pp -63.3 147.1 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 124.095 0.958 . . . . 0.0 111.079 -174.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -78.64 133.93 37.21 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.5 m -120.15 155.51 23.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 125.064 1.346 . . . . 0.0 108.396 173.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.94 92.57 2.68 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -169.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -92.43 93.98 8.87 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -175.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 5.9 m-90 -66.33 -46.31 77.29 Favored 'General case' 0 C--O 1.232 0.153 0 O-C-N 122.341 -0.224 . . . . 0.0 110.724 173.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.49 -50.14 3.14 Favored Glycine 0 CA--C 1.531 1.084 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -169.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.0 t70 . . . . . 0 C--O 1.249 1.037 0 C-N-CA 126.818 2.047 . . . . 0.0 108.259 169.52 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.252 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.8 m -143.91 164.8 29.53 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.124 1.37 . . . . 0.0 109.144 -177.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -177.71 177.95 48.37 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 30.1 tp60 -68.79 -27.97 66.36 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.265 0.626 . . . . 0.0 111.41 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.9 t -61.77 124.65 16.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 30.7 ptt-85 -160.58 -178.14 6.68 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.896 1.278 . . . . 0.0 108.704 -176.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.8 m -116.15 154.71 29.53 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 171.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 11.0 pt -120.99 174.98 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.985 1.314 . . . . 0.0 109.038 -171.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.9 68.31 0.88 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 175.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.8 m -122.33 166.04 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 177.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -169.25 -26.24 0.02 OUTLIER Glycine 0 CA--C 1.527 0.839 0 CA-C-N 115.623 -0.717 . . . . 0.0 113.879 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -157.95 38.61 0.53 Allowed Glycine 0 CA--C 1.527 0.798 0 C-N-CA 124.022 0.82 . . . . 0.0 111.274 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.5 p -68.33 159.72 79.31 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 123.806 0.842 . . . . 0.0 109.967 177.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -54.08 -41.73 73.05 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.783 2.322 . . . . 0.0 112.719 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -161.11 2.91 0.06 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.248 1.019 . . . . 0.0 112.692 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -68.95 -28.09 66.32 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 120.2 1.364 . . . . 0.0 110.501 -175.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.3 mt -51.18 -39.62 56.83 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 125.168 1.387 . . . . 0.0 109.755 169.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -71.43 -45.35 62.9 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-N 118.655 0.661 . . . . 0.0 109.46 -177.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.0 mmtt -64.0 -46.22 85.53 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -177.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 92.6 mt -73.08 -38.28 66.47 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 118.795 -0.621 . . . . 0.0 110.112 -176.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.9 tptt -59.84 -40.15 87.56 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.402 1.001 . . . . 0.0 110.848 170.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -63.7 -43.58 96.2 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 119.084 0.856 . . . . 0.0 110.077 176.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -60.7 -35.09 75.42 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 120.143 1.338 . . . . 0.0 111.686 177.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.78 -23.78 65.28 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.04 0.836 . . . . 0.0 112.099 173.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -104.84 -20.72 13.5 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.068 1.347 . . . . 0.0 111.776 -177.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -110.69 -20.34 12.55 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 119.324 0.965 . . . . 0.0 112.358 -173.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -129.97 0.06 4.75 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.231 1.412 . . . . 0.0 111.539 178.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 63.77 6.94 2.92 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 127.05 2.14 . . . . 0.0 114.316 177.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.3 pp -65.03 157.0 5.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 O-C-N 121.63 -0.668 . . . . 0.0 111.878 -171.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 96.9 mtt-85 -67.35 142.11 56.89 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 22.6 m -137.61 151.96 26.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 173.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.8 m -146.18 130.91 17.97 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -125.16 112.48 16.5 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -169.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 8.2 m-90 -78.29 158.31 28.93 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.889 0.876 . . . . 0.0 110.533 178.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -82.53 48.06 3.89 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 109.866 -1.293 . . . . 0.0 109.866 169.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.2 t70 . . . . . 0 C--O 1.247 0.935 0 C-N-CA 124.914 1.286 . . . . 0.0 111.363 -174.228 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.337 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.8 p -66.14 -29.5 69.81 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.353 1.061 . . . . 0.0 112.351 178.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 171.35 -168.46 41.59 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -71.02 25.06 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.481 1.513 . . . . 0.0 113.677 178.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.467 ' HA ' HG22 ' A' ' 29' ' ' ILE . 4.1 t -61.27 147.25 10.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 125.708 1.603 . . . . 0.0 110.111 -174.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -151.41 174.94 12.76 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 126.196 1.798 . . . . 0.0 108.69 -174.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.8 m -136.69 147.74 46.96 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 169.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.7 pt -126.68 163.5 28.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 123.638 0.775 . . . . 0.0 108.936 -169.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.28 40.77 0.87 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.669 0.788 . . . . 0.0 109.254 176.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 27.5 m -67.07 133.18 31.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 O-C-N 121.243 -0.91 . . . . 0.0 108.584 177.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.46 -52.58 42.13 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 171.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 160.12 41.91 0.02 OUTLIER Glycine 0 CA--C 1.526 0.763 0 CA-C-O 119.086 -0.841 . . . . 0.0 112.923 176.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.7 m -67.05 123.17 85.58 Favored Pre-proline 0 N--CA 1.454 -0.227 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 176.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -50.91 -34.77 47.0 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.274 1.983 . . . . 0.0 113.218 -178.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -74.48 -36.29 63.28 Favored 'General case' 0 N--CA 1.456 -0.148 0 O-C-N 122.121 -0.362 . . . . 0.0 110.161 -175.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -80.6 -35.88 33.52 Favored 'General case' 0 CA--C 1.521 -0.142 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -177.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 88.0 mt -56.62 -41.87 77.84 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 169.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -66.77 -56.45 10.44 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 118.544 0.611 . . . . 0.0 109.907 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -61.94 -45.35 94.05 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 118.495 0.589 . . . . 0.0 111.083 -175.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.4 mt -74.62 -35.08 62.92 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 118.517 -0.754 . . . . 0.0 110.382 -174.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.4 tptt -61.76 -39.87 93.16 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 119.935 1.243 . . . . 0.0 110.092 169.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -63.06 -39.14 93.84 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.95 0.795 . . . . 0.0 110.407 178.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -63.9 -40.43 96.49 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 119.866 1.212 . . . . 0.0 111.336 172.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.7 -23.99 66.89 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.048 0.84 . . . . 0.0 112.343 177.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 41.4 mtpt -84.35 -38.09 20.77 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.643 0.777 . . . . 0.0 110.11 172.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -70.47 -42.21 71.74 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.883 0.873 . . . . 0.0 110.426 -174.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -135.84 165.71 25.0 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.064 1.346 . . . . 0.0 109.738 -173.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -71.03 7.04 1.31 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.064 1.346 . . . . 0.0 113.535 -175.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.467 HG22 ' HA ' ' A' ' 5' ' ' VAL . 2.0 pp -64.42 154.66 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 124.294 1.038 . . . . 0.0 111.347 -171.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -89.95 152.15 21.35 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.014 0.435 . . . . 0.0 110.307 178.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.0 m -142.89 157.07 17.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 125.9 1.68 . . . . 0.0 107.568 174.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 32.2 m -149.41 133.53 17.23 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 173.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -121.76 110.45 15.94 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 -169.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -70.68 -32.7 70.05 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -170.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 64.49 39.9 97.23 Favored Glycine 0 CA--C 1.532 1.113 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -172.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.5 t70 . . . . . 0 C--O 1.248 0.989 0 C-N-CA 125.037 1.335 . . . . 0.0 111.298 -176.682 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.3 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.1 m -64.13 -24.67 67.78 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.219 1.008 . . . . 0.0 113.078 -176.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -178.68 -178.51 48.05 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 109.914 -1.275 . . . . 0.0 109.914 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -139.88 18.1 2.48 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.388 1.075 . . . . 0.0 111.699 -177.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.419 ' HA ' HG22 ' A' ' 29' ' ' ILE . 21.2 t -59.54 139.9 18.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 123.617 0.767 . . . . 0.0 109.583 -176.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 33.0 ptt85 -144.28 167.36 22.63 Favored 'General case' 0 C--O 1.231 0.1 0 C-N-CA 125.495 1.518 . . . . 0.0 107.691 175.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.3 m -126.99 153.57 45.73 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.409 HG12 ' H ' ' A' ' 32' ' ' THR . 10.5 pt -126.78 170.56 16.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 124.658 1.183 . . . . 0.0 108.163 -173.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.13 75.68 1.45 Allowed 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 -178.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.7 m -125.08 153.53 32.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 C-N-CA 123.434 0.694 . . . . 0.0 109.713 -173.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -81.68 33.34 2.58 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 124.477 1.037 . . . . 0.0 112.574 -177.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 54.81 39.01 66.04 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-N 118.084 0.942 . . . . 0.0 111.428 -172.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -60.59 126.69 85.51 Favored Pre-proline 0 N--CA 1.451 -0.414 0 C-N-CA 125.038 1.335 . . . . 0.0 109.459 -169.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -53.59 -23.24 24.84 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.187 2.591 . . . . 0.0 113.91 173.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -92.37 -4.18 54.22 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.246 1.018 . . . . 0.0 111.878 -177.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -117.45 -36.69 3.66 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 123.763 0.825 . . . . 0.0 109.424 -178.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 28.4 mt -47.05 -34.65 6.01 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.523 1.129 . . . . 0.0 111.481 169.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.4 mttp -56.62 -25.66 53.76 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -118.53 -38.56 3.12 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 118.97 0.804 . . . . 0.0 110.303 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -68.39 -41.07 81.04 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-N 118.468 0.576 . . . . 0.0 111.277 -175.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 48.9 tptt -68.92 -34.74 75.88 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 118.499 0.591 . . . . 0.0 110.092 176.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -63.62 -45.39 90.52 Favored 'General case' 0 C--O 1.222 -0.367 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 175.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -60.1 -41.6 92.86 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 119.287 0.949 . . . . 0.0 110.516 178.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.13 -2.59 4.34 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.485 1.114 . . . . 0.0 113.829 176.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -121.72 -27.4 4.7 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.226 1.41 . . . . 0.0 110.308 175.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -70.41 -39.94 74.14 Favored 'General case' 0 C--N 1.338 0.107 0 C-N-CA 124.109 0.963 . . . . 0.0 109.343 175.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -122.84 166.58 14.76 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.729 1.211 . . . . 0.0 109.195 178.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -73.23 -1.31 17.25 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.632 1.173 . . . . 0.0 113.014 -178.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.419 HG22 ' HA ' ' A' ' 5' ' ' VAL . 2.2 pp -61.39 162.61 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 124.669 1.188 . . . . 0.0 110.83 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.48 147.66 52.57 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.0 m -127.07 167.54 21.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 124.853 1.261 . . . . 0.0 110.173 -169.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.409 ' H ' HG12 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -129.69 125.19 35.4 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.277 1.431 . . . . 0.0 108.657 -169.727 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -128.56 94.83 3.97 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 -175.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -71.75 -24.7 61.82 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -171.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.16 25.75 68.54 Favored Glycine 0 CA--C 1.537 1.465 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 -169.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.5 t70 . . . . . 0 C--O 1.249 1.038 0 C-N-CA 125.394 1.478 . . . . 0.0 111.48 -177.439 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.293 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.2 m -143.48 161.01 39.54 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.173 1.389 . . . . 0.0 109.048 -177.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -151.34 23.99 0.97 Allowed Glycine 0 CA--C 1.529 0.924 0 C-N-CA 123.636 0.636 . . . . 0.0 112.71 -175.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -61.77 149.4 40.02 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 117.946 0.873 . . . . 0.0 108.77 171.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.9 t -138.51 135.64 43.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 172.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 36.9 mtp180 -144.64 160.6 40.92 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 129.171 2.989 . . . . 0.0 104.146 170.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.5 m -139.84 151.84 46.01 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 169.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.469 HG12 ' H ' ' A' ' 32' ' ' THR . 2.5 pt -127.2 165.89 25.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.216 1.006 . . . . 0.0 109.007 -169.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -142.91 40.85 1.53 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.804 0.842 . . . . 0.0 109.593 -178.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 34.6 m -69.25 144.1 14.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 O-C-N 121.425 -0.797 . . . . 0.0 109.365 178.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -166.48 30.93 0.2 Allowed Glycine 0 CA--C 1.528 0.878 0 C-N-CA 123.573 0.606 . . . . 0.0 112.591 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -176.32 27.02 0.07 OUTLIER Glycine 0 CA--C 1.529 0.911 0 CA-C-N 117.705 0.753 . . . . 0.0 112.644 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.0 p -143.83 59.68 7.45 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 125.304 1.442 . . . . 0.0 108.226 -169.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -62.42 -26.05 76.44 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.6 2.2 . . . . 0.0 113.11 -169.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -71.27 -30.82 66.75 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.454 0.57 . . . . 0.0 110.96 177.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -75.64 -19.4 59.22 Favored 'General case' 0 N--CA 1.462 0.144 0 O-C-N 121.262 -0.899 . . . . 0.0 111.358 -176.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.0 mt -52.54 -31.21 34.55 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.116 0.966 . . . . 0.0 110.613 169.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 42.0 mtmt -62.66 -32.23 73.26 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 118.837 0.744 . . . . 0.0 111.444 177.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -85.39 -48.89 8.58 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 177.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -64.66 -40.84 96.13 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.309 0.644 . . . . 0.0 111.478 -170.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -64.7 -31.46 72.69 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 119.012 -0.518 . . . . 0.0 111.14 175.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -68.82 -46.58 68.21 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 118.921 0.782 . . . . 0.0 109.1 174.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -59.07 -37.75 77.82 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 119.451 1.023 . . . . 0.0 111.062 177.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.25 -13.89 21.96 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.253 1.021 . . . . 0.0 113.572 176.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -117.38 -30.49 5.55 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 125.052 1.341 . . . . 0.0 110.291 -179.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -77.66 -24.32 49.44 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 123.967 0.907 . . . . 0.0 111.109 177.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -138.83 168.72 19.19 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.69 1.196 . . . . 0.0 110.303 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -71.78 -10.35 59.64 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.423 1.489 . . . . 0.0 113.359 -177.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.8 pp -58.15 151.32 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 124.458 1.103 . . . . 0.0 113.547 -169.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 43.7 ttm105 -83.67 150.16 26.04 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 174.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.6 m -135.85 149.06 27.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 107.273 -1.381 . . . . 0.0 107.273 169.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.469 ' H ' HG12 ' A' ' 8' ' ' ILE . 2.6 m -144.66 139.75 28.2 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 178.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -131.12 118.26 20.26 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 -169.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 12.9 m-90 -95.82 151.24 19.57 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 122.907 0.483 . . . . 0.0 109.955 173.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -72.96 -41.77 47.34 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 108.928 -1.669 . . . . 0.0 108.928 169.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.3 t70 . . . . . 0 C--O 1.246 0.907 0 C-N-CA 126.996 2.119 . . . . 0.0 107.719 169.889 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.387 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.9 m -64.18 -23.96 67.51 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.229 1.011 . . . . 0.0 113.157 -176.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -177.27 179.9 47.86 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 109.859 -1.297 . . . . 0.0 109.859 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -155.07 164.17 39.25 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.983 1.313 . . . . 0.0 109.047 177.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.4 p -143.74 127.53 13.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 106.314 -1.736 . . . . 0.0 106.314 169.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.75 170.31 18.56 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.595 1.558 . . . . 0.0 108.336 177.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.3 m -97.85 161.53 13.7 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 169.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.7 pt -120.2 174.37 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 125.127 1.371 . . . . 0.0 108.041 -179.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.51 88.15 1.69 Allowed 'General case' 0 C--O 1.232 0.173 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 169.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.7 p -134.02 155.76 40.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -171.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -175.91 -65.68 0.06 OUTLIER Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.782 -0.527 . . . . 0.0 111.782 170.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -83.0 39.15 2.73 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 124.341 0.972 . . . . 0.0 112.398 -174.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.1 p -148.36 71.44 10.89 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 126.617 1.967 . . . . 0.0 106.07 -169.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -52.61 -34.78 64.84 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 123.045 2.497 . . . . 0.0 114.128 -169.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -66.49 -36.9 83.88 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.938 0.399 . . . . 0.0 110.211 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -76.2 -25.27 54.99 Favored 'General case' 0 N--CA 1.454 -0.236 0 O-C-N 121.719 -0.613 . . . . 0.0 110.52 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 91.2 mt -61.27 -37.81 84.48 Favored 'General case' 0 C--O 1.227 -0.127 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 169.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -70.96 -49.85 40.92 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 119.083 0.856 . . . . 0.0 109.47 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -59.43 -48.19 82.61 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 117.834 0.288 . . . . 0.0 110.6 -178.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.0 mt -74.58 -33.75 62.73 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 118.356 -0.83 . . . . 0.0 110.296 -175.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -61.13 -37.95 84.64 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 120.102 1.319 . . . . 0.0 110.464 169.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -62.7 -45.73 91.43 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 119.788 1.176 . . . . 0.0 109.406 175.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -59.12 -28.68 66.76 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 118.818 -0.61 . . . . 0.0 112.304 175.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.33 -21.57 64.11 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.363 0.983 . . . . 0.0 112.771 175.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.41 -33.06 10.15 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 118.548 0.613 . . . . 0.0 110.454 169.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -67.46 -29.37 68.81 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 118.842 0.746 . . . . 0.0 111.08 -175.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -140.62 179.82 6.47 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.823 1.649 . . . . 0.0 109.775 -174.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -91.85 11.39 25.01 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.911 1.284 . . . . 0.0 112.105 -173.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.8 pt -61.97 156.02 4.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 124.423 1.089 . . . . 0.0 112.131 -171.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.1 ptm180 -107.12 74.77 0.99 Allowed 'General case' 0 C--O 1.235 0.319 0 C-N-CA 123.901 0.881 . . . . 0.0 109.263 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 29.8 m -54.5 139.57 13.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.056 178.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.9 m -142.87 119.91 11.38 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 104.562 -2.385 . . . . 0.0 104.562 -175.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -114.58 111.04 20.73 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -169.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 9.7 m-90 -80.07 154.52 28.07 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.144 0.578 . . . . 0.0 110.037 175.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -86.81 40.09 3.08 Favored Glycine 0 CA--C 1.532 1.121 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 169.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.3 t70 . . . . . 0 C--O 1.248 0.999 0 C-N-CA 125.129 1.372 . . . . 0.0 111.192 -173.89 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.358 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.9 m -143.79 164.39 30.64 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.078 1.351 . . . . 0.0 109.26 -177.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -178.97 179.82 48.82 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 178.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -66.54 -35.66 80.78 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.093 0.557 . . . . 0.0 110.951 178.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.9 p -61.63 147.35 11.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 123.743 0.817 . . . . 0.0 110.648 -177.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -148.1 171.4 15.93 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 125.348 1.459 . . . . 0.0 109.263 -175.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.3 m -134.51 153.85 51.73 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 171.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.409 HG12 ' H ' ' A' ' 32' ' ' THR . 7.7 pt -129.3 167.51 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 125.713 1.605 . . . . 0.0 107.755 -175.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.31 39.56 0.91 Allowed 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.533 0.683 . . . . 0.0 110.603 175.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 28.3 m -69.03 144.87 13.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 O-C-N 121.289 -0.882 . . . . 0.0 109.866 176.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -172.1 147.6 10.15 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 106.632 -2.587 . . . . 0.0 106.632 172.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 55.06 24.58 35.77 Favored Glycine 0 CA--C 1.537 1.451 0 CA-C-N 117.797 0.799 . . . . 0.0 113.422 -170.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -140.63 61.12 14.98 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 125.289 1.436 . . . . 0.0 109.711 -171.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -62.27 -23.81 75.56 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.517 2.145 . . . . 0.0 112.711 -175.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -67.36 -19.22 65.4 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.033 0.933 . . . . 0.0 112.271 176.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -90.19 -26.14 20.27 Favored 'General case' 0 N--CA 1.465 0.275 0 O-C-N 121.392 -0.817 . . . . 0.0 110.174 -178.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 59.0 mt -55.05 -30.06 58.8 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 169.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -64.68 -23.71 67.34 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 119.051 -0.499 . . . . 0.0 112.041 -177.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -99.76 -45.6 5.69 Favored 'General case' 0 C--N 1.34 0.156 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 176.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 83.5 mt -72.4 -29.89 64.15 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 118.648 -0.691 . . . . 0.0 111.702 -169.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 27.0 mmtp -62.98 -38.35 90.79 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 119.578 1.081 . . . . 0.0 110.43 169.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -63.93 -45.99 86.77 Favored 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -59.82 -42.47 93.6 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.432 1.015 . . . . 0.0 111.036 177.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.91 -6.15 11.5 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.387 1.075 . . . . 0.0 113.889 177.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -121.57 -25.05 5.2 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.068 1.347 . . . . 0.0 110.052 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -70.15 -40.46 74.75 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 125.054 1.342 . . . . 0.0 108.837 172.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -134.97 166.23 23.51 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.714 1.206 . . . . 0.0 109.236 175.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -76.2 10.36 2.02 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.796 1.239 . . . . 0.0 112.954 -176.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.4 pp -62.17 153.4 6.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-O 122.093 0.949 . . . . 0.0 112.667 -169.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.93 144.26 47.38 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 124.14 0.976 . . . . 0.0 109.329 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.5 m -143.56 152.59 16.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 125.955 1.702 . . . . 0.0 106.497 169.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.409 ' H ' HG12 ' A' ' 8' ' ' ILE . 27.5 m -143.84 133.42 23.56 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 173.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -120.67 102.19 8.24 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -169.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 24.3 m-90 -75.87 155.19 35.52 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 171.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -66.88 -49.66 52.96 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 108.285 -1.926 . . . . 0.0 108.285 169.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.3 t70 . . . . . 0 C--O 1.246 0.881 0 C-N-CA 126.871 2.069 . . . . 0.0 107.797 169.919 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.253 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.4 m -59.04 149.87 26.38 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.275 1.03 . . . . 0.0 111.309 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 177.09 -172.41 45.32 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.0 tp60 64.51 -9.74 0.17 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 127.329 2.252 . . . . 0.0 115.268 174.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 32.6 m -52.12 141.85 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 120.112 1.324 . . . . 0.0 111.652 -175.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 69.9 mtm-85 -124.75 -31.69 3.16 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 118.487 -0.768 . . . . 0.0 112.951 176.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.4 m 64.61 151.84 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.032 1.333 . . . . 0.0 110.056 -169.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.0 pt -135.2 172.53 15.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 125.029 1.332 . . . . 0.0 108.615 -169.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.2 37.17 0.54 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.233 0.613 . . . . 0.0 110.962 177.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.406 HG11 HD12 ' A' ' 20' ' ' LEU . 18.1 m -67.33 153.44 8.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 O-C-N 121.069 -1.019 . . . . 0.0 112.47 -174.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 174.64 139.54 3.03 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 108.512 -1.835 . . . . 0.0 108.512 176.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 64.11 29.36 74.71 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-N 117.181 0.491 . . . . 0.0 111.92 -172.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.4 p -141.25 65.23 21.47 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 125.462 1.505 . . . . 0.0 108.286 -172.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.15 -23.89 31.15 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 124.078 3.185 . . . . 0.0 115.841 -169.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -102.41 -11.59 18.5 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.783 0.833 . . . . 0.0 111.429 -173.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -88.77 -40.39 13.24 Favored 'General case' 0 CA--C 1.519 -0.225 0 O-C-N 121.103 -0.998 . . . . 0.0 108.583 -176.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.4 pp -57.28 -25.69 59.64 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-O 118.535 -0.745 . . . . 0.0 110.989 169.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -73.09 -45.89 54.54 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.337 0.971 . . . . 0.0 110.023 177.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -63.21 -43.71 97.36 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 177.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.406 HD12 HG11 ' A' ' 10' ' ' VAL . 96.1 mt -68.64 -38.78 80.75 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 118.78 -0.628 . . . . 0.0 110.296 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -58.86 -41.5 87.15 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.579 1.081 . . . . 0.0 110.726 171.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -61.3 -41.98 97.89 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.9 0.773 . . . . 0.0 110.041 176.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -62.72 -38.53 90.83 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 119.419 1.009 . . . . 0.0 111.802 174.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.86 -30.83 71.88 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.972 0.806 . . . . 0.0 111.561 177.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -80.21 -35.85 35.65 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.222 0.609 . . . . 0.0 110.216 174.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -76.84 -40.63 47.1 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 118.574 0.625 . . . . 0.0 111.174 -173.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -132.08 175.14 9.49 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.835 1.254 . . . . 0.0 111.13 -169.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -65.35 -17.7 64.73 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.819 1.248 . . . . 0.0 113.541 -177.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.0 pp -55.79 144.89 6.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 123.9 0.88 . . . . 0.0 112.759 -169.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 8.4 ptm85 -83.9 161.58 20.8 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 121.181 0.515 . . . . 0.0 109.845 171.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.8 m -140.3 156.07 23.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 125.24 1.416 . . . . 0.0 108.158 171.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.2 m -144.59 124.06 13.15 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 -177.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -119.19 83.89 2.11 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.223 0.609 . . . . 0.0 109.751 -169.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 13.5 m-90 -64.28 -42.68 96.3 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.46 173.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 65.3 29.35 75.06 Favored Glycine 0 CA--C 1.535 1.333 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 -169.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.9 t70 . . . . . 0 C--O 1.248 1.008 0 C-N-CA 125.075 1.35 . . . . 0.0 111.581 -175.388 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.351 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.8 m -57.18 -26.06 59.99 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.779 1.231 . . . . 0.0 113.62 -173.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -59.53 -19.64 48.75 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 123.879 0.752 . . . . 0.0 113.562 176.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 18.9 tp60 -66.19 -27.42 67.98 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.691 1.246 . . . . 0.0 111.784 175.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.0 t -63.57 138.99 22.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -149.27 174.35 12.5 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 124.909 1.284 . . . . 0.0 109.816 -174.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.9 m -108.15 160.3 15.92 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.563 1.545 . . . . 0.0 108.426 172.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.411 HG12 ' H ' ' A' ' 32' ' ' THR . 4.8 pt -131.95 163.66 36.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 169.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.78 73.18 1.33 Allowed 'General case' 0 C--O 1.233 0.21 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 175.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.3 m -125.52 162.13 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 121.876 0.846 . . . . 0.0 111.624 -173.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -176.71 165.58 35.88 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 126.12 1.819 . . . . 0.0 108.953 171.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 57.75 19.87 37.59 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 124.324 0.964 . . . . 0.0 114.7 173.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.2 m -140.74 73.01 29.03 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 118.325 1.062 . . . . 0.0 108.997 -171.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -44.02 -34.91 6.89 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.706 2.937 . . . . 0.0 113.644 173.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 51.3 mp0 -66.52 -9.68 37.13 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.43 1.892 . . . . 0.0 112.589 -176.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -130.15 -44.73 1.14 Allowed 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 125.219 1.408 . . . . 0.0 108.786 -178.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.1 pp -68.2 -27.23 66.21 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 119.888 1.222 . . . . 0.0 111.439 -175.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -68.0 -39.15 83.26 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 120.122 1.328 . . . . 0.0 110.417 171.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -68.63 -42.33 78.19 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 118.616 0.644 . . . . 0.0 109.736 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 79.3 mt -69.46 -34.82 74.94 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.458 0.572 . . . . 0.0 110.509 177.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -61.08 -42.8 99.18 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 119.285 0.948 . . . . 0.0 110.563 169.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -62.32 -38.19 88.46 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.76 0.709 . . . . 0.0 110.101 176.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -62.23 -41.71 98.65 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.174 0.99 . . . . 0.0 110.586 176.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.13 -45.76 91.91 Favored 'General case' 0 C--N 1.338 0.089 0 C-N-CA 122.869 0.467 . . . . 0.0 110.481 174.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -66.06 -32.77 74.44 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 119.038 -0.506 . . . . 0.0 111.161 177.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.2 ttpt -81.16 -49.19 11.12 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 118.955 0.798 . . . . 0.0 110.823 -173.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.99 7.33 21.55 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.137 0.975 . . . . 0.0 112.999 -169.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 54.5 t30 65.58 1.66 1.79 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.913 2.085 . . . . 0.0 114.094 -178.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.6 pp -63.23 147.49 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 121.626 0.727 . . . . 0.0 111.368 -172.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 43.1 ptt85 -67.59 149.41 50.12 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.572 175.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.6 m -144.08 152.8 15.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 125.323 1.449 . . . . 0.0 107.769 176.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.411 ' H ' HG12 ' A' ' 8' ' ' ILE . 10.9 m -140.85 127.29 19.95 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -178.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -121.05 102.09 8.1 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -170.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 1.9 m-90 -70.87 -34.45 71.63 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 123.558 0.743 . . . . 0.0 112.441 -175.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.16 27.26 72.81 Favored Glycine 0 CA--C 1.535 1.324 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 -169.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 22.8 t70 . . . . . 0 C--O 1.25 1.096 0 C-N-CA 125.083 1.353 . . . . 0.0 111.25 -177.759 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.288 0 N-CA-C 111.707 -0.557 . . . . 0.0 111.707 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.9 p -66.74 -30.48 70.71 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.406 1.082 . . . . 0.0 112.287 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 70.04 -160.03 53.34 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 -177.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.6 pm0 -68.55 1.4 3.15 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.644 1.578 . . . . 0.0 114.676 -173.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.9 p -55.51 145.62 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 124.134 0.974 . . . . 0.0 111.372 -177.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 40.4 ptt85 -147.81 174.8 11.48 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 125.19 1.396 . . . . 0.0 108.438 171.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 92.5 m -123.7 155.17 38.31 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 174.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.8 pt -128.41 172.75 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.865 1.666 . . . . 0.0 108.266 -169.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.63 35.67 0.71 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 118.505 0.593 . . . . 0.0 111.639 174.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.0 m -67.63 146.09 13.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 O-C-N 121.165 -0.959 . . . . 0.0 109.244 177.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -88.41 39.12 3.13 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.164 0.888 . . . . 0.0 110.913 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 54.81 33.12 55.71 Favored Glycine 0 CA--C 1.533 1.188 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 -169.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.14 125.37 85.27 Favored Pre-proline 0 N--CA 1.448 -0.53 0 C-N-CA 125.66 1.584 . . . . 0.0 110.078 -169.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -56.14 -15.41 14.14 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.621 2.881 . . . . 0.0 114.986 174.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -94.14 -15.72 24.41 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.574 1.15 . . . . 0.0 111.561 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -116.48 -35.42 4.27 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 121.44 -0.787 . . . . 0.0 111.043 -169.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 76.1 mt -51.51 -30.89 21.83 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.654 0.661 . . . . 0.0 110.97 170.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -58.0 -23.28 53.38 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 125.035 1.334 . . . . 0.0 112.835 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -113.2 -41.48 3.69 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 123.761 0.824 . . . . 0.0 109.537 176.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -64.32 -40.4 95.84 Favored 'General case' 0 N--CA 1.457 -0.088 0 C-N-CA 122.924 0.49 . . . . 0.0 112.023 -174.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -66.48 -37.64 85.55 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 118.86 0.754 . . . . 0.0 110.12 178.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -63.66 -47.63 80.49 Favored 'General case' 0 C--O 1.225 -0.217 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 175.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -59.6 -40.25 86.88 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.109 0.964 . . . . 0.0 111.051 -179.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.99 -43.61 70.13 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 124.172 0.989 . . . . 0.0 110.955 177.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -82.12 -34.24 29.31 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 119.302 -0.38 . . . . 0.0 111.151 177.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -71.29 -39.97 71.16 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 118.614 0.643 . . . . 0.0 110.717 -170.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -119.05 6.98 11.3 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.763 0.825 . . . . 0.0 112.082 -172.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 55.7 t30 62.39 1.01 0.67 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 127.07 2.148 . . . . 0.0 114.602 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.7 pp -62.56 152.95 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.517 1.127 . . . . 0.0 111.497 -174.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.07 152.1 44.34 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 172.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.8 m -141.22 149.17 20.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 169.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.5 m -143.18 132.82 23.74 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -122.78 105.19 9.82 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -169.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 13.6 m-90 -79.81 153.37 29.18 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 122.45 0.3 . . . . 0.0 110.396 -177.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -84.62 43.87 3.28 Favored Glycine 0 CA--C 1.532 1.107 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 169.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.0 t70 . . . . . 0 C--O 1.248 0.982 0 C-N-CA 125.066 1.346 . . . . 0.0 111.251 -173.478 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.341 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.6 m -60.39 154.76 19.63 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.262 1.025 . . . . 0.0 111.401 178.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 178.22 -178.21 48.52 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 179.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 41.3 tp60 -65.65 -33.51 76.07 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 122.961 0.504 . . . . 0.0 110.83 177.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -61.63 123.5 14.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 C-N-CA 123.62 0.768 . . . . 0.0 109.422 176.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 29.4 ptt-85 -161.29 158.49 27.21 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 123.981 0.912 . . . . 0.0 109.005 -175.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.8 m -82.31 158.85 23.28 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 169.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.4 pt -125.99 168.42 18.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 125.141 1.376 . . . . 0.0 108.432 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.13 49.1 1.27 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.939 0.876 . . . . 0.0 110.118 176.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.1 t -60.38 134.08 25.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 169.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -147.92 -26.94 0.07 OUTLIER Glycine 0 CA--C 1.524 0.6 0 CA-C-O 119.482 -0.621 . . . . 0.0 114.175 -172.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -166.21 44.55 0.27 Allowed Glycine 0 CA--C 1.523 0.566 0 N-CA-C 108.249 -1.94 . . . . 0.0 108.249 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -138.58 78.03 32.68 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 125.663 1.585 . . . . 0.0 108.15 -168.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -63.16 -21.66 72.54 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 121.906 1.738 . . . . 0.0 112.093 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -66.53 -20.18 65.96 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.572 -0.705 . . . . 0.0 111.641 173.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -90.05 -38.15 13.78 Favored 'General case' 0 C--N 1.338 0.099 0 O-C-N 121.629 -0.669 . . . . 0.0 109.599 174.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.3 mt -55.59 -32.52 63.15 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.23 0.923 . . . . 0.0 110.433 169.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -64.48 -21.8 66.77 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.205 1.002 . . . . 0.0 112.499 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -126.91 -45.35 1.59 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 119.247 0.93 . . . . 0.0 111.969 -169.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 32.4 mt -70.85 -30.52 66.95 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 121.504 -0.747 . . . . 0.0 110.749 -174.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -62.31 -37.61 86.24 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.059 0.845 . . . . 0.0 111.003 170.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -68.23 -41.45 81.21 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 175.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -60.37 -37.42 80.69 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 121.387 -0.821 . . . . 0.0 111.317 178.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.99 -11.81 9.37 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.692 1.197 . . . . 0.0 113.707 174.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -118.18 -26.64 6.28 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.476 1.51 . . . . 0.0 109.75 -179.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -71.3 -37.8 71.81 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 123.623 0.769 . . . . 0.0 109.731 173.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -134.93 169.24 17.7 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 125.416 1.486 . . . . 0.0 109.249 -178.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -75.94 -1.46 25.67 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.37 1.068 . . . . 0.0 113.043 -176.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.3 pp -58.67 147.29 7.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 123.946 0.898 . . . . 0.0 111.638 -171.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 31.8 ptt-85 -75.06 153.61 38.32 Favored 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 123.142 0.577 . . . . 0.0 109.684 174.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.6 m -141.19 155.03 20.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 124.971 1.309 . . . . 0.0 107.647 171.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.0 m -149.38 141.17 23.64 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 173.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -130.32 110.45 11.53 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -169.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 18.4 m-90 -85.51 170.36 12.72 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.946 0.898 . . . . 0.0 109.778 172.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -130.57 65.45 0.59 Allowed Glycine 0 CA--C 1.524 0.602 0 N-CA-C 105.883 -2.887 . . . . 0.0 105.883 171.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.4 t70 . . . . . 0 C--O 1.247 0.962 0 C-N-CA 125.256 1.423 . . . . 0.0 111.582 -169.855 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.306 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.4 p -66.88 -28.75 68.58 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.099 0.96 . . . . 0.0 112.337 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 56.71 41.93 90.69 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 123.886 0.755 . . . . 0.0 111.832 -178.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 51.21 20.93 0.98 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 127.827 2.451 . . . . 0.0 115.291 -177.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.2 p -45.93 134.74 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 125.412 1.485 . . . . 0.0 113.464 -171.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -160.22 179.22 8.88 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 126.581 1.952 . . . . 0.0 108.566 177.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.9 m -123.63 156.88 35.0 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 126.33 1.852 . . . . 0.0 107.196 175.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.438 HG12 ' H ' ' A' ' 32' ' ' THR . 4.3 pt -118.5 167.42 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.671 1.189 . . . . 0.0 108.835 -174.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -147.0 69.85 1.18 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 174.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.5 m -118.31 158.09 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 122.999 0.52 . . . . 0.0 110.158 -177.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 173.97 150.14 7.44 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 108.291 -1.924 . . . . 0.0 108.291 178.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 61.78 31.02 76.66 Favored Glycine 0 CA--C 1.534 1.279 0 N-CA-C 111.77 -0.532 . . . . 0.0 111.77 -171.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.0 p -138.0 58.39 15.52 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 125.703 1.601 . . . . 0.0 108.995 -169.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -62.66 -20.42 70.87 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.027 2.485 . . . . 0.0 113.316 -169.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -87.91 -4.3 58.85 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.501 0.72 . . . . 0.0 112.155 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -127.69 -34.44 2.2 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.572 0.749 . . . . 0.0 110.692 -173.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.6 pp -62.31 -25.26 67.77 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-O 118.129 -0.938 . . . . 0.0 110.62 169.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.0 ptpp? -68.42 -37.67 80.51 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 119.987 1.267 . . . . 0.0 111.299 171.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -69.86 -43.45 71.86 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 72.3 mt -69.55 -34.08 73.69 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 118.986 -0.531 . . . . 0.0 110.546 177.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -62.32 -39.43 93.01 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.583 1.083 . . . . 0.0 111.297 171.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -59.9 -46.85 88.02 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.696 1.135 . . . . 0.0 109.141 172.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -57.25 -33.32 67.47 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.565 1.146 . . . . 0.0 111.517 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.77 -23.45 66.2 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.129 0.972 . . . . 0.0 112.771 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.36 -31.62 11.24 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 123.018 0.527 . . . . 0.0 110.28 171.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.2 ttmt -66.5 -36.43 82.7 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 118.602 0.637 . . . . 0.0 111.342 -176.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -134.82 176.22 8.84 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.743 1.217 . . . . 0.0 111.06 -169.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -80.32 1.76 27.44 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.68 1.192 . . . . 0.0 112.216 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.1 pp -59.98 158.86 1.94 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 124.0 0.92 . . . . 0.0 110.352 177.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -116.98 154.44 30.89 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 172.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 29.0 m -128.94 147.99 33.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 123.316 0.647 . . . . 0.0 110.14 -175.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.438 ' H ' HG12 ' A' ' 8' ' ' ILE . 16.0 m -144.76 131.23 19.8 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 176.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -123.51 110.23 14.8 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -169.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 11.3 m-90 -74.09 158.54 34.07 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.862 0.865 . . . . 0.0 109.652 172.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -65.57 -44.59 92.53 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 108.802 -1.719 . . . . 0.0 108.802 169.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.5 t70 . . . . . 0 C--O 1.246 0.887 0 C-N-CA 127.111 2.164 . . . . 0.0 107.676 169.806 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.299 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.2 m -143.57 162.94 34.57 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.1 1.36 . . . . 0.0 109.198 -177.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 177.91 -178.31 48.45 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.07 24.3 2.35 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.176 0.99 . . . . 0.0 111.566 -178.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.5 t -64.92 132.16 30.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 33.5 ptt-85 -155.74 157.07 35.96 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 124.386 1.074 . . . . 0.0 108.508 171.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.8 m -81.37 160.1 24.19 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 169.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.407 HG12 ' H ' ' A' ' 32' ' ' THR . 7.9 pt -122.66 167.45 16.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 125.0 1.32 . . . . 0.0 108.993 177.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.19 45.5 1.15 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 122.213 1.006 . . . . 0.0 108.503 170.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.2 p -70.72 144.02 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 O-C-N 121.444 -0.785 . . . . 0.0 110.737 -170.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -175.98 159.15 26.42 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 172.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 58.02 18.89 35.58 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.355 0.979 . . . . 0.0 113.915 -176.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.5 p -144.66 71.9 15.45 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 125.282 1.433 . . . . 0.0 108.178 -169.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -60.45 -24.02 76.7 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.296 1.997 . . . . 0.0 112.848 -176.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.5 mp0 -62.36 -39.52 93.44 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.602 0.761 . . . . 0.0 109.678 173.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -79.04 -24.14 43.8 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 121.476 -0.765 . . . . 0.0 110.775 -178.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.6 mt -60.92 -38.49 85.96 Favored 'General case' 0 CA--C 1.526 0.052 0 CA-C-N 119.65 1.114 . . . . 0.0 108.027 169.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -72.54 -49.46 32.53 Favored 'General case' 0 C--N 1.341 0.223 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -60.92 -45.94 92.67 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 118.596 0.635 . . . . 0.0 111.04 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 94.4 mt -72.93 -33.99 66.29 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 118.5 -0.762 . . . . 0.0 110.103 -177.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -60.99 -40.33 93.11 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.937 1.244 . . . . 0.0 110.315 169.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -62.11 -41.39 98.18 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.668 0.667 . . . . 0.0 109.941 177.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -63.45 -40.26 96.67 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 119.35 0.977 . . . . 0.0 111.628 175.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.8 -42.89 98.49 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 118.784 0.72 . . . . 0.0 110.404 176.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 42.2 mtpt -67.08 -37.28 83.72 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.979 -0.45 . . . . 0.0 110.941 175.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 66.3 tttm -80.44 -40.51 26.19 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 118.674 0.67 . . . . 0.0 111.851 -169.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -130.5 10.26 5.2 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.947 0.899 . . . . 0.0 113.076 -169.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 64.04 7.8 3.6 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.133 1.773 . . . . 0.0 114.05 177.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.5 pp -64.2 155.83 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 121.96 0.886 . . . . 0.0 112.551 -169.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 28.1 ttp-105 -62.44 134.25 56.17 Favored 'General case' 0 CA--C 1.527 0.073 0 C-N-CA 124.361 1.064 . . . . 0.0 109.28 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.6 m -139.56 144.29 29.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 172.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.407 ' H ' HG12 ' A' ' 8' ' ' ILE . 18.2 m -140.2 110.24 6.51 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 178.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -99.56 84.86 3.02 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.48 0.712 . . . . 0.0 109.993 -169.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 14.0 m-90 -64.65 -47.86 76.93 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.32 169.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.91 -12.51 42.2 Favored Glycine 0 CA--C 1.536 1.364 0 CA-C-O 118.923 -0.931 . . . . 0.0 113.003 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.2 t0 . . . . . 0 C--O 1.248 0.996 0 C-N-CA 127.508 2.323 . . . . 0.0 112.123 -171.463 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.319 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.6 m -62.6 -30.44 71.34 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.302 1.041 . . . . 0.0 112.914 -175.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 151.45 -29.75 0.95 Allowed Glycine 0 CA--C 1.529 0.926 0 C-N-CA 124.568 1.08 . . . . 0.0 111.583 178.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -150.77 154.35 37.17 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 126.06 1.744 . . . . 0.0 107.028 176.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.0 p -151.27 152.6 11.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 169.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 71.6 mtt180 -140.67 177.19 8.2 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 125.309 1.444 . . . . 0.0 108.169 -177.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.0 m -144.08 149.13 36.11 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 169.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.3 pt -135.15 171.79 17.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 124.932 1.293 . . . . 0.0 108.406 -175.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.58 43.01 1.18 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.867 0.841 . . . . 0.0 109.826 176.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.9 p -73.37 148.47 8.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 O-C-N 121.437 -0.789 . . . . 0.0 109.804 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -173.39 166.89 39.43 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 108.378 -1.889 . . . . 0.0 108.378 169.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 54.5 21.26 20.11 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.069 1.319 . . . . 0.0 114.974 176.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.7 m -145.94 75.32 13.05 Favored Pre-proline 0 CA--C 1.538 0.497 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 -169.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -50.01 -34.52 38.2 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.434 2.756 . . . . 0.0 113.639 -177.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -68.25 -41.64 80.85 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.906 0.384 . . . . 0.0 110.15 -176.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -74.72 -36.18 62.68 Favored 'General case' 0 N--CA 1.436 -1.131 0 O-C-N 121.215 -0.928 . . . . 0.0 109.429 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.3 mt -57.26 -38.43 73.84 Favored 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 123.806 0.843 . . . . 0.0 109.721 172.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 43.1 mtpt -68.13 -49.13 63.08 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 118.741 0.7 . . . . 0.0 109.855 176.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -60.8 -43.82 97.66 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 118.797 0.726 . . . . 0.0 110.954 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 69.0 mt -74.64 -31.68 62.03 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 118.552 -0.737 . . . . 0.0 110.599 -178.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -62.07 -41.58 98.31 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.815 1.189 . . . . 0.0 110.254 169.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -63.38 -42.92 98.86 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.638 0.654 . . . . 0.0 109.617 176.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.0 tp10 -60.23 -39.26 86.04 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.055 -1.028 . . . . 0.0 111.037 176.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.14 -3.1 6.67 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.827 1.251 . . . . 0.0 113.798 174.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -118.2 -25.54 6.59 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.23 1.412 . . . . 0.0 110.036 174.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.4 ttpt -68.45 -41.6 80.02 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 123.791 0.836 . . . . 0.0 108.905 172.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -132.49 161.25 34.21 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.193 1.397 . . . . 0.0 109.205 175.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -74.31 -7.08 51.59 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.016 0.926 . . . . 0.0 113.341 -173.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.8 pp -51.76 145.6 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 125.251 1.421 . . . . 0.0 113.944 -169.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.9 ttp180 -59.37 143.98 48.03 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 124.776 1.23 . . . . 0.0 109.476 172.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.4 m -140.18 153.55 22.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 C-N-CA 125.607 1.563 . . . . 0.0 106.789 169.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.9 m -141.46 128.24 20.43 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 -176.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -121.4 119.24 31.54 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -169.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 19.8 m-90 -94.73 157.43 15.95 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 169.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.61 -48.3 82.65 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 108.661 -1.776 . . . . 0.0 108.661 169.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.7 t70 . . . . . 0 C--O 1.247 0.961 0 C-N-CA 126.947 2.099 . . . . 0.0 107.73 169.721 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.343 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.5 m -60.24 155.19 18.13 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.264 1.026 . . . . 0.0 111.426 178.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 179.14 -179.24 48.92 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 179.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -141.31 31.06 1.73 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.524 1.129 . . . . 0.0 110.937 -178.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.403 ' HA ' HG22 ' A' ' 29' ' ' ILE . 53.3 t -58.83 124.38 12.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 172.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 30.1 ptt-85 -155.43 -179.71 8.35 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 126.804 2.041 . . . . 0.0 106.599 -178.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.9 m -129.6 152.63 48.91 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 175.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.455 HG12 ' H ' ' A' ' 32' ' ' THR . 1.9 pt -117.07 167.13 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.765 1.226 . . . . 0.0 108.446 -171.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -144.52 36.08 1.19 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.775 0.83 . . . . 0.0 109.522 177.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.4 m -69.17 150.58 10.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 O-C-N 121.346 -0.846 . . . . 0.0 109.493 -178.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -81.97 42.27 2.83 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.548 1.071 . . . . 0.0 111.774 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 57.45 35.01 70.17 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 124.117 0.865 . . . . 0.0 111.691 -177.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.74 125.17 87.09 Favored Pre-proline 0 N--CA 1.45 -0.466 0 C-N-CA 124.615 1.166 . . . . 0.0 108.642 -174.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -65.39 -18.08 59.33 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 121.699 1.6 . . . . 0.0 111.475 175.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -77.75 -11.36 59.87 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.096 0.958 . . . . 0.0 111.085 178.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -125.58 -47.43 1.7 Allowed 'General case' 0 CA--C 1.519 -0.25 0 C-N-CA 123.281 0.632 . . . . 0.0 109.725 -169.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.4 pp -57.0 -27.9 61.98 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 118.77 0.714 . . . . 0.0 111.663 177.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -68.6 -13.88 62.64 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 118.703 -0.665 . . . . 0.0 112.736 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -111.43 -42.59 3.85 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.22 0.918 . . . . 0.0 109.074 173.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -62.96 -41.61 99.57 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.339 0.656 . . . . 0.0 111.518 -177.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.9 tptp -67.97 -31.77 71.73 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.186 0.903 . . . . 0.0 111.014 178.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -66.31 -46.17 77.83 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 172.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -60.77 -38.3 84.79 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.462 -0.774 . . . . 0.0 111.18 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.4 -15.78 40.04 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.483 1.113 . . . . 0.0 113.347 176.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -109.04 -27.17 9.79 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.886 1.274 . . . . 0.0 109.976 176.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -75.08 -35.94 61.77 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.932 0.893 . . . . 0.0 110.414 -179.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -140.03 169.91 16.84 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.329 1.452 . . . . 0.0 109.634 -177.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -76.75 15.47 0.64 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.901 1.28 . . . . 0.0 112.627 -174.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.403 HG22 ' HA ' ' A' ' 5' ' ' VAL . 1.4 pp -70.28 158.48 6.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 O-C-N 120.666 -1.271 . . . . 0.0 110.286 -174.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 41.8 ttm105 -98.93 147.29 25.13 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 29.9 m -136.67 154.58 32.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 170.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.455 ' H ' HG12 ' A' ' 8' ' ' ILE . 24.7 m -153.15 144.48 23.2 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 169.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -130.71 112.01 12.7 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -169.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 13.2 m-90 -93.84 150.7 20.16 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 122.887 0.475 . . . . 0.0 110.151 179.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -82.71 43.77 3.13 Favored Glycine 0 CA--C 1.532 1.154 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 169.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.1 t70 . . . . . 0 C--O 1.247 0.944 0 C-N-CA 125.075 1.35 . . . . 0.0 111.246 -173.924 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.303 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.3 m -60.27 153.56 22.14 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.295 1.038 . . . . 0.0 111.275 178.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 177.1 -178.33 48.22 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -151.67 164.46 36.87 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.041 1.337 . . . . 0.0 108.947 176.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -138.64 131.37 38.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 176.067 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -160.33 158.93 30.56 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 125.998 1.719 . . . . 0.0 107.552 172.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.4 m -99.23 152.47 19.87 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 169.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.475 HG12 ' H ' ' A' ' 32' ' ' THR . 8.0 pt -113.38 173.81 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 124.365 1.066 . . . . 0.0 109.066 -176.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.92 72.31 1.17 Allowed 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 172.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.409 HG22 HD12 ' A' ' 8' ' ' ILE . 13.5 m -124.06 157.8 30.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 177.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -167.87 136.3 4.04 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 108.979 -1.649 . . . . 0.0 108.979 171.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 56.22 23.08 39.16 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 124.247 0.927 . . . . 0.0 114.19 179.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.0 p -68.58 150.23 97.73 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 119.072 1.436 . . . . 0.0 108.886 176.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.4 -25.99 29.74 Favored 'Trans proline' 0 CA--C 1.533 0.463 0 C-N-CA 121.965 1.777 . . . . 0.0 112.041 -172.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -159.52 -12.91 0.06 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.279 1.032 . . . . 0.0 112.019 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -66.21 -36.74 83.84 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 120.591 -1.318 . . . . 0.0 110.557 -173.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.6 pp -65.38 -21.67 66.71 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-O 118.424 -0.798 . . . . 0.0 112.16 172.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -77.85 -45.65 23.7 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 119.861 1.209 . . . . 0.0 108.935 175.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -58.44 -46.73 85.95 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.251 0.478 . . . . 0.0 110.316 173.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.0 mt -70.34 -34.48 72.71 Favored 'General case' 0 C--O 1.226 -0.154 0 CA-C-O 118.41 -0.805 . . . . 0.0 110.616 -178.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -60.19 -42.36 94.91 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 120.335 1.425 . . . . 0.0 110.799 169.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -61.52 -40.13 93.53 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 119.316 0.962 . . . . 0.0 110.174 175.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -62.23 -31.9 72.5 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.498 -0.751 . . . . 0.0 111.288 173.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.42 -28.72 67.33 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 120.162 1.346 . . . . 0.0 112.138 173.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -78.86 -33.1 46.11 Favored 'General case' 0 N--CA 1.463 0.19 0 O-C-N 121.82 -0.55 . . . . 0.0 109.998 172.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -90.5 -23.71 20.86 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -169.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -142.09 172.67 12.37 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.827 1.651 . . . . 0.0 109.931 -176.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -81.97 2.04 32.63 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.838 1.255 . . . . 0.0 112.982 -173.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.5 pt -53.18 151.05 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 125.635 1.574 . . . . 0.0 113.881 -169.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 34.2 ttp180 -94.34 75.39 3.92 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.426 1.49 . . . . 0.0 108.989 -177.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.5 m -62.93 139.66 20.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 171.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.475 ' H ' HG12 ' A' ' 8' ' ' ILE . 21.0 m -144.76 125.01 13.73 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 104.257 -2.497 . . . . 0.0 104.257 177.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -117.7 109.69 16.93 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -169.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 11.8 m-90 -72.24 165.2 24.9 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.993 0.917 . . . . 0.0 109.997 171.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -68.84 -45.4 64.57 Favored Glycine 0 CA--C 1.531 1.054 0 N-CA-C 108.328 -1.909 . . . . 0.0 108.328 169.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.3 t70 . . . . . 0 C--O 1.246 0.876 0 C-N-CA 127.111 2.165 . . . . 0.0 107.756 169.81 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.287 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.1 m -65.15 -21.93 66.85 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.285 1.034 . . . . 0.0 113.275 -176.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -178.73 -173.19 43.85 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 125.021 1.296 . . . . 0.0 109.995 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -145.21 153.03 40.9 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.072 1.349 . . . . 0.0 108.475 176.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.3 t -146.01 140.78 21.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 174.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 23.5 ptt-85 -152.25 165.66 34.18 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 126.978 2.111 . . . . 0.0 105.959 168.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.1 m -136.17 153.95 51.11 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -173.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.408 HG12 ' H ' ' A' ' 32' ' ' THR . 1.9 pt -127.33 169.15 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 125.002 1.321 . . . . 0.0 108.887 -169.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.07 37.14 0.94 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.514 0.726 . . . . 0.0 110.332 176.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.0 m -72.68 152.58 7.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 O-C-N 121.116 -0.99 . . . . 0.0 109.528 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -81.93 40.56 2.66 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.624 1.107 . . . . 0.0 111.727 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 53.76 34.4 50.7 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.32 0.962 . . . . 0.0 111.839 -171.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.3 m -61.89 124.42 81.62 Favored Pre-proline 0 N--CA 1.445 -0.715 0 C-N-CA 125.269 1.428 . . . . 0.0 108.68 -169.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -52.82 -27.49 34.8 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.801 2.334 . . . . 0.0 112.91 172.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -70.39 -26.44 63.7 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.63 0.772 . . . . 0.0 111.073 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -102.41 -37.06 8.19 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 124.363 1.065 . . . . 0.0 109.232 -171.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 65.5 mt -53.38 -19.2 3.19 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.257 1.023 . . . . 0.0 112.277 169.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -58.96 -28.54 66.4 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 118.945 0.793 . . . . 0.0 112.589 172.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -131.77 -37.08 1.19 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.008 0.822 . . . . 0.0 111.639 -173.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -61.57 -40.42 94.67 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 119.021 0.828 . . . . 0.0 111.374 -176.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.6 tptt -66.88 -32.58 73.94 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 119.303 -0.38 . . . . 0.0 111.005 177.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -69.0 -46.38 68.17 Favored 'General case' 0 C--O 1.224 -0.262 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 175.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -58.2 -40.17 80.87 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 119.168 0.895 . . . . 0.0 111.005 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.93 -15.66 33.61 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.138 0.975 . . . . 0.0 113.444 177.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -113.76 -29.83 6.97 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.993 1.317 . . . . 0.0 110.062 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -73.19 -34.55 66.04 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 123.873 0.869 . . . . 0.0 110.411 178.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -133.86 168.41 18.81 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.351 1.06 . . . . 0.0 110.654 -173.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -69.09 -9.52 53.07 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.023 1.729 . . . . 0.0 113.533 -177.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.6 pp -60.49 157.0 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.81 1.244 . . . . 0.0 111.952 -173.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 12.0 ptp85 -97.51 159.85 14.68 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.652 0.739 . . . . 0.0 109.648 174.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.3 m -139.22 155.01 25.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 171.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.408 ' H ' HG12 ' A' ' 8' ' ' ILE . 38.9 m -149.43 144.21 26.21 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 170.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -129.96 107.23 9.2 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -169.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 13.3 m-90 -84.21 151.29 24.92 Favored 'General case' 0 N--CA 1.461 0.118 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 -179.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -83.03 45.57 3.47 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 169.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.9 t70 . . . . . 0 C--O 1.249 1.066 0 C-N-CA 125.089 1.356 . . . . 0.0 111.306 -174.177 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.397 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.2 p -63.89 -23.56 67.4 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.297 1.039 . . . . 0.0 111.939 173.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -152.51 -175.29 23.91 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 126.473 1.987 . . . . 0.0 108.499 169.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.91 140.65 23.6 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 125.475 1.51 . . . . 0.0 107.332 -177.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.2 t -136.04 136.11 49.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -176.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -151.9 145.55 24.98 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 104.539 -2.393 . . . . 0.0 104.539 173.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.7 m -102.92 145.41 29.87 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 175.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.489 HG12 ' H ' ' A' ' 32' ' ' THR . 8.4 pt -101.87 174.83 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.226 1.01 . . . . 0.0 109.254 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.83 46.86 1.26 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.629 0.771 . . . . 0.0 109.004 170.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.2 p -80.64 145.98 8.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 O-C-N 121.277 -0.889 . . . . 0.0 109.073 -175.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -86.27 35.67 3.28 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.692 1.139 . . . . 0.0 112.395 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 56.07 41.96 86.41 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.275 0.941 . . . . 0.0 113.15 173.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.5 m -61.55 137.45 94.82 Favored Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 177.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -51.42 -27.23 23.67 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.37 2.713 . . . . 0.0 115.466 -177.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -93.89 -29.68 15.17 Favored 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 123.264 0.626 . . . . 0.0 110.858 -178.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -71.88 -33.45 68.38 Favored 'General case' 0 N--CA 1.462 0.169 0 O-C-N 121.256 -0.902 . . . . 0.0 108.829 175.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 76.6 mt -62.44 -5.09 2.23 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.713 1.205 . . . . 0.0 112.445 169.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.4 mttp -109.24 -56.08 2.33 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 119.287 0.949 . . . . 0.0 108.937 170.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -62.08 -49.87 74.21 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.162 0.585 . . . . 0.0 111.098 -174.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 25.8 mt -76.16 -29.31 57.69 Favored 'General case' 0 C--O 1.224 -0.244 0 O-C-N 122.008 -0.432 . . . . 0.0 109.969 -177.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.3 tptt -63.3 -39.47 94.65 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 119.125 0.875 . . . . 0.0 110.503 171.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -64.68 -44.1 91.4 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 173.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -56.7 -36.9 70.18 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.666 0.786 . . . . 0.0 111.115 175.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.28 -14.03 61.35 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.562 1.145 . . . . 0.0 113.385 177.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.1 mptp? -104.72 -33.7 8.37 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.219 1.008 . . . . 0.0 109.867 172.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 32.6 tttm -66.97 -37.57 84.5 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 123.396 0.679 . . . . 0.0 110.519 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -136.05 163.46 30.25 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 126.468 1.907 . . . . 0.0 108.646 -175.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -82.14 6.43 16.49 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.006 0.923 . . . . 0.0 112.771 -174.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.0 pp -59.73 156.04 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 124.528 1.131 . . . . 0.0 112.754 -172.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 33.1 ttp180 -98.89 81.28 2.6 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.806 1.243 . . . . 0.0 109.975 -169.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.4 m -63.21 139.55 21.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.324 169.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.489 ' H ' HG12 ' A' ' 8' ' ' ILE . 19.1 m -146.04 122.06 10.73 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 104.116 -2.55 . . . . 0.0 104.116 173.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -112.53 111.95 23.14 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -169.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 10.3 m-90 -83.07 147.03 28.37 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 174.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.98 -41.23 61.69 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 169.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.6 t70 . . . . . 0 C--O 1.246 0.889 0 C-N-CA 126.885 2.074 . . . . 0.0 107.867 170.004 . . . . . . . . 0 0 . 1 stop_ save_